{
    "paper_id": "586f6726f95775c85824fcb5049c9dbe79958e53",
    "metadata": {
        "title": "",
        "authors": []
    },
    "abstract": [
        {
            "text": "publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. SUBJECT INDEX Boldface numerals indicate volume number A Aarskog-Scott syndrome, 63:149 Ab2s, 42:149-157 ABC transporters, 6555, 56-57, 59 Abelson disease anti-A-MuLv antibodies in study of c-ablencoded protein, 37:77-78 c-ah1 expression pattern. normal and leukemic cells, 37:78-79 complexity genetics of susceptibility, 37:88-89 helper virus role in neoplastic transformation, 37:87-88 proliferating cells as transformation targets in oitro, 37:88 transformation of cells from genetically resistant mice, 37:89-90 use of site-directed antibodies, 37:90, 91 variations in disease process induced by mutants, 37:W complexity of transformation in oitro associated cellular changes, 37:93-94 cultured B cell lines in study of, early effects of a-ubl expression, 3791 preneoplastic growth properties of infected pre-B cells, 37:Sl-92 tumorigenicity progression, 37:92-93 3794-95 history of, 37:75-76 neoplastic transformation NIH 3T3 fibroblasts, 37:83-84 pre-B cells, 37:79-80 rapid induction of thymomas, 37:83 target cells in monocyte-macrophage techniques for, mature B and plasma transformed cell lines with differentiation lineage, 37:82-83 cells, 37:80-81 potential, 37:82 non-neoplastic changes induced, 37:84-85 agar colony formation from fetal liver lethality, 37:86-87 resistance of GM-CFC to leukemia-erythroblasts, 37:85 associated inhibition activity, 37:85 overview, 37:74-75 properties of a-ubl and tyrosine kinase transforming protein, 37:76 Abelsoii-murine leukemia virus fetal liver cell infection, 39:40-41 helper T cell infection, 39:41 plarmacytoniagenesis, 64:230 transfected cells, rearrangement by V(D)J joining of antigen receptor genes, IL-3-regulated growth and, 39:40-41 IL-2-regulated growth and, 39:41 56~48-49 transformed mast cell lines, lymphokine production by, 53:4-6 Abelson virus B cell formation and, 41:195, 209, 217, hybrid resistance and, 41:397 ubl, tumor antigens derived from, ABL-MYC retrovirus, plasmacytomagenesis, 219, 225 57:296-297 64~231-238 1 2 SUBJECT INDEX Accessibility model, 61:84, 86 Accessory cells germline transcription, 54:241 B cell formation and, 41:220 hybrid resistance and, 41:350, 373 immune reconstitution and, 40:416-417 isotype-specific responses and, 40:219 T cell activation and, 41:7-14, 21 T cell subsets and, 41:63-66, 69 Accessory genes, HIV-1 disease, 63:85-86, Accessory molecules 94, 105 CD4 or CDB, role in immune response, CD40-dependent B cell activation, cytotoxic T cells and, 41:150-152, 158, T cell receptor and, 45:108-110 54:124-125 63:56-57 168-170 Acetylcholine receptor, see also Experimental autoimmune myasthenia gravis; Myasthenia gravis antigenic structure of, 42:240-248 discovery of, 42:233-236 Ig heavy-chain variable region genes and, 49:31, 46, 50-51 main immunogenic region, Ahs to, 42:240-241, 246, 262 muscle, 42:239 neuroinuscular transmission and, 42:236-237 neuronal, 42:239 polypeptide chain, 42:238 skeletal muscle, 42:238 structure of, 42:237-240 suppressor T cells and, 42:269 T cell epitopes and, 42:241-245 autoimmune thyroiditis and, 46:268 human erythrocyte, autoantibody effects on, 42:260-263",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "humoral immune response and, 45:78 hybrid resistance and, IIIV infection, 54:37-38 Kaposi's sarcoma. 54:38-39 membrane cofactor protein, 61:219-220 NK cells and, 47:285, 302, 303 synthetic T and B cell sites and, 45219, virus-induced immunosuppression and, 264 45:335, 336, 351-357, 360, 363, 365 animal infection with chimpanzee, infection of, thyroiditis and, 46:263, 49:363, 368-374 317-319 antigens, 46972, 273 cellular immune responses, 46:287, 289, experimental models, 46:276-278, 281, genetic control, 46:283, 285-287 humoral responses, 46:298-307, 309 prevention, 46:308, 310. 312, 314, 315 290. 29.3-295 282 autoreuctive T cells and, 45:427 I3 cell formation and, 41:182, 183 6 cell precursors, 41:189. 191, 192, 194, bone marrow cultures. 41:213 Ig genes, 41:203. 204 l y~n~~l~o h e m o~~o~e t i e tissue organization,",
            "cite_spans": [
                {
                    "start": 15,
                    "end": 28,
                    "text": "response and,",
                    "ref_id": null
                },
                {
                    "start": 29,
                    "end": 57,
                    "text": "45:78 hybrid resistance and,",
                    "ref_id": null
                },
                {
                    "start": 151,
                    "end": 178,
                    "text": "cells and, 47:285, 302, 303",
                    "ref_id": null
                },
                {
                    "start": 189,
                    "end": 201,
                    "text": "T and B cell",
                    "ref_id": null
                },
                {
                    "start": 202,
                    "end": 296,
                    "text": "sites and, 45219, virus-induced immunosuppression and, 264 45:335, 336, 351-357, 360, 363, 365",
                    "ref_id": null
                },
                {
                    "start": 345,
                    "end": 617,
                    "text": "thyroiditis and, 46:263, 49:363, 368-374 317-319 antigens, 46972, 273 cellular immune responses, 46:287, 289, experimental models, 46:276-278, 281, genetic control, 46:283, 285-287 humoral responses, 46:298-307, 309 prevention, 46:308, 310. 312, 314, 315 290. 29.3-295 282",
                    "ref_id": null
                },
                {
                    "start": 659,
                    "end": 727,
                    "text": "formation and, 41:182, 183 6 cell precursors, 41:189. 191, 192, 194,",
                    "ref_id": null
                },
                {
                    "start": 757,
                    "end": 766,
                    "text": "Ig genes,",
                    "ref_id": null
                },
                {
                    "start": 767,
                    "end": 778,
                    "text": "41:203. 204",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "cold-reactive antilymphocyte, IgG levels in, combining site, structure variability, complement receptor 1 and, 46:193, 196, complement Iksynthesis and, 47:l binding Factors, 47:12. 14, 15, 17, 19, [21] [22] [23] 25, 1iyl)rid rrsistance and",
            "cite_spans": [
                {
                    "start": 104,
                    "end": 134,
                    "text": "1 and, 46:193, 196, complement",
                    "ref_id": null
                },
                {
                    "start": 135,
                    "end": 151,
                    "text": "Iksynthesis and,",
                    "ref_id": null
                },
                {
                    "start": 152,
                    "end": 173,
                    "text": "47:l binding Factors,",
                    "ref_id": null
                },
                {
                    "start": 174,
                    "end": 184,
                    "text": "47:12. 14,",
                    "ref_id": null
                },
                {
                    "start": 185,
                    "end": 188,
                    "text": "15,",
                    "ref_id": null
                },
                {
                    "start": 189,
                    "end": 192,
                    "text": "17,",
                    "ref_id": null
                },
                {
                    "start": 193,
                    "end": 196,
                    "text": "19,",
                    "ref_id": null
                },
                {
                    "start": 197,
                    "end": 201,
                    "text": "[21]",
                    "ref_id": null
                },
                {
                    "start": 202,
                    "end": 206,
                    "text": "[22]",
                    "ref_id": null
                },
                {
                    "start": 207,
                    "end": 211,
                    "text": "[23]",
                    "ref_id": null
                },
                {
                    "start": 212,
                    "end": 215,
                    "text": "25,",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Antibodies (continued)"
        },
        {
            "text": "Ig gene superfilmily and, 44:4. 9, 38, 44 Ig heaby-chin variahle region genes mid, 49:l-3. 61 , segments, 49:34 organization, 49:4, 6 V, , families, 49:9, 14. 16 V, , gene expression, 44:163 immunocompetent cells, 44:173, 177, receptor, 44:182 striicture. 44:157, 158 systemic effects, 190, 192; 66 MG and, 42:262 monoclonal, see Monoclonal antibodies inurine lupus models and, 46:99 and, 41301, 302, 307, 309 Ig germline, 46:65, 66, 72, 74, 76, 77 lupus strains, 4664 T crll antigen receptor, 46:79, 88, 90, 98 neutralizing, 4 8 9 -9 6 HIV infection and, 47:407, 408, 410, 413 N K cells and, 47:189 adaptive imniunity. 47:292-294 alteration. 47300 antimicrobial activity, 47: 286-288 cell-mediated cytotoxicity, 47:190, 196 congenital defects, 47:224 cytotoxicity, 47:249-251, 254, 257-259, differentiation. 47:231, 233 effector mechanisms, 47:235, 237, 238, 240, 241, 243-248 hematopoiesis, 47:274, 275, 277, 281 identification, 47:196, 198 malignant expansion, 47:227-229 surface phenotype, 47:201, 202, 204- T and B cell sites and, 45:196, 49:113, 45:233, 236 bacterial antigens, 45:231 candidate synthetic peptidevaccines, 45:253, [255] [256] [257] [258] [259] 45:215, 216 immunological considerations, 45:197 parasitic antigens, 45:228, 229 peptides, 45:251 viral antigens, 225, 227 Tac, 42:167, 169, 171, 172 T cell activation and, 41:6, 7, 9, 11, 13 T cell development and, 44:207, 255 ontogeny , Z and MECL1, 66 regulation of antigen processing, [30] [31] 64:3, [5] [6] [7] [8] 5222 unfolding and proteolysis, assembly of class I molecules, 52:42-76 control of class I export to cell surface, cytokines and B cell growth, 52:199 polyclonal activators, other stimulatory cytokines, transforming growth-factor,l3, 52:199 52:198-199 Antigen Abs and, 4465, 44234, 85 chimeric antibodies, 4479, 80,  87 receptors and, 38:17 Atomic solvation parameter, 43:lOl ATP cytolysis and, 41:277 as effector molecule in CTL cytotoxicity, 60:301-302 effect 011 target cell killing, 60:310 in IL-3-receptor interactions, 3939 TAP peptide binding and, [87] [88] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] 41:16, 18 ATPase, antigen-presenting cells and, antinuclear, see Antinuclear antibodies antithymocyte, CD5 B cell production, aPL antibodies and, 49:212, 226, 257-258 pathogenic potential, 49:252-253, 257 specificity, 49:238, 248-249 autoimmime thyroiditis and, 46:298, 317 B cell formation and, 41:227, 228, 231 CD5 B cell and, 47:150, 155, 157, physiology, antibodies and, 49:193, 198, 258 clinical aspects, 49:208-209, 216 immunology, 49:225, 235-236, 240 in oiuo IL-2 production in autoimmune disease, 50~178-183 immunological memory and, 42:64 murine, CD5 B, cell effect on, role of IL-2-induced cytokines in, 50:210-213 autoreactive T cells and, 45418, 425, 426 N K cells and, 47:300, 301 IgG, Autologous mixed lymphocyte responses, homing and, 44:354, 366 maps of 46:l N K cells and, 47:216, 224, 235. 263, 289 regulators of complement activation and, SCID and, 49:382 45:388. 409 spontaneous autoimmune thyroiditis and, superantigens, 54:113-115; 65:14, 208-210 47:462 Clostridium and Pseudamonas toxins, M y c o p h r u~ czrthritihs mitogen, 54:113 streptococcal M proteins, 54:114-115 surface antigens of human leukocytes and, 49:81, 111, 115 T cell receptor and, 45 SCID and, 49:387, 391 B cell formation and, 41:186 lymphocyte homing and, 44:316, 320 Basophils, 48:176, 177; 61:15, 20, [360] [361] 49:165, 170 binding and, 39:72-73 Ia expression in membrane and, la structure and, [76] [77] [78] 39:67, 69, 71 NRGG as antigen, [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [55] [56] 47:45, 46, 47, 87 antigen presentation, [72] [73] [74] [75] [76] [92] [93] [94] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [59] [60] [61] [62] [63] [64] 103, [158] [159] [160] [161] 49:162, [164] [165] [166] [167] 165 CD40 expression, 61:2, [11] [12] [32] [33] [34] [35] [36] [37] monoclonal antibody studies and, 41:297 censoring, [308] [309] [311] [312] chicken, repertoire precursors and, 41:188, 189 cell size changes, 41:202, 203 cell surface markers, 41:189 distinctions, 41:198, I99 functional assays, 41:196, 187 tumor cell lines, 41:195, 196 bone marrow cultiires and, 41:208, 209 CBNN 44:37, 42 49:2, 3, 21, 33, 53, 56 regulation, [49] [50] [51] [52] [53] [54] [55] [56] 493, 11 Vk, gene expression, 41, 43, [49] [50] [51] [52] 44:189, 190, 194, 195 bio1ogic.d effects, 44:164 immunocompetent cells, 44:172, 173, 177, 178 receptor, 44:182, 183 genes and, 38:50, 73, 153, 156, 188, 189 antigen binding, 38:115 expression, 38:53-55, 57, 58 47:188, 199, 225 47:201, 209, 40194, [195] [196] [197] phenotype of, 208 nonclustered antigens, 52:164-174 activated T cells inducing resting B cells to proliferate and differentiate, 41:198, 199 functional usays, 41: 199-202 Lv-5 family of glycoproteins, 41: 189-193 markers, 41:193-195 phosphatidylinositol-linked lymphocyte technical considerations, 41:196, 197 tiiinor cell lines, 41:195, 196 antigens, 41:197, 198 prenatal B cell genesis, 63:207-208, 212 pre-pre B cells, 43:237 pro-B cells. 59:286, 298; 63:23, 25 long-term proliferating development and, 44209, 243, 252 -T cell interactions, 39:57-58, 83-85, epitopic specificity and, 39:87- B cell precursors, 41:193, 194, 197 genetically determined defects, 41231 inducible cell line, 41:222 soluble mediators, 41:234, 235 T cell subsets and, 41:66, 76, 77, 95 major, expression, plasmacyte, 52:174 B cell surface antigens, other antigens of plasmacytes, 52:174 PC-1, a plasma cell threonine-specific protein kinase, 52:174 non- Ig clustered, 52:144 CDlO or formation and, 41:183, 184, 235-238 B cell precursors, 41:191, 193-199, cytokines and, 46:115, 117 IIIV infection and, 47:395-397 human, (D44 expression, 54:293-294 hybrid resistance and, 41:333, 334 cytokines and, 46:127. 137 Bruton's agaiiiinaglobulineinia, see X-linked agarnniaglobulinemia Bniton's disease, see X-linked a~aiiiinaglobrilinemia Bruton's tyrosine kinase. see Btk BSAP, [169] [170] [171] [172] [173] [174] [175] [176] 317 Btk gene, 184, 196 B cell development, 195 components and, 38:204, 206, convertase, 38:205, 206, 213, C4b-binding protein, complement components and, 38:205, 211, 221, 222, 234-236 C4-binthg protein, 61:203, 204, 235-236 complement receptor 1 and, 46:184, 185, complement receptor 2 and, 46:202 function, 234 189, 195, 197 C5, complement components and, 38:204, convertases, 38:205, 206, 213, 222, 236 C521, 61:255; 62:261, 269, 275, 286 attracting myeloid cells, 58:380 as neutrophil receptor, 39:96-97 C6. coinpleinent components and, 38:204, C7, complement components and, 38:204, C8, complement components and, 38:205 C9, complement components and, 38:205, cA2 G and, 39:125 receptors and, 39:126 NK cells and, 47:291 cytotoxicity, 253, 254, 261 effecter mechanisms. 47:241, 244, 245 lymphokines, 47:26S, 41:317, 318 role in apoptosis, 5061 SCID and, formation and, 41:197 CD8 inolecules and, 44271 CD23 antigen and, [163] [164] [165] 176 Carbohydrates ( resistance and, 41:358, 363, 369 aPL antibodies and, 49:193, 258-259 affinity purification, 49:229-231 antibody subsets, 49:232",
            "cite_spans": [
                {
                    "start": 94,
                    "end": 95,
                    "text": ",",
                    "ref_id": null
                },
                {
                    "start": 96,
                    "end": 105,
                    "text": "segments,",
                    "ref_id": null
                },
                {
                    "start": 106,
                    "end": 125,
                    "text": "49:34 organization,",
                    "ref_id": null
                },
                {
                    "start": 126,
                    "end": 131,
                    "text": "49:4,",
                    "ref_id": null
                },
                {
                    "start": 132,
                    "end": 136,
                    "text": "6 V,",
                    "ref_id": null
                },
                {
                    "start": 137,
                    "end": 138,
                    "text": ",",
                    "ref_id": null
                },
                {
                    "start": 139,
                    "end": 148,
                    "text": "families,",
                    "ref_id": null
                },
                {
                    "start": 149,
                    "end": 154,
                    "text": "49:9,",
                    "ref_id": null
                },
                {
                    "start": 155,
                    "end": 164,
                    "text": "14. 16 V,",
                    "ref_id": null
                },
                {
                    "start": 165,
                    "end": 166,
                    "text": ",",
                    "ref_id": null
                },
                {
                    "start": 167,
                    "end": 183,
                    "text": "gene expression,",
                    "ref_id": null
                },
                {
                    "start": 184,
                    "end": 213,
                    "text": "44:163 immunocompetent cells,",
                    "ref_id": null
                },
                {
                    "start": 214,
                    "end": 221,
                    "text": "44:173,",
                    "ref_id": null
                },
                {
                    "start": 222,
                    "end": 226,
                    "text": "177,",
                    "ref_id": null
                },
                {
                    "start": 227,
                    "end": 236,
                    "text": "receptor,",
                    "ref_id": null
                },
                {
                    "start": 237,
                    "end": 263,
                    "text": "44:182 striicture. 44:157,",
                    "ref_id": null
                },
                {
                    "start": 264,
                    "end": 285,
                    "text": "158 systemic effects,",
                    "ref_id": null
                },
                {
                    "start": 286,
                    "end": 290,
                    "text": "190,",
                    "ref_id": null
                },
                {
                    "start": 291,
                    "end": 295,
                    "text": "192;",
                    "ref_id": null
                },
                {
                    "start": 296,
                    "end": 298,
                    "text": "66",
                    "ref_id": null
                },
                {
                    "start": 299,
                    "end": 306,
                    "text": "MG and,",
                    "ref_id": null
                },
                {
                    "start": 307,
                    "end": 313,
                    "text": "42:262",
                    "ref_id": null
                },
                {
                    "start": 366,
                    "end": 536,
                    "text": "models and, 46:99 and, 41301, 302, 307, 309 Ig germline, 46:65, 66, 72, 74, 76, 77 lupus strains, 4664 T crll antigen receptor, 46:79, 88, 90, 98 neutralizing, 4 8 9 -9 6",
                    "ref_id": null
                },
                {
                    "start": 541,
                    "end": 599,
                    "text": "infection and, 47:407, 408, 410, 413 N K cells and, 47:189",
                    "ref_id": null
                },
                {
                    "start": 677,
                    "end": 1011,
                    "text": "286-288 cell-mediated cytotoxicity, 47:190, 196 congenital defects, 47:224 cytotoxicity, 47:249-251, 254, 257-259, differentiation. 47:231, 233 effector mechanisms, 47:235, 237, 238, 240, 241, 243-248 hematopoiesis, 47:274, 275, 277, 281 identification, 47:196, 198 malignant expansion, 47:227-229 surface phenotype, 47:201, 202, 204-",
                    "ref_id": null
                },
                {
                    "start": 1012,
                    "end": 1035,
                    "text": "T and B cell sites and,",
                    "ref_id": null
                },
                {
                    "start": 1036,
                    "end": 1043,
                    "text": "45:196,",
                    "ref_id": null
                },
                {
                    "start": 1044,
                    "end": 1051,
                    "text": "49:113,",
                    "ref_id": null
                },
                {
                    "start": 1052,
                    "end": 1059,
                    "text": "45:233,",
                    "ref_id": null
                },
                {
                    "start": 1060,
                    "end": 1083,
                    "text": "236 bacterial antigens,",
                    "ref_id": null
                },
                {
                    "start": 1084,
                    "end": 1127,
                    "text": "45:231 candidate synthetic peptidevaccines,",
                    "ref_id": null
                },
                {
                    "start": 1128,
                    "end": 1135,
                    "text": "45:253,",
                    "ref_id": null
                },
                {
                    "start": 1136,
                    "end": 1141,
                    "text": "[255]",
                    "ref_id": null
                },
                {
                    "start": 1142,
                    "end": 1147,
                    "text": "[256]",
                    "ref_id": null
                },
                {
                    "start": 1148,
                    "end": 1153,
                    "text": "[257]",
                    "ref_id": null
                },
                {
                    "start": 1154,
                    "end": 1159,
                    "text": "[258]",
                    "ref_id": null
                },
                {
                    "start": 1160,
                    "end": 1165,
                    "text": "[259]",
                    "ref_id": null
                },
                {
                    "start": 1166,
                    "end": 1173,
                    "text": "45:215,",
                    "ref_id": null
                },
                {
                    "start": 1174,
                    "end": 1207,
                    "text": "216 immunological considerations,",
                    "ref_id": null
                },
                {
                    "start": 1208,
                    "end": 1234,
                    "text": "45:197 parasitic antigens,",
                    "ref_id": null
                },
                {
                    "start": 1235,
                    "end": 1242,
                    "text": "45:228,",
                    "ref_id": null
                },
                {
                    "start": 1243,
                    "end": 1256,
                    "text": "229 peptides,",
                    "ref_id": null
                },
                {
                    "start": 1257,
                    "end": 1279,
                    "text": "45:251 viral antigens,",
                    "ref_id": null
                },
                {
                    "start": 1280,
                    "end": 1284,
                    "text": "225,",
                    "ref_id": null
                },
                {
                    "start": 1285,
                    "end": 1293,
                    "text": "227 Tac,",
                    "ref_id": null
                },
                {
                    "start": 1294,
                    "end": 1301,
                    "text": "42:167,",
                    "ref_id": null
                },
                {
                    "start": 1302,
                    "end": 1306,
                    "text": "169,",
                    "ref_id": null
                },
                {
                    "start": 1307,
                    "end": 1311,
                    "text": "171,",
                    "ref_id": null
                },
                {
                    "start": 1312,
                    "end": 1338,
                    "text": "172 T cell activation and,",
                    "ref_id": null
                },
                {
                    "start": 1339,
                    "end": 1344,
                    "text": "41:6,",
                    "ref_id": null
                },
                {
                    "start": 1345,
                    "end": 1347,
                    "text": "7,",
                    "ref_id": null
                },
                {
                    "start": 1348,
                    "end": 1350,
                    "text": "9,",
                    "ref_id": null
                },
                {
                    "start": 1351,
                    "end": 1354,
                    "text": "11,",
                    "ref_id": null
                },
                {
                    "start": 1355,
                    "end": 1381,
                    "text": "13 T cell development and,",
                    "ref_id": null
                },
                {
                    "start": 1382,
                    "end": 1389,
                    "text": "44:207,",
                    "ref_id": null
                },
                {
                    "start": 1390,
                    "end": 1393,
                    "text": "255",
                    "ref_id": null
                },
                {
                    "start": 1405,
                    "end": 1417,
                    "text": "Z and MECL1,",
                    "ref_id": null
                },
                {
                    "start": 1418,
                    "end": 1454,
                    "text": "66 regulation of antigen processing,",
                    "ref_id": null
                },
                {
                    "start": 1455,
                    "end": 1459,
                    "text": "[30]",
                    "ref_id": null
                },
                {
                    "start": 1460,
                    "end": 1464,
                    "text": "[31]",
                    "ref_id": null
                },
                {
                    "start": 1465,
                    "end": 1470,
                    "text": "64:3,",
                    "ref_id": null
                },
                {
                    "start": 1471,
                    "end": 1474,
                    "text": "[5]",
                    "ref_id": null
                },
                {
                    "start": 1475,
                    "end": 1478,
                    "text": "[6]",
                    "ref_id": null
                },
                {
                    "start": 1479,
                    "end": 1482,
                    "text": "[7]",
                    "ref_id": null
                },
                {
                    "start": 1483,
                    "end": 1486,
                    "text": "[8]",
                    "ref_id": null
                },
                {
                    "start": 1487,
                    "end": 1518,
                    "text": "5222 unfolding and proteolysis,",
                    "ref_id": null
                },
                {
                    "start": 1602,
                    "end": 1630,
                    "text": "cytokines and B cell growth,",
                    "ref_id": null
                },
                {
                    "start": 1631,
                    "end": 1660,
                    "text": "52:199 polyclonal activators,",
                    "ref_id": null
                },
                {
                    "start": 1721,
                    "end": 1738,
                    "text": "52:199 52:198-199",
                    "ref_id": null
                },
                {
                    "start": 1747,
                    "end": 1755,
                    "text": "Abs and,",
                    "ref_id": null
                },
                {
                    "start": 1756,
                    "end": 1761,
                    "text": "4465,",
                    "ref_id": null
                },
                {
                    "start": 1762,
                    "end": 1768,
                    "text": "44234,",
                    "ref_id": null
                },
                {
                    "start": 1769,
                    "end": 1792,
                    "text": "85 chimeric antibodies,",
                    "ref_id": null
                },
                {
                    "start": 1793,
                    "end": 1798,
                    "text": "4479,",
                    "ref_id": null
                },
                {
                    "start": 1799,
                    "end": 1802,
                    "text": "80,",
                    "ref_id": null
                },
                {
                    "start": 1803,
                    "end": 1803,
                    "text": "",
                    "ref_id": null
                },
                {
                    "start": 1804,
                    "end": 1806,
                    "text": "87",
                    "ref_id": null
                },
                {
                    "start": 1807,
                    "end": 1827,
                    "text": "receptors and, 38:17",
                    "ref_id": null
                },
                {
                    "start": 1867,
                    "end": 1888,
                    "text": "cytolysis and, 41:277",
                    "ref_id": null
                },
                {
                    "start": 2029,
                    "end": 2041,
                    "text": "binding and,",
                    "ref_id": null
                },
                {
                    "start": 2042,
                    "end": 2046,
                    "text": "[87]",
                    "ref_id": null
                },
                {
                    "start": 2047,
                    "end": 2051,
                    "text": "[88]",
                    "ref_id": null
                },
                {
                    "start": 2052,
                    "end": 2056,
                    "text": "[65]",
                    "ref_id": null
                },
                {
                    "start": 2057,
                    "end": 2061,
                    "text": "[66]",
                    "ref_id": null
                },
                {
                    "start": 2062,
                    "end": 2066,
                    "text": "[67]",
                    "ref_id": null
                },
                {
                    "start": 2067,
                    "end": 2071,
                    "text": "[68]",
                    "ref_id": null
                },
                {
                    "start": 2072,
                    "end": 2076,
                    "text": "[69]",
                    "ref_id": null
                },
                {
                    "start": 2077,
                    "end": 2081,
                    "text": "[70]",
                    "ref_id": null
                },
                {
                    "start": 2082,
                    "end": 2086,
                    "text": "[71]",
                    "ref_id": null
                },
                {
                    "start": 2087,
                    "end": 2091,
                    "text": "[72]",
                    "ref_id": null
                },
                {
                    "start": 2092,
                    "end": 2096,
                    "text": "[73]",
                    "ref_id": null
                },
                {
                    "start": 2097,
                    "end": 2101,
                    "text": "[74]",
                    "ref_id": null
                },
                {
                    "start": 2102,
                    "end": 2106,
                    "text": "[75]",
                    "ref_id": null
                },
                {
                    "start": 2107,
                    "end": 2111,
                    "text": "[76]",
                    "ref_id": null
                },
                {
                    "start": 2112,
                    "end": 2116,
                    "text": "[77]",
                    "ref_id": null
                },
                {
                    "start": 2117,
                    "end": 2123,
                    "text": "41:16,",
                    "ref_id": null
                },
                {
                    "start": 2124,
                    "end": 2126,
                    "text": "18",
                    "ref_id": null
                },
                {
                    "start": 2247,
                    "end": 2283,
                    "text": "antibodies and, 49:212, 226, 257-258",
                    "ref_id": null
                },
                {
                    "start": 2362,
                    "end": 2378,
                    "text": "thyroiditis and,",
                    "ref_id": null
                },
                {
                    "start": 2379,
                    "end": 2386,
                    "text": "46:298,",
                    "ref_id": null
                },
                {
                    "start": 2387,
                    "end": 2412,
                    "text": "317 B cell formation and,",
                    "ref_id": null
                },
                {
                    "start": 2413,
                    "end": 2420,
                    "text": "41:227,",
                    "ref_id": null
                },
                {
                    "start": 2421,
                    "end": 2425,
                    "text": "228,",
                    "ref_id": null
                },
                {
                    "start": 2426,
                    "end": 2445,
                    "text": "231 CD5 B cell and,",
                    "ref_id": null
                },
                {
                    "start": 2446,
                    "end": 2453,
                    "text": "47:150,",
                    "ref_id": null
                },
                {
                    "start": 2454,
                    "end": 2458,
                    "text": "155,",
                    "ref_id": null
                },
                {
                    "start": 2459,
                    "end": 2463,
                    "text": "157,",
                    "ref_id": null
                },
                {
                    "start": 2464,
                    "end": 2475,
                    "text": "physiology,",
                    "ref_id": null
                },
                {
                    "start": 2476,
                    "end": 2575,
                    "text": "antibodies and, 49:193, 198, 258 clinical aspects, 49:208-209, 216 immunology, 49:225, 235-236, 240",
                    "ref_id": null
                },
                {
                    "start": 2648,
                    "end": 2659,
                    "text": "memory and,",
                    "ref_id": null
                },
                {
                    "start": 2660,
                    "end": 2673,
                    "text": "42:64 murine,",
                    "ref_id": null
                },
                {
                    "start": 2674,
                    "end": 2680,
                    "text": "CD5 B,",
                    "ref_id": null
                },
                {
                    "start": 2681,
                    "end": 2696,
                    "text": "cell effect on,",
                    "ref_id": null
                },
                {
                    "start": 2764,
                    "end": 2768,
                    "text": "and,",
                    "ref_id": null
                },
                {
                    "start": 2769,
                    "end": 2775,
                    "text": "45418,",
                    "ref_id": null
                },
                {
                    "start": 2776,
                    "end": 2780,
                    "text": "425,",
                    "ref_id": null
                },
                {
                    "start": 2781,
                    "end": 2799,
                    "text": "426 N K cells and,",
                    "ref_id": null
                },
                {
                    "start": 2800,
                    "end": 2807,
                    "text": "47:300,",
                    "ref_id": null
                },
                {
                    "start": 2808,
                    "end": 2816,
                    "text": "301 IgG,",
                    "ref_id": null
                },
                {
                    "start": 2856,
                    "end": 2879,
                    "text": "homing and, 44:354, 366",
                    "ref_id": null
                },
                {
                    "start": 2888,
                    "end": 2907,
                    "text": "46:l N K cells and,",
                    "ref_id": null
                },
                {
                    "start": 2908,
                    "end": 2915,
                    "text": "47:216,",
                    "ref_id": null
                },
                {
                    "start": 2916,
                    "end": 2920,
                    "text": "224,",
                    "ref_id": null
                },
                {
                    "start": 2921,
                    "end": 2930,
                    "text": "235. 263,",
                    "ref_id": null
                },
                {
                    "start": 2931,
                    "end": 2934,
                    "text": "289",
                    "ref_id": null
                },
                {
                    "start": 2976,
                    "end": 2985,
                    "text": "SCID and,",
                    "ref_id": null
                },
                {
                    "start": 2986,
                    "end": 3004,
                    "text": "49:382 45:388. 409",
                    "ref_id": null
                },
                {
                    "start": 3028,
                    "end": 3093,
                    "text": "thyroiditis and, superantigens, 54:113-115; 65:14, 208-210 47:462",
                    "ref_id": null
                },
                {
                    "start": 3159,
                    "end": 3211,
                    "text": "mitogen, 54:113 streptococcal M proteins, 54:114-115",
                    "ref_id": null
                },
                {
                    "start": 3238,
                    "end": 3293,
                    "text": "leukocytes and, 49:81, 111, 115 T cell receptor and, 45",
                    "ref_id": null
                },
                {
                    "start": 3294,
                    "end": 3303,
                    "text": "SCID and,",
                    "ref_id": null
                },
                {
                    "start": 3304,
                    "end": 3311,
                    "text": "49:387,",
                    "ref_id": null
                },
                {
                    "start": 3312,
                    "end": 3315,
                    "text": "391",
                    "ref_id": null
                },
                {
                    "start": 3323,
                    "end": 3337,
                    "text": "formation and,",
                    "ref_id": null
                },
                {
                    "start": 3338,
                    "end": 3367,
                    "text": "41:186 lymphocyte homing and,",
                    "ref_id": null
                },
                {
                    "start": 3368,
                    "end": 3375,
                    "text": "44:316,",
                    "ref_id": null
                },
                {
                    "start": 3376,
                    "end": 3390,
                    "text": "320 Basophils,",
                    "ref_id": null
                },
                {
                    "start": 3391,
                    "end": 3398,
                    "text": "48:176,",
                    "ref_id": null
                },
                {
                    "start": 3399,
                    "end": 3403,
                    "text": "177;",
                    "ref_id": null
                },
                {
                    "start": 3404,
                    "end": 3410,
                    "text": "61:15,",
                    "ref_id": null
                },
                {
                    "start": 3411,
                    "end": 3414,
                    "text": "20,",
                    "ref_id": null
                },
                {
                    "start": 3415,
                    "end": 3420,
                    "text": "[360]",
                    "ref_id": null
                },
                {
                    "start": 3421,
                    "end": 3426,
                    "text": "[361]",
                    "ref_id": null
                },
                {
                    "start": 3427,
                    "end": 3434,
                    "text": "49:165,",
                    "ref_id": null
                },
                {
                    "start": 3435,
                    "end": 3438,
                    "text": "170",
                    "ref_id": null
                },
                {
                    "start": 3439,
                    "end": 3460,
                    "text": "binding and, 39:72-73",
                    "ref_id": null
                },
                {
                    "start": 3495,
                    "end": 3509,
                    "text": "structure and,",
                    "ref_id": null
                },
                {
                    "start": 3510,
                    "end": 3514,
                    "text": "[76]",
                    "ref_id": null
                },
                {
                    "start": 3515,
                    "end": 3519,
                    "text": "[77]",
                    "ref_id": null
                },
                {
                    "start": 3520,
                    "end": 3524,
                    "text": "[78]",
                    "ref_id": null
                },
                {
                    "start": 3525,
                    "end": 3531,
                    "text": "39:67,",
                    "ref_id": null
                },
                {
                    "start": 3532,
                    "end": 3535,
                    "text": "69,",
                    "ref_id": null
                },
                {
                    "start": 3536,
                    "end": 3555,
                    "text": "71 NRGG as antigen,",
                    "ref_id": null
                },
                {
                    "start": 3556,
                    "end": 3560,
                    "text": "[39]",
                    "ref_id": null
                },
                {
                    "start": 3561,
                    "end": 3565,
                    "text": "[40]",
                    "ref_id": null
                },
                {
                    "start": 3566,
                    "end": 3570,
                    "text": "[41]",
                    "ref_id": null
                },
                {
                    "start": 3571,
                    "end": 3575,
                    "text": "[42]",
                    "ref_id": null
                },
                {
                    "start": 3576,
                    "end": 3580,
                    "text": "[43]",
                    "ref_id": null
                },
                {
                    "start": 3581,
                    "end": 3585,
                    "text": "[44]",
                    "ref_id": null
                },
                {
                    "start": 3586,
                    "end": 3590,
                    "text": "[45]",
                    "ref_id": null
                },
                {
                    "start": 3591,
                    "end": 3595,
                    "text": "[46]",
                    "ref_id": null
                },
                {
                    "start": 3596,
                    "end": 3600,
                    "text": "[47]",
                    "ref_id": null
                },
                {
                    "start": 3601,
                    "end": 3605,
                    "text": "[48]",
                    "ref_id": null
                },
                {
                    "start": 3606,
                    "end": 3610,
                    "text": "[49]",
                    "ref_id": null
                },
                {
                    "start": 3611,
                    "end": 3615,
                    "text": "[50]",
                    "ref_id": null
                },
                {
                    "start": 3616,
                    "end": 3620,
                    "text": "[51]",
                    "ref_id": null
                },
                {
                    "start": 3621,
                    "end": 3625,
                    "text": "[52]",
                    "ref_id": null
                },
                {
                    "start": 3626,
                    "end": 3630,
                    "text": "[53]",
                    "ref_id": null
                },
                {
                    "start": 3631,
                    "end": 3635,
                    "text": "[54]",
                    "ref_id": null
                },
                {
                    "start": 3636,
                    "end": 3640,
                    "text": "[55]",
                    "ref_id": null
                },
                {
                    "start": 3641,
                    "end": 3645,
                    "text": "[56]",
                    "ref_id": null
                },
                {
                    "start": 3646,
                    "end": 3650,
                    "text": "[39]",
                    "ref_id": null
                },
                {
                    "start": 3651,
                    "end": 3655,
                    "text": "[40]",
                    "ref_id": null
                },
                {
                    "start": 3656,
                    "end": 3660,
                    "text": "[41]",
                    "ref_id": null
                },
                {
                    "start": 3661,
                    "end": 3665,
                    "text": "[42]",
                    "ref_id": null
                },
                {
                    "start": 3666,
                    "end": 3670,
                    "text": "[43]",
                    "ref_id": null
                },
                {
                    "start": 3671,
                    "end": 3675,
                    "text": "[44]",
                    "ref_id": null
                },
                {
                    "start": 3676,
                    "end": 3680,
                    "text": "[45]",
                    "ref_id": null
                },
                {
                    "start": 3681,
                    "end": 3685,
                    "text": "[46]",
                    "ref_id": null
                },
                {
                    "start": 3686,
                    "end": 3690,
                    "text": "[47]",
                    "ref_id": null
                },
                {
                    "start": 3691,
                    "end": 3695,
                    "text": "[48]",
                    "ref_id": null
                },
                {
                    "start": 3696,
                    "end": 3700,
                    "text": "[49]",
                    "ref_id": null
                },
                {
                    "start": 3701,
                    "end": 3705,
                    "text": "[50]",
                    "ref_id": null
                },
                {
                    "start": 3706,
                    "end": 3710,
                    "text": "[51]",
                    "ref_id": null
                },
                {
                    "start": 3711,
                    "end": 3715,
                    "text": "[52]",
                    "ref_id": null
                },
                {
                    "start": 3716,
                    "end": 3720,
                    "text": "[53]",
                    "ref_id": null
                },
                {
                    "start": 3721,
                    "end": 3725,
                    "text": "[55]",
                    "ref_id": null
                },
                {
                    "start": 3726,
                    "end": 3730,
                    "text": "[56]",
                    "ref_id": null
                },
                {
                    "start": 3731,
                    "end": 3737,
                    "text": "47:45,",
                    "ref_id": null
                },
                {
                    "start": 3738,
                    "end": 3741,
                    "text": "46,",
                    "ref_id": null
                },
                {
                    "start": 3742,
                    "end": 3745,
                    "text": "47,",
                    "ref_id": null
                },
                {
                    "start": 3746,
                    "end": 3770,
                    "text": "87 antigen presentation,",
                    "ref_id": null
                },
                {
                    "start": 3771,
                    "end": 3775,
                    "text": "[72]",
                    "ref_id": null
                },
                {
                    "start": 3776,
                    "end": 3780,
                    "text": "[73]",
                    "ref_id": null
                },
                {
                    "start": 3781,
                    "end": 3785,
                    "text": "[74]",
                    "ref_id": null
                },
                {
                    "start": 3786,
                    "end": 3790,
                    "text": "[75]",
                    "ref_id": null
                },
                {
                    "start": 3791,
                    "end": 3795,
                    "text": "[76]",
                    "ref_id": null
                },
                {
                    "start": 3796,
                    "end": 3800,
                    "text": "[92]",
                    "ref_id": null
                },
                {
                    "start": 3801,
                    "end": 3805,
                    "text": "[93]",
                    "ref_id": null
                },
                {
                    "start": 3806,
                    "end": 3810,
                    "text": "[94]",
                    "ref_id": null
                },
                {
                    "start": 3811,
                    "end": 3815,
                    "text": "[47]",
                    "ref_id": null
                },
                {
                    "start": 3816,
                    "end": 3820,
                    "text": "[48]",
                    "ref_id": null
                },
                {
                    "start": 3821,
                    "end": 3825,
                    "text": "[49]",
                    "ref_id": null
                },
                {
                    "start": 3826,
                    "end": 3830,
                    "text": "[50]",
                    "ref_id": null
                },
                {
                    "start": 3831,
                    "end": 3835,
                    "text": "[51]",
                    "ref_id": null
                },
                {
                    "start": 3836,
                    "end": 3840,
                    "text": "[52]",
                    "ref_id": null
                },
                {
                    "start": 3841,
                    "end": 3845,
                    "text": "[53]",
                    "ref_id": null
                },
                {
                    "start": 3846,
                    "end": 3850,
                    "text": "[54]",
                    "ref_id": null
                },
                {
                    "start": 3851,
                    "end": 3855,
                    "text": "[55]",
                    "ref_id": null
                },
                {
                    "start": 3856,
                    "end": 3860,
                    "text": "[56]",
                    "ref_id": null
                },
                {
                    "start": 3861,
                    "end": 3865,
                    "text": "[57]",
                    "ref_id": null
                },
                {
                    "start": 3866,
                    "end": 3870,
                    "text": "[58]",
                    "ref_id": null
                },
                {
                    "start": 3871,
                    "end": 3875,
                    "text": "[59]",
                    "ref_id": null
                },
                {
                    "start": 3876,
                    "end": 3880,
                    "text": "[60]",
                    "ref_id": null
                },
                {
                    "start": 3881,
                    "end": 3885,
                    "text": "[61]",
                    "ref_id": null
                },
                {
                    "start": 3886,
                    "end": 3890,
                    "text": "[62]",
                    "ref_id": null
                },
                {
                    "start": 3891,
                    "end": 3895,
                    "text": "[63]",
                    "ref_id": null
                },
                {
                    "start": 3896,
                    "end": 3900,
                    "text": "[64]",
                    "ref_id": null
                },
                {
                    "start": 3901,
                    "end": 3905,
                    "text": "[59]",
                    "ref_id": null
                },
                {
                    "start": 3906,
                    "end": 3910,
                    "text": "[60]",
                    "ref_id": null
                },
                {
                    "start": 3911,
                    "end": 3915,
                    "text": "[61]",
                    "ref_id": null
                },
                {
                    "start": 3916,
                    "end": 3920,
                    "text": "[62]",
                    "ref_id": null
                },
                {
                    "start": 3921,
                    "end": 3925,
                    "text": "[63]",
                    "ref_id": null
                },
                {
                    "start": 3926,
                    "end": 3930,
                    "text": "[64]",
                    "ref_id": null
                },
                {
                    "start": 3931,
                    "end": 3935,
                    "text": "103,",
                    "ref_id": null
                },
                {
                    "start": 3936,
                    "end": 3941,
                    "text": "[158]",
                    "ref_id": null
                },
                {
                    "start": 3942,
                    "end": 3947,
                    "text": "[159]",
                    "ref_id": null
                },
                {
                    "start": 3948,
                    "end": 3953,
                    "text": "[160]",
                    "ref_id": null
                },
                {
                    "start": 3954,
                    "end": 3959,
                    "text": "[161]",
                    "ref_id": null
                },
                {
                    "start": 3960,
                    "end": 3967,
                    "text": "49:162,",
                    "ref_id": null
                },
                {
                    "start": 3968,
                    "end": 3973,
                    "text": "[164]",
                    "ref_id": null
                },
                {
                    "start": 3974,
                    "end": 3979,
                    "text": "[165]",
                    "ref_id": null
                },
                {
                    "start": 3980,
                    "end": 3985,
                    "text": "[166]",
                    "ref_id": null
                },
                {
                    "start": 3986,
                    "end": 3991,
                    "text": "[167]",
                    "ref_id": null
                },
                {
                    "start": 3992,
                    "end": 4012,
                    "text": "165 CD40 expression,",
                    "ref_id": null
                },
                {
                    "start": 4013,
                    "end": 4018,
                    "text": "61:2,",
                    "ref_id": null
                },
                {
                    "start": 4019,
                    "end": 4023,
                    "text": "[11]",
                    "ref_id": null
                },
                {
                    "start": 4024,
                    "end": 4028,
                    "text": "[12]",
                    "ref_id": null
                },
                {
                    "start": 4029,
                    "end": 4033,
                    "text": "[32]",
                    "ref_id": null
                },
                {
                    "start": 4034,
                    "end": 4038,
                    "text": "[33]",
                    "ref_id": null
                },
                {
                    "start": 4039,
                    "end": 4043,
                    "text": "[34]",
                    "ref_id": null
                },
                {
                    "start": 4044,
                    "end": 4048,
                    "text": "[35]",
                    "ref_id": null
                },
                {
                    "start": 4049,
                    "end": 4053,
                    "text": "[36]",
                    "ref_id": null
                },
                {
                    "start": 4054,
                    "end": 4058,
                    "text": "[37]",
                    "ref_id": null
                },
                {
                    "start": 4079,
                    "end": 4091,
                    "text": "studies and,",
                    "ref_id": null
                },
                {
                    "start": 4092,
                    "end": 4109,
                    "text": "41:297 censoring,",
                    "ref_id": null
                },
                {
                    "start": 4110,
                    "end": 4115,
                    "text": "[308]",
                    "ref_id": null
                },
                {
                    "start": 4116,
                    "end": 4121,
                    "text": "[309]",
                    "ref_id": null
                },
                {
                    "start": 4122,
                    "end": 4127,
                    "text": "[311]",
                    "ref_id": null
                },
                {
                    "start": 4128,
                    "end": 4133,
                    "text": "[312]",
                    "ref_id": null
                },
                {
                    "start": 4134,
                    "end": 4142,
                    "text": "chicken,",
                    "ref_id": null
                },
                {
                    "start": 4143,
                    "end": 4153,
                    "text": "repertoire",
                    "ref_id": null
                },
                {
                    "start": 4154,
                    "end": 4169,
                    "text": "precursors and,",
                    "ref_id": null
                },
                {
                    "start": 4170,
                    "end": 4177,
                    "text": "41:188,",
                    "ref_id": null
                },
                {
                    "start": 4178,
                    "end": 4200,
                    "text": "189 cell size changes,",
                    "ref_id": null
                },
                {
                    "start": 4201,
                    "end": 4208,
                    "text": "41:202,",
                    "ref_id": null
                },
                {
                    "start": 4209,
                    "end": 4234,
                    "text": "203 cell surface markers,",
                    "ref_id": null
                },
                {
                    "start": 4235,
                    "end": 4255,
                    "text": "41:189 distinctions,",
                    "ref_id": null
                },
                {
                    "start": 4256,
                    "end": 4263,
                    "text": "41:198,",
                    "ref_id": null
                },
                {
                    "start": 4264,
                    "end": 4286,
                    "text": "I99 functional assays,",
                    "ref_id": null
                },
                {
                    "start": 4287,
                    "end": 4294,
                    "text": "41:196,",
                    "ref_id": null
                },
                {
                    "start": 4295,
                    "end": 4316,
                    "text": "187 tumor cell lines,",
                    "ref_id": null
                },
                {
                    "start": 4317,
                    "end": 4324,
                    "text": "41:195,",
                    "ref_id": null
                },
                {
                    "start": 4325,
                    "end": 4328,
                    "text": "196",
                    "ref_id": null
                },
                {
                    "start": 4341,
                    "end": 4367,
                    "text": "cultiires and, 41:208, 209",
                    "ref_id": null
                },
                {
                    "start": 4373,
                    "end": 4379,
                    "text": "44:37,",
                    "ref_id": null
                },
                {
                    "start": 4380,
                    "end": 4388,
                    "text": "42 49:2,",
                    "ref_id": null
                },
                {
                    "start": 4389,
                    "end": 4391,
                    "text": "3,",
                    "ref_id": null
                },
                {
                    "start": 4392,
                    "end": 4395,
                    "text": "21,",
                    "ref_id": null
                },
                {
                    "start": 4396,
                    "end": 4399,
                    "text": "33,",
                    "ref_id": null
                },
                {
                    "start": 4400,
                    "end": 4403,
                    "text": "53,",
                    "ref_id": null
                },
                {
                    "start": 4404,
                    "end": 4418,
                    "text": "56 regulation,",
                    "ref_id": null
                },
                {
                    "start": 4419,
                    "end": 4423,
                    "text": "[49]",
                    "ref_id": null
                },
                {
                    "start": 4424,
                    "end": 4428,
                    "text": "[50]",
                    "ref_id": null
                },
                {
                    "start": 4429,
                    "end": 4433,
                    "text": "[51]",
                    "ref_id": null
                },
                {
                    "start": 4434,
                    "end": 4438,
                    "text": "[52]",
                    "ref_id": null
                },
                {
                    "start": 4439,
                    "end": 4443,
                    "text": "[53]",
                    "ref_id": null
                },
                {
                    "start": 4444,
                    "end": 4448,
                    "text": "[54]",
                    "ref_id": null
                },
                {
                    "start": 4449,
                    "end": 4453,
                    "text": "[55]",
                    "ref_id": null
                },
                {
                    "start": 4454,
                    "end": 4458,
                    "text": "[56]",
                    "ref_id": null
                },
                {
                    "start": 4459,
                    "end": 4463,
                    "text": "493,",
                    "ref_id": null
                },
                {
                    "start": 4464,
                    "end": 4470,
                    "text": "11 Vk,",
                    "ref_id": null
                },
                {
                    "start": 4471,
                    "end": 4487,
                    "text": "gene expression,",
                    "ref_id": null
                },
                {
                    "start": 4488,
                    "end": 4491,
                    "text": "41,",
                    "ref_id": null
                },
                {
                    "start": 4492,
                    "end": 4495,
                    "text": "43,",
                    "ref_id": null
                },
                {
                    "start": 4496,
                    "end": 4500,
                    "text": "[49]",
                    "ref_id": null
                },
                {
                    "start": 4501,
                    "end": 4505,
                    "text": "[50]",
                    "ref_id": null
                },
                {
                    "start": 4506,
                    "end": 4510,
                    "text": "[51]",
                    "ref_id": null
                },
                {
                    "start": 4511,
                    "end": 4515,
                    "text": "[52]",
                    "ref_id": null
                },
                {
                    "start": 4516,
                    "end": 4523,
                    "text": "44:189,",
                    "ref_id": null
                },
                {
                    "start": 4524,
                    "end": 4528,
                    "text": "190,",
                    "ref_id": null
                },
                {
                    "start": 4529,
                    "end": 4533,
                    "text": "194,",
                    "ref_id": null
                },
                {
                    "start": 4534,
                    "end": 4557,
                    "text": "195 bio1ogic.d effects,",
                    "ref_id": null
                },
                {
                    "start": 4558,
                    "end": 4587,
                    "text": "44:164 immunocompetent cells,",
                    "ref_id": null
                },
                {
                    "start": 4588,
                    "end": 4595,
                    "text": "44:172,",
                    "ref_id": null
                },
                {
                    "start": 4596,
                    "end": 4600,
                    "text": "173,",
                    "ref_id": null
                },
                {
                    "start": 4601,
                    "end": 4605,
                    "text": "177,",
                    "ref_id": null
                },
                {
                    "start": 4606,
                    "end": 4619,
                    "text": "178 receptor,",
                    "ref_id": null
                },
                {
                    "start": 4620,
                    "end": 4627,
                    "text": "44:182,",
                    "ref_id": null
                },
                {
                    "start": 4628,
                    "end": 4631,
                    "text": "183",
                    "ref_id": null
                },
                {
                    "start": 4632,
                    "end": 4725,
                    "text": "genes and, 38:50, 73, 153, 156, 188, 189 antigen binding, 38:115 expression, 38:53-55, 57, 58",
                    "ref_id": null
                },
                {
                    "start": 4726,
                    "end": 4733,
                    "text": "47:188,",
                    "ref_id": null
                },
                {
                    "start": 4734,
                    "end": 4738,
                    "text": "199,",
                    "ref_id": null
                },
                {
                    "start": 4739,
                    "end": 4742,
                    "text": "225",
                    "ref_id": null
                },
                {
                    "start": 4743,
                    "end": 4750,
                    "text": "47:201,",
                    "ref_id": null
                },
                {
                    "start": 4751,
                    "end": 4755,
                    "text": "209,",
                    "ref_id": null
                },
                {
                    "start": 4756,
                    "end": 4762,
                    "text": "40194,",
                    "ref_id": null
                },
                {
                    "start": 4763,
                    "end": 4768,
                    "text": "[195]",
                    "ref_id": null
                },
                {
                    "start": 4769,
                    "end": 4774,
                    "text": "[196]",
                    "ref_id": null
                },
                {
                    "start": 4775,
                    "end": 4780,
                    "text": "[197]",
                    "ref_id": null
                },
                {
                    "start": 4781,
                    "end": 4794,
                    "text": "phenotype of,",
                    "ref_id": null
                },
                {
                    "start": 4879,
                    "end": 4909,
                    "text": "proliferate and differentiate,",
                    "ref_id": null
                },
                {
                    "start": 4910,
                    "end": 4951,
                    "text": "41:198, 199 functional usays, 41: 199-202",
                    "ref_id": null
                },
                {
                    "start": 4982,
                    "end": 5013,
                    "text": "41: 189-193 markers, 41:193-195",
                    "ref_id": null
                },
                {
                    "start": 5079,
                    "end": 5245,
                    "text": "41:196, 197 tiiinor cell lines, 41:195, 196 antigens, 41:197, 198 prenatal B cell genesis, 63:207-208, 212 pre-pre B cells, 43:237 pro-B cells. 59:286, 298; 63:23, 25",
                    "ref_id": null
                },
                {
                    "start": 5270,
                    "end": 5374,
                    "text": "development and, 44209, 243, 252 -T cell interactions, 39:57-58, 83-85, epitopic specificity and, 39:87-",
                    "ref_id": null
                },
                {
                    "start": 5375,
                    "end": 5410,
                    "text": "B cell precursors, 41:193, 194, 197",
                    "ref_id": null
                },
                {
                    "start": 5515,
                    "end": 5527,
                    "text": "subsets and,",
                    "ref_id": null
                },
                {
                    "start": 5528,
                    "end": 5534,
                    "text": "41:66,",
                    "ref_id": null
                },
                {
                    "start": 5535,
                    "end": 5538,
                    "text": "76,",
                    "ref_id": null
                },
                {
                    "start": 5539,
                    "end": 5542,
                    "text": "77,",
                    "ref_id": null
                },
                {
                    "start": 5543,
                    "end": 5552,
                    "text": "95 major,",
                    "ref_id": null
                },
                {
                    "start": 5553,
                    "end": 5564,
                    "text": "expression,",
                    "ref_id": null
                },
                {
                    "start": 5565,
                    "end": 5576,
                    "text": "plasmacyte,",
                    "ref_id": null
                },
                {
                    "start": 5577,
                    "end": 5608,
                    "text": "52:174 B cell surface antigens,",
                    "ref_id": null
                },
                {
                    "start": 5714,
                    "end": 5727,
                    "text": "Ig clustered,",
                    "ref_id": null
                },
                {
                    "start": 5728,
                    "end": 5742,
                    "text": "52:144 CDlO or",
                    "ref_id": null
                },
                {
                    "start": 5743,
                    "end": 5814,
                    "text": "formation and, 41:183, 184, 235-238 B cell precursors, 41:191, 193-199,",
                    "ref_id": null
                },
                {
                    "start": 5815,
                    "end": 5841,
                    "text": "cytokines and, 46:115, 117",
                    "ref_id": null
                },
                {
                    "start": 5847,
                    "end": 5872,
                    "text": "infection and, 47:395-397",
                    "ref_id": null
                },
                {
                    "start": 5880,
                    "end": 5907,
                    "text": "(D44 expression, 54:293-294",
                    "ref_id": null
                },
                {
                    "start": 5915,
                    "end": 5942,
                    "text": "resistance and, 41:333, 334",
                    "ref_id": null
                },
                {
                    "start": 5943,
                    "end": 5969,
                    "text": "cytokines and, 46:127. 137",
                    "ref_id": null
                },
                {
                    "start": 6121,
                    "end": 6130,
                    "text": "Btk BSAP,",
                    "ref_id": null
                },
                {
                    "start": 6131,
                    "end": 6136,
                    "text": "[169]",
                    "ref_id": null
                },
                {
                    "start": 6137,
                    "end": 6142,
                    "text": "[170]",
                    "ref_id": null
                },
                {
                    "start": 6143,
                    "end": 6148,
                    "text": "[171]",
                    "ref_id": null
                },
                {
                    "start": 6149,
                    "end": 6154,
                    "text": "[172]",
                    "ref_id": null
                },
                {
                    "start": 6155,
                    "end": 6160,
                    "text": "[173]",
                    "ref_id": null
                },
                {
                    "start": 6161,
                    "end": 6166,
                    "text": "[174]",
                    "ref_id": null
                },
                {
                    "start": 6167,
                    "end": 6172,
                    "text": "[175]",
                    "ref_id": null
                },
                {
                    "start": 6173,
                    "end": 6178,
                    "text": "[176]",
                    "ref_id": null
                },
                {
                    "start": 6179,
                    "end": 6182,
                    "text": "317",
                    "ref_id": null
                },
                {
                    "start": 6183,
                    "end": 6192,
                    "text": "Btk gene,",
                    "ref_id": null
                },
                {
                    "start": 6193,
                    "end": 6197,
                    "text": "184,",
                    "ref_id": null
                },
                {
                    "start": 6198,
                    "end": 6221,
                    "text": "196 B cell development,",
                    "ref_id": null
                },
                {
                    "start": 6222,
                    "end": 6225,
                    "text": "195",
                    "ref_id": null
                },
                {
                    "start": 6226,
                    "end": 6284,
                    "text": "components and, 38:204, 206, convertase, 38:205, 206, 213,",
                    "ref_id": null
                },
                {
                    "start": 6317,
                    "end": 6403,
                    "text": "components and, 38:205, 211, 221, 222, 234-236 C4-binthg protein, 61:203, 204, 235-236",
                    "ref_id": null
                },
                {
                    "start": 6424,
                    "end": 6430,
                    "text": "1 and,",
                    "ref_id": null
                },
                {
                    "start": 6431,
                    "end": 6438,
                    "text": "46:184,",
                    "ref_id": null
                },
                {
                    "start": 6439,
                    "end": 6443,
                    "text": "185,",
                    "ref_id": null
                },
                {
                    "start": 6444,
                    "end": 6470,
                    "text": "complement receptor 2 and,",
                    "ref_id": null
                },
                {
                    "start": 6471,
                    "end": 6487,
                    "text": "46:202 function,",
                    "ref_id": null
                },
                {
                    "start": 6488,
                    "end": 6496,
                    "text": "234 189,",
                    "ref_id": null
                },
                {
                    "start": 6497,
                    "end": 6501,
                    "text": "195,",
                    "ref_id": null
                },
                {
                    "start": 6502,
                    "end": 6509,
                    "text": "197 C5,",
                    "ref_id": null
                },
                {
                    "start": 6510,
                    "end": 6536,
                    "text": "complement components and,",
                    "ref_id": null
                },
                {
                    "start": 6537,
                    "end": 6544,
                    "text": "38:204,",
                    "ref_id": null
                },
                {
                    "start": 6545,
                    "end": 6557,
                    "text": "convertases,",
                    "ref_id": null
                },
                {
                    "start": 6558,
                    "end": 6565,
                    "text": "38:205,",
                    "ref_id": null
                },
                {
                    "start": 6566,
                    "end": 6570,
                    "text": "206,",
                    "ref_id": null
                },
                {
                    "start": 6571,
                    "end": 6575,
                    "text": "213,",
                    "ref_id": null
                },
                {
                    "start": 6576,
                    "end": 6580,
                    "text": "222,",
                    "ref_id": null
                },
                {
                    "start": 6581,
                    "end": 6590,
                    "text": "236 C521,",
                    "ref_id": null
                },
                {
                    "start": 6591,
                    "end": 6598,
                    "text": "61:255;",
                    "ref_id": null
                },
                {
                    "start": 6599,
                    "end": 6606,
                    "text": "62:261,",
                    "ref_id": null
                },
                {
                    "start": 6607,
                    "end": 6611,
                    "text": "269,",
                    "ref_id": null
                },
                {
                    "start": 6612,
                    "end": 6616,
                    "text": "275,",
                    "ref_id": null
                },
                {
                    "start": 6617,
                    "end": 6620,
                    "text": "286",
                    "ref_id": null
                },
                {
                    "start": 6704,
                    "end": 6847,
                    "text": "components and, 38:204, C7, complement components and, 38:204, C8, complement components and, 38:205 C9, complement components and, 38:205, cA2",
                    "ref_id": null
                },
                {
                    "start": 6848,
                    "end": 6854,
                    "text": "G and,",
                    "ref_id": null
                },
                {
                    "start": 6855,
                    "end": 6876,
                    "text": "39:125 receptors and,",
                    "ref_id": null
                },
                {
                    "start": 6877,
                    "end": 6897,
                    "text": "39:126 NK cells and,",
                    "ref_id": null
                },
                {
                    "start": 6898,
                    "end": 6918,
                    "text": "47:291 cytotoxicity,",
                    "ref_id": null
                },
                {
                    "start": 6919,
                    "end": 6923,
                    "text": "253,",
                    "ref_id": null
                },
                {
                    "start": 6924,
                    "end": 6928,
                    "text": "254,",
                    "ref_id": null
                },
                {
                    "start": 6929,
                    "end": 6961,
                    "text": "261 effecter mechanisms. 47:241,",
                    "ref_id": null
                },
                {
                    "start": 6962,
                    "end": 6966,
                    "text": "244,",
                    "ref_id": null
                },
                {
                    "start": 6967,
                    "end": 6983,
                    "text": "245 lymphokines,",
                    "ref_id": null
                },
                {
                    "start": 6984,
                    "end": 6991,
                    "text": "47:26S,",
                    "ref_id": null
                },
                {
                    "start": 6992,
                    "end": 6999,
                    "text": "41:317,",
                    "ref_id": null
                },
                {
                    "start": 7000,
                    "end": 7003,
                    "text": "318",
                    "ref_id": null
                },
                {
                    "start": 7028,
                    "end": 7037,
                    "text": "SCID and,",
                    "ref_id": null
                },
                {
                    "start": 7038,
                    "end": 7052,
                    "text": "formation and,",
                    "ref_id": null
                },
                {
                    "start": 7053,
                    "end": 7079,
                    "text": "41:197 CD8 inolecules and,",
                    "ref_id": null
                },
                {
                    "start": 7080,
                    "end": 7103,
                    "text": "44271 CD23 antigen and,",
                    "ref_id": null
                },
                {
                    "start": 7104,
                    "end": 7109,
                    "text": "[163]",
                    "ref_id": null
                },
                {
                    "start": 7110,
                    "end": 7115,
                    "text": "[164]",
                    "ref_id": null
                },
                {
                    "start": 7116,
                    "end": 7121,
                    "text": "[165]",
                    "ref_id": null
                },
                {
                    "start": 7122,
                    "end": 7125,
                    "text": "176",
                    "ref_id": null
                },
                {
                    "start": 7142,
                    "end": 7174,
                    "text": "resistance and, 41:358, 363, 369",
                    "ref_id": null
                },
                {
                    "start": 7179,
                    "end": 7210,
                    "text": "antibodies and, 49:193, 258-259",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "368"
        },
        {
            "text": "Cardiolipin, see a h Anticardiolipin antibodies binding to cell membrane, 49:194, 197 clinical aspects, 49:200, [204] [205] 49:198 LA antibodies, 49240, leukocytes and, 49:78, [80] [81] [82] [83] 5939, 40, 42, 45, 46, 48, [50] [51] [52] [53] Ig heay-chain variable region genes and, CD5, 48:246; 62, 69 49:42 CD6, 48:247 CD7, 48247 CD45 and, [304] [305] [306] 48~283; 198 B cell studies, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] 33, [35] [36] 34 CD4' cells and, 66:18, 26, [35] [36] 66:18, 26, [35] [36]  leukocytes and, 49:87, [113] [114] 63:136 lymphocyte adhesion, 6624, 37, 39, 44 p56'\" and, 66:11, 12, [19] [20] [21] 26, [37] [38] [39] p59'\" and, 37, 38, [39] [40] [41] [42] [43] 26 p72\"\" and, 66:21, [23] [24] 26 [49] [50] [51] [52] [53] 55 T cell studies, [18] [19] [20] [21] [22] [32] [33] [34] [35] [36] 63:138 CD45KA, 66:7, 15, 16, 36 CD45RB, 66:35 CD45RO. 66:7, 15, 16, 35 CD46,  formation and, 41:185, 235, 237, 239 rearrangements and, 41:194, 195, 198, 200, bone marrow cultures, 41:209, 212 antigen and, 49:163-165, 169, 176 cytotoxicity and, 41:271, 272 deficiencies, 64:193-195 eosinophils, 60:164-178 flowing leukocytes to platelets, 58:355 hybrid resistance and, 41:368, 393 leukocyte-endothelial, 58:376-378 lymphocytes, 66: 15-17 in 1 and, 46:192, 199 49:328, 335 eosinophils, 44:166, 169 leukocyte integrins and, 46:151, 160, 161, lymphoc integrins and, 46:159, 160, 46:2, 3, [5] [6] [7] 6, 55 MHC, 46:28, 31, 33 structure, 18, 19. 21. 23, T cell receptor, 4636, 39, 42, 43, 45 mnrine and human Jaks, location, 60:3-4 rnurine lupus models and, 46:63, 64 NK cells and, 47:227, 228 prevention, 46:312, 313 activation, 45:421-426 origin, 45:418-420 physiology, 45:427, 428, 430. 431 regulation, 45:4:31, 432 R cell forination and. 41:182. 184, 1 B cell prrcursors, 41:191, 196, 200 CD4 and CD8 molecules and, CD4 molecular biology, 44:285, 292, 293 CD5 B cell and aging, 47:122 Ig gene expression, 47:151, 152, 154, 156, 158 physiology, 47:133, 134, 136, 140, 142 surface antigen, 47:146 CD8 molecular biology, 44:271, 273, 274, 154. coniplenient receptor 1 and, 46:188, cotnpleinent receptor 2 and, 46:201, 202, c,ytolysis and, 41274, 276, 280, 281, 285 cytotoxicity and, genes and, 49:5, 8, 2.2, 32 regulation, 49:55 VH gene expression, [47] [48] 44:155, 179, 189 iminunosenescence and, 46237, 249 leukocyte integrins and, 46:156, 164, 171, 46:29, 32, 3.3 structure, 46:11, 13, 15, 17, 18, 21, T cell receptor, 46:36, 37 1 and, 46:187, 188, 191, 193, 194, 199 46:198-200 erythrocytes, 46:198 immunoregulation, 46:200, 201 ligand binding sites, 46:193-196 regulation, 46:196, 197 soluble, in IBD and, 42:299 IgE hiosyithesis and, 44:173, 174, 182 formation and, 41:197 and estrogens, 54:50 IBD and, 42:316-319 IL-1 and, 44:160, 161, 182, 186, 189, 190 MG therapy and, 42270-271 mode of action, 64:195-196 prostaglandin synthesis and, 42:312- leukocytes and. 49:89-90, 101, 111, 125 T cell activation and, 41:4, 5. 9, 11, 12, 25 T cell suhsets and, 41:62, T cell 52:195-200 antigen-dependent activation, 52:199 polyclond activators, 52:195-196, 195-199, 196-198, 198-199, 199 CD40-dependent activation, 52:ZOO-203 IL-6 and B cell growth, 52203-204 B cell 87, 105, 121, 122, 126, 127, 133; 41:269, 270; 43:195; 62:87, 228 genes and, 38:87, 116, 174 Langerhans cell, formation and, 41:181, 235-237, 239 B cell precursors, 41:188, 189, 191-192, 194, 195, 197. 199-201 bone marrow cultnres, 41210, 212, 214-218 56:195 organization, 56: 188-191 preferential rearrangement, 56: 197-198 preferential selection, 56:197-198 preferentid use, 56:195-196 D-proximal formation and, 41:181, 182, 235-238 B cell precursors, 41:188, 191, 196, 197 1 and, 46:193, 198. 200 complement receptor 2 and, 46:203, 205, 207, 208, 211 CTL and, 41 IBD and, 183, IgA , Heavy-chain variable region, genes and antibody repertoire generation in rabbit 56:192 IgD, 56:192 JII, Interleukin-2, 44: 189; 48:77; 52:171-172, 177-178, 195-196, 204-205; 59225, 254; 61:147, 149, 190, 351-352; 62 formation and, 41:192, 194, 198 inflammation and, 64:188-193, 195-197 liver and lung, 64:178-179 thyroiditis and, 46:263, 318 163-173 53159 64: 195-197, 198-199 Cytotoxicity, lymphocyte and complement-mediated 193, 198-201 207, 209, 210, 213 complement receptor 1 and, 46:190, 191, complement receptor 2 and, 46:203, 205 resistance and, 41:355, 390 infection, cytotoxic T cells and, 65278 NK cells and, 47:244, 245, 283, 284 thyroiditis and, 46:283, 289, autoreactive T cells and, 45:430, 431, 433 B cell formation and, 41:199, 222, 231 B cell growth and, 4016 CD4 and CD8 molecules and, 44:299 cytolysis and, 41:284, 286 cytokines and, 46:112 functions, 46:114, 115, 117, 122 immune responses, 46:133 hybrid resistance and, 41:400, 407 IgE biosynthesis and, 44:153, 154, 185 maps of Ig-like loci and, 46:30, 33, 34 multiple myeloma and, 42224 NK cells and, 47:278, 279 Lymphotoxin-a, 615, 22, 24, 26 Lymphotoxin-P, 61:22, 23 66:197 background, 66:198 in IBD, 42:290 immune system and, 206 properties, 66:199, forination and, 238 B cell precursors, 41:IYl. 192, 194, 195 formation and, 41:194, 197 CD4 and CD8 niolecules and, 297, 299, 300, 302, 303 CD4 molecular biology, CD8 molecular biology, 44:271, 272, 296 282, 284 CD5 B ceIl and, 47:137, 142, respinse and, 45:5-8, 80 389, 391, 392 antigens, 45:8, 10, 19. 20 helper T cells, 45:25, 26 interleukins. 45:62, 66, 67 physicd interaction, 4537, 41, 43, hybrid resistance and, 41:348, 357, 361, 46-48, 52-54 369, 378, 403 models and, 46:65, 79, 81, 82, 85, 86, 90, 91, 94 NK cells and, 47:187, 188, 292 cytotoxicity, 47:190 effecter mechanisms, 47239, 240, 242, surface phenotype, 47:201, 211 257, 259, 261 recognition, 224 regulators of complement activation and, restricted antigen recognition, AChR and, restriction, see Major histocompatibility SCID and, 49:384, cytokines and, 46:112, 115, HIV infection and, 47:380, 381, 392, 397 humoral immune response and, 45:40, 62 Ig, 43:239 IgE biosynthesis and, 47:16 Ig gene superfamily and, 44:18 Ig heavy-chain variable region genes and, 44:174, 195 and, 44 IBD and, 42:289 Mitogenic signaling, Ig, Mitogens kinase adoptive T cell therapy of tumors and, 47:71, 73, 100 antinuclear antibodies and, 44:107 autoimmune thyroiditis and, 46:289, 310 autoreactive T cells and, 45:426 B cell formation and, 41:192, 200, 228, 231 CD5 B cell and, 47:140, 142, 147 CD23 antigen and, 49:170 complement receptor 2 and, 46:206, 208 cytotoxicity and, 41:272, 284. 285 donor lymphocytes and, 38:283, 284 helper T cell cytoknes and, 46:122 IIIV infection and, 47:390, 391, 398, 399 human T cell activation and, 41:7, 8, 11, humoral immune response and, 45:67, 49:314 12, 26, 27 70, 72 antigens, 45:23 helper T cells, 45:26, 29, [33] [34] [35] 45:64, 73, 75 physical interaction, 45:43 hybrid resistance and, 41:350, 393, 44:154, 168, 189 human disease, 44:192, 194 54:113, 141 N K cells and, 47:206, 261, 264 potential effector mechanisms, 47:467 SCID and, 387, 398 1 and, 46:196, 200, complement receptor 2 and, 46:203, 204, CTL and, 41:169, 170 &microglobulin , cells and, 42:182; 47:198, 296 CD16, 42:188, [190] [191] cell precursors, 41:195, 198 genetically detennined defects, 41:224, 226, 228, 231, 232 B cells, 59:300 box1 motif, 60:12 Btk genes, 195 CD4 molecules and, 44:291, 296 CD5 B cell and, 47:132, 146, 154, 155 CD5' B cell lines, 55:330 CD23 antigen and, cell cycle checkpoints, 5829 complement receptor 1 and, 46:193, 194, complement receptor 2 and, 46:211 CTL and, 41:138, 169 thyroiditis and, 46:279, 288, 289, 295 B cell formation and, 41:192, 199, 225, 231, 236, 237 CD23 antigen and, sulfasalazine and, 42:187, [204] [205] [206] 42:187, [194] [195] [196] [197] [198] 205 CD3, 42:187, [198] [199] [200] [201] [205] [206] [192] [193] [194] 42:187, [190] [191] 188 IBD and, 4228.5, 286. 287, 307 and, 47:189, 190, 194, 201-204 formation and, 41:191, 194, 197, CD4 molecules and, 44285, 288 CD5 B cell and, 47:144 CD8 molecules and, 44274, 276 complement receptor 2 and, 46201 conjugate, 58:322 CTL and, 41:159 in CD45 and, 66:24, 37, 39, 44 p55, transcriptional regulation, p56'\", binding to CD4 and CD8 cytoplasmic tails, CD45 and, 66:11, 12, [19] [20] [21] 26, [37] [38] [39] interaction with CD4 and CD8 phosphor CD45 and, 37, 38, [39] [40] [41] [42] [43] piOK\", located on human chromosome 22, 1170\"\"~ inTOR and, 61:188-190 p70\"1' , CD45 and, 26 p72\"', CD45 and, 6621, [23] [24] 26 h 11 man i ni m unode ficieney virus and, 45:350, 352, [354] [355] [356] [357] [358] [359] [360] [361] [362] 367 IRD and, 42:289, [294] [295] [296] [297] 47:6, 7 , 9. 12. 38 binding factors, 4721, 22 ineasles and, 45:338. 340, 342, 346 N K cells and, PGE. IRD and, , corticosteroids and, 42:316 . 318-319 phagocytic invasion. MG and, 42:261 phagocl; tosis, IBD and, 42307 C3b and, 42:308 formation and, 41:212, 213 CD23 antigen and, 49:167 complement receptor 1 and, 46:183, 186, by eosinophils, 39:208 hybrid resistance and, 41:340, 357, 370 Ir genes and, 38:94 leukocyte integrins and, 46:151, 161 B cell precursors, 41:192, 201 Ig genes, 41:204, 205 lymphahemopoietic tissues, 41:187 NZB mice, 41:227, 229 WMI anemic mice, 41:2a4 CD4 and CD8 molecules and, 44:266, 277, CD5 B cell and, 47:120, 122 279 mdignancies, 47: 124 physiology, 47:132, 135, 140, 142 cytotoxicify and, 41:273, 287 genetically engineered antibody molecules helper T cell cytokines and, 46:111, 123, IIIV infection and, 47:384 human B cell, 44:70, 139 B cell antigen receptor, rnodek and, 4664. 82, 94 N K cells and, 47292, CD4 and CD8 molecules and. 44:268, 269 CD.5 B cell and, 47:125, 126, 141 iniiiiiinoseiiescence and, 46:224. 226, 228,  leukoc~yte integrins and, 4 6 IF8 T cell activation and, 41:8, 9, 11. 12, 14 Phosphates CTL and. 41:153 T cell activation and. 41:16, 24 49:194, [236] [237] 242, 248 Phosphatidic acid, d'L antibodies and.",
            "cite_spans": [
                {
                    "start": 74,
                    "end": 81,
                    "text": "49:194,",
                    "ref_id": null
                },
                {
                    "start": 82,
                    "end": 103,
                    "text": "197 clinical aspects,",
                    "ref_id": null
                },
                {
                    "start": 104,
                    "end": 111,
                    "text": "49:200,",
                    "ref_id": null
                },
                {
                    "start": 112,
                    "end": 117,
                    "text": "[204]",
                    "ref_id": null
                },
                {
                    "start": 118,
                    "end": 123,
                    "text": "[205]",
                    "ref_id": null
                },
                {
                    "start": 124,
                    "end": 145,
                    "text": "49:198 LA antibodies,",
                    "ref_id": null
                },
                {
                    "start": 146,
                    "end": 152,
                    "text": "49240,",
                    "ref_id": null
                },
                {
                    "start": 153,
                    "end": 168,
                    "text": "leukocytes and,",
                    "ref_id": null
                },
                {
                    "start": 169,
                    "end": 175,
                    "text": "49:78,",
                    "ref_id": null
                },
                {
                    "start": 176,
                    "end": 180,
                    "text": "[80]",
                    "ref_id": null
                },
                {
                    "start": 181,
                    "end": 185,
                    "text": "[81]",
                    "ref_id": null
                },
                {
                    "start": 186,
                    "end": 190,
                    "text": "[82]",
                    "ref_id": null
                },
                {
                    "start": 191,
                    "end": 195,
                    "text": "[83]",
                    "ref_id": null
                },
                {
                    "start": 196,
                    "end": 201,
                    "text": "5939,",
                    "ref_id": null
                },
                {
                    "start": 202,
                    "end": 205,
                    "text": "40,",
                    "ref_id": null
                },
                {
                    "start": 206,
                    "end": 209,
                    "text": "42,",
                    "ref_id": null
                },
                {
                    "start": 210,
                    "end": 213,
                    "text": "45,",
                    "ref_id": null
                },
                {
                    "start": 214,
                    "end": 217,
                    "text": "46,",
                    "ref_id": null
                },
                {
                    "start": 218,
                    "end": 221,
                    "text": "48,",
                    "ref_id": null
                },
                {
                    "start": 222,
                    "end": 226,
                    "text": "[50]",
                    "ref_id": null
                },
                {
                    "start": 227,
                    "end": 231,
                    "text": "[51]",
                    "ref_id": null
                },
                {
                    "start": 232,
                    "end": 236,
                    "text": "[52]",
                    "ref_id": null
                },
                {
                    "start": 237,
                    "end": 241,
                    "text": "[53]",
                    "ref_id": null
                },
                {
                    "start": 272,
                    "end": 282,
                    "text": "genes and,",
                    "ref_id": null
                },
                {
                    "start": 283,
                    "end": 287,
                    "text": "CD5,",
                    "ref_id": null
                },
                {
                    "start": 288,
                    "end": 295,
                    "text": "48:246;",
                    "ref_id": null
                },
                {
                    "start": 296,
                    "end": 299,
                    "text": "62,",
                    "ref_id": null
                },
                {
                    "start": 300,
                    "end": 313,
                    "text": "69 49:42 CD6,",
                    "ref_id": null
                },
                {
                    "start": 314,
                    "end": 325,
                    "text": "48:247 CD7,",
                    "ref_id": null
                },
                {
                    "start": 326,
                    "end": 341,
                    "text": "48247 CD45 and,",
                    "ref_id": null
                },
                {
                    "start": 342,
                    "end": 347,
                    "text": "[304]",
                    "ref_id": null
                },
                {
                    "start": 348,
                    "end": 353,
                    "text": "[305]",
                    "ref_id": null
                },
                {
                    "start": 354,
                    "end": 359,
                    "text": "[306]",
                    "ref_id": null
                },
                {
                    "start": 360,
                    "end": 367,
                    "text": "48~283;",
                    "ref_id": null
                },
                {
                    "start": 368,
                    "end": 387,
                    "text": "198 B cell studies,",
                    "ref_id": null
                },
                {
                    "start": 388,
                    "end": 392,
                    "text": "[22]",
                    "ref_id": null
                },
                {
                    "start": 393,
                    "end": 397,
                    "text": "[23]",
                    "ref_id": null
                },
                {
                    "start": 398,
                    "end": 402,
                    "text": "[24]",
                    "ref_id": null
                },
                {
                    "start": 403,
                    "end": 407,
                    "text": "[25]",
                    "ref_id": null
                },
                {
                    "start": 408,
                    "end": 412,
                    "text": "[26]",
                    "ref_id": null
                },
                {
                    "start": 413,
                    "end": 417,
                    "text": "[27]",
                    "ref_id": null
                },
                {
                    "start": 418,
                    "end": 422,
                    "text": "[28]",
                    "ref_id": null
                },
                {
                    "start": 423,
                    "end": 427,
                    "text": "[29]",
                    "ref_id": null
                },
                {
                    "start": 428,
                    "end": 432,
                    "text": "[30]",
                    "ref_id": null
                },
                {
                    "start": 433,
                    "end": 437,
                    "text": "[31]",
                    "ref_id": null
                },
                {
                    "start": 438,
                    "end": 442,
                    "text": "[32]",
                    "ref_id": null
                },
                {
                    "start": 443,
                    "end": 447,
                    "text": "[33]",
                    "ref_id": null
                },
                {
                    "start": 448,
                    "end": 452,
                    "text": "[34]",
                    "ref_id": null
                },
                {
                    "start": 453,
                    "end": 457,
                    "text": "[35]",
                    "ref_id": null
                },
                {
                    "start": 458,
                    "end": 462,
                    "text": "[36]",
                    "ref_id": null
                },
                {
                    "start": 463,
                    "end": 467,
                    "text": "[37]",
                    "ref_id": null
                },
                {
                    "start": 468,
                    "end": 471,
                    "text": "33,",
                    "ref_id": null
                },
                {
                    "start": 472,
                    "end": 476,
                    "text": "[35]",
                    "ref_id": null
                },
                {
                    "start": 477,
                    "end": 481,
                    "text": "[36]",
                    "ref_id": null
                },
                {
                    "start": 482,
                    "end": 484,
                    "text": "34",
                    "ref_id": null
                },
                {
                    "start": 490,
                    "end": 500,
                    "text": "cells and,",
                    "ref_id": null
                },
                {
                    "start": 501,
                    "end": 507,
                    "text": "66:18,",
                    "ref_id": null
                },
                {
                    "start": 508,
                    "end": 511,
                    "text": "26,",
                    "ref_id": null
                },
                {
                    "start": 512,
                    "end": 516,
                    "text": "[35]",
                    "ref_id": null
                },
                {
                    "start": 517,
                    "end": 521,
                    "text": "[36]",
                    "ref_id": null
                },
                {
                    "start": 522,
                    "end": 528,
                    "text": "66:18,",
                    "ref_id": null
                },
                {
                    "start": 529,
                    "end": 532,
                    "text": "26,",
                    "ref_id": null
                },
                {
                    "start": 533,
                    "end": 537,
                    "text": "[35]",
                    "ref_id": null
                },
                {
                    "start": 538,
                    "end": 542,
                    "text": "[36]",
                    "ref_id": null
                },
                {
                    "start": 543,
                    "end": 543,
                    "text": "",
                    "ref_id": null
                },
                {
                    "start": 544,
                    "end": 559,
                    "text": "leukocytes and,",
                    "ref_id": null
                },
                {
                    "start": 560,
                    "end": 566,
                    "text": "49:87,",
                    "ref_id": null
                },
                {
                    "start": 567,
                    "end": 572,
                    "text": "[113]",
                    "ref_id": null
                },
                {
                    "start": 573,
                    "end": 578,
                    "text": "[114]",
                    "ref_id": null
                },
                {
                    "start": 579,
                    "end": 606,
                    "text": "63:136 lymphocyte adhesion,",
                    "ref_id": null
                },
                {
                    "start": 607,
                    "end": 612,
                    "text": "6624,",
                    "ref_id": null
                },
                {
                    "start": 613,
                    "end": 616,
                    "text": "37,",
                    "ref_id": null
                },
                {
                    "start": 617,
                    "end": 620,
                    "text": "39,",
                    "ref_id": null
                },
                {
                    "start": 621,
                    "end": 634,
                    "text": "44 p56'\" and,",
                    "ref_id": null
                },
                {
                    "start": 635,
                    "end": 641,
                    "text": "66:11,",
                    "ref_id": null
                },
                {
                    "start": 642,
                    "end": 645,
                    "text": "12,",
                    "ref_id": null
                },
                {
                    "start": 646,
                    "end": 650,
                    "text": "[19]",
                    "ref_id": null
                },
                {
                    "start": 651,
                    "end": 655,
                    "text": "[20]",
                    "ref_id": null
                },
                {
                    "start": 656,
                    "end": 660,
                    "text": "[21]",
                    "ref_id": null
                },
                {
                    "start": 661,
                    "end": 664,
                    "text": "26,",
                    "ref_id": null
                },
                {
                    "start": 665,
                    "end": 669,
                    "text": "[37]",
                    "ref_id": null
                },
                {
                    "start": 670,
                    "end": 674,
                    "text": "[38]",
                    "ref_id": null
                },
                {
                    "start": 675,
                    "end": 679,
                    "text": "[39]",
                    "ref_id": null
                },
                {
                    "start": 680,
                    "end": 690,
                    "text": "p59'\" and,",
                    "ref_id": null
                },
                {
                    "start": 691,
                    "end": 694,
                    "text": "37,",
                    "ref_id": null
                },
                {
                    "start": 695,
                    "end": 698,
                    "text": "38,",
                    "ref_id": null
                },
                {
                    "start": 699,
                    "end": 703,
                    "text": "[39]",
                    "ref_id": null
                },
                {
                    "start": 704,
                    "end": 708,
                    "text": "[40]",
                    "ref_id": null
                },
                {
                    "start": 709,
                    "end": 713,
                    "text": "[41]",
                    "ref_id": null
                },
                {
                    "start": 714,
                    "end": 718,
                    "text": "[42]",
                    "ref_id": null
                },
                {
                    "start": 719,
                    "end": 723,
                    "text": "[43]",
                    "ref_id": null
                },
                {
                    "start": 724,
                    "end": 737,
                    "text": "26 p72\"\" and,",
                    "ref_id": null
                },
                {
                    "start": 738,
                    "end": 744,
                    "text": "66:21,",
                    "ref_id": null
                },
                {
                    "start": 745,
                    "end": 749,
                    "text": "[23]",
                    "ref_id": null
                },
                {
                    "start": 750,
                    "end": 754,
                    "text": "[24]",
                    "ref_id": null
                },
                {
                    "start": 755,
                    "end": 757,
                    "text": "26",
                    "ref_id": null
                },
                {
                    "start": 758,
                    "end": 762,
                    "text": "[49]",
                    "ref_id": null
                },
                {
                    "start": 763,
                    "end": 767,
                    "text": "[50]",
                    "ref_id": null
                },
                {
                    "start": 768,
                    "end": 772,
                    "text": "[51]",
                    "ref_id": null
                },
                {
                    "start": 773,
                    "end": 777,
                    "text": "[52]",
                    "ref_id": null
                },
                {
                    "start": 778,
                    "end": 782,
                    "text": "[53]",
                    "ref_id": null
                },
                {
                    "start": 783,
                    "end": 801,
                    "text": "55 T cell studies,",
                    "ref_id": null
                },
                {
                    "start": 802,
                    "end": 806,
                    "text": "[18]",
                    "ref_id": null
                },
                {
                    "start": 807,
                    "end": 811,
                    "text": "[19]",
                    "ref_id": null
                },
                {
                    "start": 812,
                    "end": 816,
                    "text": "[20]",
                    "ref_id": null
                },
                {
                    "start": 817,
                    "end": 821,
                    "text": "[21]",
                    "ref_id": null
                },
                {
                    "start": 822,
                    "end": 826,
                    "text": "[22]",
                    "ref_id": null
                },
                {
                    "start": 827,
                    "end": 831,
                    "text": "[32]",
                    "ref_id": null
                },
                {
                    "start": 832,
                    "end": 836,
                    "text": "[33]",
                    "ref_id": null
                },
                {
                    "start": 837,
                    "end": 841,
                    "text": "[34]",
                    "ref_id": null
                },
                {
                    "start": 842,
                    "end": 846,
                    "text": "[35]",
                    "ref_id": null
                },
                {
                    "start": 847,
                    "end": 851,
                    "text": "[36]",
                    "ref_id": null
                },
                {
                    "start": 852,
                    "end": 866,
                    "text": "63:138 CD45KA,",
                    "ref_id": null
                },
                {
                    "start": 867,
                    "end": 872,
                    "text": "66:7,",
                    "ref_id": null
                },
                {
                    "start": 873,
                    "end": 876,
                    "text": "15,",
                    "ref_id": null
                },
                {
                    "start": 877,
                    "end": 880,
                    "text": "16,",
                    "ref_id": null
                },
                {
                    "start": 881,
                    "end": 891,
                    "text": "36 CD45RB,",
                    "ref_id": null
                },
                {
                    "start": 892,
                    "end": 911,
                    "text": "66:35 CD45RO. 66:7,",
                    "ref_id": null
                },
                {
                    "start": 912,
                    "end": 915,
                    "text": "15,",
                    "ref_id": null
                },
                {
                    "start": 916,
                    "end": 919,
                    "text": "16,",
                    "ref_id": null
                },
                {
                    "start": 920,
                    "end": 928,
                    "text": "35 CD46,",
                    "ref_id": null
                },
                {
                    "start": 929,
                    "end": 929,
                    "text": "",
                    "ref_id": null
                },
                {
                    "start": 930,
                    "end": 944,
                    "text": "formation and,",
                    "ref_id": null
                },
                {
                    "start": 945,
                    "end": 952,
                    "text": "41:185,",
                    "ref_id": null
                },
                {
                    "start": 953,
                    "end": 957,
                    "text": "235,",
                    "ref_id": null
                },
                {
                    "start": 958,
                    "end": 962,
                    "text": "237,",
                    "ref_id": null
                },
                {
                    "start": 963,
                    "end": 986,
                    "text": "239 rearrangements and,",
                    "ref_id": null
                },
                {
                    "start": 987,
                    "end": 994,
                    "text": "41:194,",
                    "ref_id": null
                },
                {
                    "start": 995,
                    "end": 999,
                    "text": "195,",
                    "ref_id": null
                },
                {
                    "start": 1000,
                    "end": 1004,
                    "text": "198,",
                    "ref_id": null
                },
                {
                    "start": 1005,
                    "end": 1009,
                    "text": "200,",
                    "ref_id": null
                },
                {
                    "start": 1010,
                    "end": 1031,
                    "text": "bone marrow cultures,",
                    "ref_id": null
                },
                {
                    "start": 1032,
                    "end": 1039,
                    "text": "41:209,",
                    "ref_id": null
                },
                {
                    "start": 1040,
                    "end": 1043,
                    "text": "212",
                    "ref_id": null
                },
                {
                    "start": 1044,
                    "end": 1156,
                    "text": "antigen and, 49:163-165, 169, 176 cytotoxicity and, 41:271, 272 deficiencies, 64:193-195 eosinophils, 60:164-178",
                    "ref_id": null
                },
                {
                    "start": 1204,
                    "end": 1288,
                    "text": "resistance and, 41:368, 393 leukocyte-endothelial, 58:376-378 lymphocytes, 66: 15-17",
                    "ref_id": null
                },
                {
                    "start": 1292,
                    "end": 1298,
                    "text": "1 and,",
                    "ref_id": null
                },
                {
                    "start": 1299,
                    "end": 1306,
                    "text": "46:192,",
                    "ref_id": null
                },
                {
                    "start": 1307,
                    "end": 1318,
                    "text": "199 49:328,",
                    "ref_id": null
                },
                {
                    "start": 1319,
                    "end": 1335,
                    "text": "335 eosinophils,",
                    "ref_id": null
                },
                {
                    "start": 1336,
                    "end": 1343,
                    "text": "44:166,",
                    "ref_id": null
                },
                {
                    "start": 1344,
                    "end": 1372,
                    "text": "169 leukocyte integrins and,",
                    "ref_id": null
                },
                {
                    "start": 1373,
                    "end": 1380,
                    "text": "46:151,",
                    "ref_id": null
                },
                {
                    "start": 1381,
                    "end": 1385,
                    "text": "160,",
                    "ref_id": null
                },
                {
                    "start": 1386,
                    "end": 1390,
                    "text": "161,",
                    "ref_id": null
                },
                {
                    "start": 1391,
                    "end": 1398,
                    "text": "lymphoc",
                    "ref_id": null
                },
                {
                    "start": 1399,
                    "end": 1413,
                    "text": "integrins and,",
                    "ref_id": null
                },
                {
                    "start": 1414,
                    "end": 1421,
                    "text": "46:159,",
                    "ref_id": null
                },
                {
                    "start": 1422,
                    "end": 1426,
                    "text": "160,",
                    "ref_id": null
                },
                {
                    "start": 1427,
                    "end": 1432,
                    "text": "46:2,",
                    "ref_id": null
                },
                {
                    "start": 1433,
                    "end": 1435,
                    "text": "3,",
                    "ref_id": null
                },
                {
                    "start": 1436,
                    "end": 1439,
                    "text": "[5]",
                    "ref_id": null
                },
                {
                    "start": 1440,
                    "end": 1443,
                    "text": "[6]",
                    "ref_id": null
                },
                {
                    "start": 1444,
                    "end": 1447,
                    "text": "[7]",
                    "ref_id": null
                },
                {
                    "start": 1448,
                    "end": 1450,
                    "text": "6,",
                    "ref_id": null
                },
                {
                    "start": 1451,
                    "end": 1458,
                    "text": "55 MHC,",
                    "ref_id": null
                },
                {
                    "start": 1459,
                    "end": 1465,
                    "text": "46:28,",
                    "ref_id": null
                },
                {
                    "start": 1466,
                    "end": 1469,
                    "text": "31,",
                    "ref_id": null
                },
                {
                    "start": 1470,
                    "end": 1483,
                    "text": "33 structure,",
                    "ref_id": null
                },
                {
                    "start": 1484,
                    "end": 1487,
                    "text": "18,",
                    "ref_id": null
                },
                {
                    "start": 1488,
                    "end": 1499,
                    "text": "19. 21. 23,",
                    "ref_id": null
                },
                {
                    "start": 1500,
                    "end": 1516,
                    "text": "T cell receptor,",
                    "ref_id": null
                },
                {
                    "start": 1517,
                    "end": 1522,
                    "text": "4636,",
                    "ref_id": null
                },
                {
                    "start": 1523,
                    "end": 1526,
                    "text": "39,",
                    "ref_id": null
                },
                {
                    "start": 1527,
                    "end": 1530,
                    "text": "42,",
                    "ref_id": null
                },
                {
                    "start": 1531,
                    "end": 1534,
                    "text": "43,",
                    "ref_id": null
                },
                {
                    "start": 1535,
                    "end": 1537,
                    "text": "45",
                    "ref_id": null
                },
                {
                    "start": 1592,
                    "end": 1603,
                    "text": "models and,",
                    "ref_id": null
                },
                {
                    "start": 1604,
                    "end": 1610,
                    "text": "46:63,",
                    "ref_id": null
                },
                {
                    "start": 1611,
                    "end": 1627,
                    "text": "64 NK cells and,",
                    "ref_id": null
                },
                {
                    "start": 1628,
                    "end": 1635,
                    "text": "47:227,",
                    "ref_id": null
                },
                {
                    "start": 1636,
                    "end": 1639,
                    "text": "228",
                    "ref_id": null
                },
                {
                    "start": 1640,
                    "end": 1764,
                    "text": "prevention, 46:312, 313 activation, 45:421-426 origin, 45:418-420 physiology, 45:427, 428, 430. 431 regulation, 45:4:31, 432",
                    "ref_id": null
                },
                {
                    "start": 1783,
                    "end": 1838,
                    "text": "and. 41:182. 184, 1 B cell prrcursors, 41:191, 196, 200",
                    "ref_id": null
                },
                {
                    "start": 1839,
                    "end": 1865,
                    "text": "CD4 and CD8 molecules and,",
                    "ref_id": null
                },
                {
                    "start": 1866,
                    "end": 1888,
                    "text": "CD4 molecular biology,",
                    "ref_id": null
                },
                {
                    "start": 1889,
                    "end": 1896,
                    "text": "44:285,",
                    "ref_id": null
                },
                {
                    "start": 1897,
                    "end": 1901,
                    "text": "292,",
                    "ref_id": null
                },
                {
                    "start": 1902,
                    "end": 1927,
                    "text": "293 CD5 B cell and aging,",
                    "ref_id": null
                },
                {
                    "start": 1928,
                    "end": 1954,
                    "text": "47:122 Ig gene expression,",
                    "ref_id": null
                },
                {
                    "start": 1955,
                    "end": 1962,
                    "text": "47:151,",
                    "ref_id": null
                },
                {
                    "start": 1963,
                    "end": 1967,
                    "text": "152,",
                    "ref_id": null
                },
                {
                    "start": 1968,
                    "end": 1972,
                    "text": "154,",
                    "ref_id": null
                },
                {
                    "start": 1973,
                    "end": 1977,
                    "text": "156,",
                    "ref_id": null
                },
                {
                    "start": 1978,
                    "end": 1993,
                    "text": "158 physiology,",
                    "ref_id": null
                },
                {
                    "start": 1994,
                    "end": 2001,
                    "text": "47:133,",
                    "ref_id": null
                },
                {
                    "start": 2002,
                    "end": 2006,
                    "text": "134,",
                    "ref_id": null
                },
                {
                    "start": 2007,
                    "end": 2011,
                    "text": "136,",
                    "ref_id": null
                },
                {
                    "start": 2012,
                    "end": 2016,
                    "text": "140,",
                    "ref_id": null
                },
                {
                    "start": 2017,
                    "end": 2037,
                    "text": "142 surface antigen,",
                    "ref_id": null
                },
                {
                    "start": 2038,
                    "end": 2067,
                    "text": "47:146 CD8 molecular biology,",
                    "ref_id": null
                },
                {
                    "start": 2068,
                    "end": 2075,
                    "text": "44:271,",
                    "ref_id": null
                },
                {
                    "start": 2076,
                    "end": 2080,
                    "text": "273,",
                    "ref_id": null
                },
                {
                    "start": 2081,
                    "end": 2085,
                    "text": "274,",
                    "ref_id": null
                },
                {
                    "start": 2086,
                    "end": 2090,
                    "text": "154.",
                    "ref_id": null
                },
                {
                    "start": 2113,
                    "end": 2229,
                    "text": "1 and, 46:188, cotnpleinent receptor 2 and, 46:201, 202, c,ytolysis and, 41274, 276, 280, 281, 285 cytotoxicity and,",
                    "ref_id": null
                },
                {
                    "start": 2230,
                    "end": 2240,
                    "text": "genes and,",
                    "ref_id": null
                },
                {
                    "start": 2241,
                    "end": 2246,
                    "text": "49:5,",
                    "ref_id": null
                },
                {
                    "start": 2247,
                    "end": 2249,
                    "text": "8,",
                    "ref_id": null
                },
                {
                    "start": 2250,
                    "end": 2254,
                    "text": "2.2,",
                    "ref_id": null
                },
                {
                    "start": 2255,
                    "end": 2269,
                    "text": "32 regulation,",
                    "ref_id": null
                },
                {
                    "start": 2270,
                    "end": 2295,
                    "text": "49:55 VH gene expression,",
                    "ref_id": null
                },
                {
                    "start": 2296,
                    "end": 2300,
                    "text": "[47]",
                    "ref_id": null
                },
                {
                    "start": 2301,
                    "end": 2305,
                    "text": "[48]",
                    "ref_id": null
                },
                {
                    "start": 2306,
                    "end": 2313,
                    "text": "44:155,",
                    "ref_id": null
                },
                {
                    "start": 2314,
                    "end": 2318,
                    "text": "179,",
                    "ref_id": null
                },
                {
                    "start": 2319,
                    "end": 2345,
                    "text": "189 iminunosenescence and,",
                    "ref_id": null
                },
                {
                    "start": 2346,
                    "end": 2352,
                    "text": "46237,",
                    "ref_id": null
                },
                {
                    "start": 2353,
                    "end": 2381,
                    "text": "249 leukocyte integrins and,",
                    "ref_id": null
                },
                {
                    "start": 2382,
                    "end": 2389,
                    "text": "46:156,",
                    "ref_id": null
                },
                {
                    "start": 2390,
                    "end": 2394,
                    "text": "164,",
                    "ref_id": null
                },
                {
                    "start": 2395,
                    "end": 2399,
                    "text": "171,",
                    "ref_id": null
                },
                {
                    "start": 2400,
                    "end": 2406,
                    "text": "46:29,",
                    "ref_id": null
                },
                {
                    "start": 2407,
                    "end": 2410,
                    "text": "32,",
                    "ref_id": null
                },
                {
                    "start": 2411,
                    "end": 2425,
                    "text": "3.3 structure,",
                    "ref_id": null
                },
                {
                    "start": 2426,
                    "end": 2432,
                    "text": "46:11,",
                    "ref_id": null
                },
                {
                    "start": 2433,
                    "end": 2436,
                    "text": "13,",
                    "ref_id": null
                },
                {
                    "start": 2437,
                    "end": 2440,
                    "text": "15,",
                    "ref_id": null
                },
                {
                    "start": 2441,
                    "end": 2444,
                    "text": "17,",
                    "ref_id": null
                },
                {
                    "start": 2445,
                    "end": 2448,
                    "text": "18,",
                    "ref_id": null
                },
                {
                    "start": 2449,
                    "end": 2452,
                    "text": "21,",
                    "ref_id": null
                },
                {
                    "start": 2453,
                    "end": 2469,
                    "text": "T cell receptor,",
                    "ref_id": null
                },
                {
                    "start": 2470,
                    "end": 2476,
                    "text": "46:36,",
                    "ref_id": null
                },
                {
                    "start": 2477,
                    "end": 2479,
                    "text": "37",
                    "ref_id": null
                },
                {
                    "start": 2480,
                    "end": 2518,
                    "text": "1 and, 46:187, 188, 191, 193, 194, 199",
                    "ref_id": null
                },
                {
                    "start": 2519,
                    "end": 2649,
                    "text": "46:198-200 erythrocytes, 46:198 immunoregulation, 46:200, 201 ligand binding sites, 46:193-196 regulation, 46:196, 197 soluble, in",
                    "ref_id": null
                },
                {
                    "start": 2650,
                    "end": 2658,
                    "text": "IBD and,",
                    "ref_id": null
                },
                {
                    "start": 2659,
                    "end": 2687,
                    "text": "42:299 IgE hiosyithesis and,",
                    "ref_id": null
                },
                {
                    "start": 2688,
                    "end": 2695,
                    "text": "44:173,",
                    "ref_id": null
                },
                {
                    "start": 2696,
                    "end": 2700,
                    "text": "174,",
                    "ref_id": null
                },
                {
                    "start": 2701,
                    "end": 2704,
                    "text": "182",
                    "ref_id": null
                },
                {
                    "start": 2705,
                    "end": 2899,
                    "text": "formation and, 41:197 and estrogens, 54:50 IBD and, 42:316-319 IL-1 and, 44:160, 161, 182, 186, 189, 190 MG therapy and, 42270-271 mode of action, 64:195-196 prostaglandin synthesis and, 42:312-",
                    "ref_id": null
                },
                {
                    "start": 2900,
                    "end": 2992,
                    "text": "leukocytes and. 49:89-90, 101, 111, 125 T cell activation and, 41:4, 5. 9, 11, 12, 25 T cell",
                    "ref_id": null
                },
                {
                    "start": 2993,
                    "end": 3005,
                    "text": "suhsets and,",
                    "ref_id": null
                },
                {
                    "start": 3006,
                    "end": 3012,
                    "text": "41:62,",
                    "ref_id": null
                },
                {
                    "start": 3013,
                    "end": 3019,
                    "text": "T cell",
                    "ref_id": null
                },
                {
                    "start": 3020,
                    "end": 3211,
                    "text": "52:195-200 antigen-dependent activation, 52:199 polyclond activators, 52:195-196, 195-199, 196-198, 198-199, 199 CD40-dependent activation, 52:ZOO-203 IL-6 and B cell growth, 52203-204 B cell",
                    "ref_id": null
                },
                {
                    "start": 3212,
                    "end": 3277,
                    "text": "87, 105, 121, 122, 126, 127, 133; 41:269, 270; 43:195; 62:87, 228",
                    "ref_id": null
                },
                {
                    "start": 3278,
                    "end": 3288,
                    "text": "genes and,",
                    "ref_id": null
                },
                {
                    "start": 3289,
                    "end": 3295,
                    "text": "38:87,",
                    "ref_id": null
                },
                {
                    "start": 3296,
                    "end": 3300,
                    "text": "116,",
                    "ref_id": null
                },
                {
                    "start": 3301,
                    "end": 3321,
                    "text": "174 Langerhans cell,",
                    "ref_id": null
                },
                {
                    "start": 3322,
                    "end": 3463,
                    "text": "formation and, 41:181, 235-237, 239 B cell precursors, 41:188, 189, 191-192, 194, 195, 197. 199-201 bone marrow cultnres, 41210, 212, 214-218",
                    "ref_id": null
                },
                {
                    "start": 3464,
                    "end": 3610,
                    "text": "56:195 organization, 56: 188-191 preferential rearrangement, 56: 197-198 preferential selection, 56:197-198 preferentid use, 56:195-196 D-proximal",
                    "ref_id": null
                },
                {
                    "start": 3611,
                    "end": 3687,
                    "text": "formation and, 41:181, 182, 235-238 B cell precursors, 41:188, 191, 196, 197",
                    "ref_id": null
                },
                {
                    "start": 3688,
                    "end": 3694,
                    "text": "1 and,",
                    "ref_id": null
                },
                {
                    "start": 3695,
                    "end": 3702,
                    "text": "46:193,",
                    "ref_id": null
                },
                {
                    "start": 3703,
                    "end": 3738,
                    "text": "198. 200 complement receptor 2 and,",
                    "ref_id": null
                },
                {
                    "start": 3739,
                    "end": 3746,
                    "text": "46:203,",
                    "ref_id": null
                },
                {
                    "start": 3747,
                    "end": 3751,
                    "text": "205,",
                    "ref_id": null
                },
                {
                    "start": 3752,
                    "end": 3756,
                    "text": "207,",
                    "ref_id": null
                },
                {
                    "start": 3757,
                    "end": 3761,
                    "text": "208,",
                    "ref_id": null
                },
                {
                    "start": 3762,
                    "end": 3774,
                    "text": "211 CTL and,",
                    "ref_id": null
                },
                {
                    "start": 3775,
                    "end": 3777,
                    "text": "41",
                    "ref_id": null
                },
                {
                    "start": 3778,
                    "end": 3786,
                    "text": "IBD and,",
                    "ref_id": null
                },
                {
                    "start": 3787,
                    "end": 3791,
                    "text": "183,",
                    "ref_id": null
                },
                {
                    "start": 3878,
                    "end": 3889,
                    "text": "56:192 IgD,",
                    "ref_id": null
                },
                {
                    "start": 3890,
                    "end": 3901,
                    "text": "56:192 JII,",
                    "ref_id": null
                },
                {
                    "start": 3921,
                    "end": 4013,
                    "text": "189; 48:77; 52:171-172, 177-178, 195-196, 204-205; 59225, 254; 61:147, 149, 190, 351-352; 62",
                    "ref_id": null
                },
                {
                    "start": 4014,
                    "end": 4045,
                    "text": "formation and, 41:192, 194, 198",
                    "ref_id": null
                },
                {
                    "start": 4046,
                    "end": 4110,
                    "text": "inflammation and, 64:188-193, 195-197 liver and lung, 64:178-179",
                    "ref_id": null
                },
                {
                    "start": 4111,
                    "end": 4174,
                    "text": "thyroiditis and, 46:263, 318 163-173 53159 64: 195-197, 198-199",
                    "ref_id": null
                },
                {
                    "start": 4189,
                    "end": 4255,
                    "text": "lymphocyte and complement-mediated 193, 198-201 207, 209, 210, 213",
                    "ref_id": null
                },
                {
                    "start": 4276,
                    "end": 4334,
                    "text": "1 and, 46:190, 191, complement receptor 2 and, 46:203, 205",
                    "ref_id": null
                },
                {
                    "start": 4335,
                    "end": 4350,
                    "text": "resistance and,",
                    "ref_id": null
                },
                {
                    "start": 4351,
                    "end": 4358,
                    "text": "41:355,",
                    "ref_id": null
                },
                {
                    "start": 4359,
                    "end": 4373,
                    "text": "390 infection,",
                    "ref_id": null
                },
                {
                    "start": 4374,
                    "end": 4396,
                    "text": "cytotoxic T cells and,",
                    "ref_id": null
                },
                {
                    "start": 4397,
                    "end": 4416,
                    "text": "65278 NK cells and,",
                    "ref_id": null
                },
                {
                    "start": 4417,
                    "end": 4424,
                    "text": "47:244,",
                    "ref_id": null
                },
                {
                    "start": 4425,
                    "end": 4429,
                    "text": "245,",
                    "ref_id": null
                },
                {
                    "start": 4430,
                    "end": 4434,
                    "text": "283,",
                    "ref_id": null
                },
                {
                    "start": 4435,
                    "end": 4438,
                    "text": "284",
                    "ref_id": null
                },
                {
                    "start": 4439,
                    "end": 4455,
                    "text": "thyroiditis and,",
                    "ref_id": null
                },
                {
                    "start": 4456,
                    "end": 4463,
                    "text": "46:283,",
                    "ref_id": null
                },
                {
                    "start": 4464,
                    "end": 4468,
                    "text": "289,",
                    "ref_id": null
                },
                {
                    "start": 4469,
                    "end": 4494,
                    "text": "autoreactive T cells and,",
                    "ref_id": null
                },
                {
                    "start": 4495,
                    "end": 4502,
                    "text": "45:430,",
                    "ref_id": null
                },
                {
                    "start": 4503,
                    "end": 4507,
                    "text": "431,",
                    "ref_id": null
                },
                {
                    "start": 4508,
                    "end": 4533,
                    "text": "433 B cell formation and,",
                    "ref_id": null
                },
                {
                    "start": 4534,
                    "end": 4541,
                    "text": "41:199,",
                    "ref_id": null
                },
                {
                    "start": 4542,
                    "end": 4546,
                    "text": "222,",
                    "ref_id": null
                },
                {
                    "start": 4547,
                    "end": 4569,
                    "text": "231 B cell growth and,",
                    "ref_id": null
                },
                {
                    "start": 4570,
                    "end": 4601,
                    "text": "4016 CD4 and CD8 molecules and,",
                    "ref_id": null
                },
                {
                    "start": 4602,
                    "end": 4623,
                    "text": "44:299 cytolysis and,",
                    "ref_id": null
                },
                {
                    "start": 4624,
                    "end": 4631,
                    "text": "41:284,",
                    "ref_id": null
                },
                {
                    "start": 4632,
                    "end": 4635,
                    "text": "286",
                    "ref_id": null
                },
                {
                    "start": 4636,
                    "end": 4650,
                    "text": "cytokines and,",
                    "ref_id": null
                },
                {
                    "start": 4651,
                    "end": 4668,
                    "text": "46:112 functions,",
                    "ref_id": null
                },
                {
                    "start": 4669,
                    "end": 4676,
                    "text": "46:114,",
                    "ref_id": null
                },
                {
                    "start": 4677,
                    "end": 4681,
                    "text": "115,",
                    "ref_id": null
                },
                {
                    "start": 4682,
                    "end": 4686,
                    "text": "117,",
                    "ref_id": null
                },
                {
                    "start": 4687,
                    "end": 4708,
                    "text": "122 immune responses,",
                    "ref_id": null
                },
                {
                    "start": 4709,
                    "end": 4738,
                    "text": "46:133 hybrid resistance and,",
                    "ref_id": null
                },
                {
                    "start": 4739,
                    "end": 4746,
                    "text": "41:400,",
                    "ref_id": null
                },
                {
                    "start": 4747,
                    "end": 4772,
                    "text": "407 IgE biosynthesis and,",
                    "ref_id": null
                },
                {
                    "start": 4773,
                    "end": 4780,
                    "text": "44:153,",
                    "ref_id": null
                },
                {
                    "start": 4781,
                    "end": 4785,
                    "text": "154,",
                    "ref_id": null
                },
                {
                    "start": 4786,
                    "end": 4789,
                    "text": "185",
                    "ref_id": null
                },
                {
                    "start": 4798,
                    "end": 4939,
                    "text": "Ig-like loci and, 46:30, 33, 34 multiple myeloma and, 42224 NK cells and, 47:278, 279 Lymphotoxin-a, 615, 22, 24, 26 Lymphotoxin-P, 61:22, 23",
                    "ref_id": null
                },
                {
                    "start": 4940,
                    "end": 4958,
                    "text": "66:197 background,",
                    "ref_id": null
                },
                {
                    "start": 4959,
                    "end": 4973,
                    "text": "66:198 in IBD,",
                    "ref_id": null
                },
                {
                    "start": 4974,
                    "end": 4980,
                    "text": "42:290",
                    "ref_id": null
                },
                {
                    "start": 4988,
                    "end": 4999,
                    "text": "system and,",
                    "ref_id": null
                },
                {
                    "start": 5000,
                    "end": 5015,
                    "text": "206 properties,",
                    "ref_id": null
                },
                {
                    "start": 5016,
                    "end": 5023,
                    "text": "66:199,",
                    "ref_id": null
                },
                {
                    "start": 5024,
                    "end": 5039,
                    "text": "forination and,",
                    "ref_id": null
                },
                {
                    "start": 5040,
                    "end": 5062,
                    "text": "238 B cell precursors,",
                    "ref_id": null
                },
                {
                    "start": 5063,
                    "end": 5075,
                    "text": "41:IYl. 192,",
                    "ref_id": null
                },
                {
                    "start": 5076,
                    "end": 5080,
                    "text": "194,",
                    "ref_id": null
                },
                {
                    "start": 5081,
                    "end": 5084,
                    "text": "195",
                    "ref_id": null
                },
                {
                    "start": 5085,
                    "end": 5099,
                    "text": "formation and,",
                    "ref_id": null
                },
                {
                    "start": 5100,
                    "end": 5107,
                    "text": "41:194,",
                    "ref_id": null
                },
                {
                    "start": 5108,
                    "end": 5139,
                    "text": "197 CD4 and CD8 niolecules and,",
                    "ref_id": null
                },
                {
                    "start": 5140,
                    "end": 5144,
                    "text": "297,",
                    "ref_id": null
                },
                {
                    "start": 5145,
                    "end": 5149,
                    "text": "299,",
                    "ref_id": null
                },
                {
                    "start": 5150,
                    "end": 5154,
                    "text": "300,",
                    "ref_id": null
                },
                {
                    "start": 5155,
                    "end": 5159,
                    "text": "302,",
                    "ref_id": null
                },
                {
                    "start": 5160,
                    "end": 5186,
                    "text": "303 CD4 molecular biology,",
                    "ref_id": null
                },
                {
                    "start": 5187,
                    "end": 5209,
                    "text": "CD8 molecular biology,",
                    "ref_id": null
                },
                {
                    "start": 5210,
                    "end": 5217,
                    "text": "44:271,",
                    "ref_id": null
                },
                {
                    "start": 5218,
                    "end": 5222,
                    "text": "272,",
                    "ref_id": null
                },
                {
                    "start": 5223,
                    "end": 5231,
                    "text": "296 282,",
                    "ref_id": null
                },
                {
                    "start": 5232,
                    "end": 5251,
                    "text": "284 CD5 B ceIl and,",
                    "ref_id": null
                },
                {
                    "start": 5252,
                    "end": 5259,
                    "text": "47:137,",
                    "ref_id": null
                },
                {
                    "start": 5260,
                    "end": 5264,
                    "text": "142,",
                    "ref_id": null
                },
                {
                    "start": 5265,
                    "end": 5487,
                    "text": "respinse and, 45:5-8, 80 389, 391, 392 antigens, 45:8, 10, 19. 20 helper T cells, 45:25, 26 interleukins. 45:62, 66, 67 physicd interaction, 4537, 41, 43, hybrid resistance and, 41:348, 357, 361, 46-48, 52-54 369, 378, 403",
                    "ref_id": null
                },
                {
                    "start": 5488,
                    "end": 5499,
                    "text": "models and,",
                    "ref_id": null
                },
                {
                    "start": 5500,
                    "end": 5506,
                    "text": "46:65,",
                    "ref_id": null
                },
                {
                    "start": 5507,
                    "end": 5510,
                    "text": "79,",
                    "ref_id": null
                },
                {
                    "start": 5511,
                    "end": 5514,
                    "text": "81,",
                    "ref_id": null
                },
                {
                    "start": 5515,
                    "end": 5518,
                    "text": "82,",
                    "ref_id": null
                },
                {
                    "start": 5519,
                    "end": 5522,
                    "text": "85,",
                    "ref_id": null
                },
                {
                    "start": 5523,
                    "end": 5526,
                    "text": "86,",
                    "ref_id": null
                },
                {
                    "start": 5527,
                    "end": 5530,
                    "text": "90,",
                    "ref_id": null
                },
                {
                    "start": 5531,
                    "end": 5534,
                    "text": "91,",
                    "ref_id": null
                },
                {
                    "start": 5535,
                    "end": 5551,
                    "text": "94 NK cells and,",
                    "ref_id": null
                },
                {
                    "start": 5552,
                    "end": 5559,
                    "text": "47:187,",
                    "ref_id": null
                },
                {
                    "start": 5560,
                    "end": 5564,
                    "text": "188,",
                    "ref_id": null
                },
                {
                    "start": 5565,
                    "end": 5582,
                    "text": "292 cytotoxicity,",
                    "ref_id": null
                },
                {
                    "start": 5583,
                    "end": 5610,
                    "text": "47:190 effecter mechanisms,",
                    "ref_id": null
                },
                {
                    "start": 5611,
                    "end": 5617,
                    "text": "47239,",
                    "ref_id": null
                },
                {
                    "start": 5618,
                    "end": 5622,
                    "text": "240,",
                    "ref_id": null
                },
                {
                    "start": 5623,
                    "end": 5627,
                    "text": "242,",
                    "ref_id": null
                },
                {
                    "start": 5628,
                    "end": 5646,
                    "text": "surface phenotype,",
                    "ref_id": null
                },
                {
                    "start": 5647,
                    "end": 5654,
                    "text": "47:201,",
                    "ref_id": null
                },
                {
                    "start": 5655,
                    "end": 5663,
                    "text": "211 257,",
                    "ref_id": null
                },
                {
                    "start": 5664,
                    "end": 5668,
                    "text": "259,",
                    "ref_id": null
                },
                {
                    "start": 5669,
                    "end": 5685,
                    "text": "261 recognition,",
                    "ref_id": null
                },
                {
                    "start": 5686,
                    "end": 5689,
                    "text": "224",
                    "ref_id": null
                },
                {
                    "start": 5763,
                    "end": 5772,
                    "text": "AChR and,",
                    "ref_id": null
                },
                {
                    "start": 5815,
                    "end": 5824,
                    "text": "SCID and,",
                    "ref_id": null
                },
                {
                    "start": 5825,
                    "end": 5832,
                    "text": "49:384,",
                    "ref_id": null
                },
                {
                    "start": 5833,
                    "end": 5847,
                    "text": "cytokines and,",
                    "ref_id": null
                },
                {
                    "start": 5848,
                    "end": 5855,
                    "text": "46:112,",
                    "ref_id": null
                },
                {
                    "start": 5856,
                    "end": 5860,
                    "text": "115,",
                    "ref_id": null
                },
                {
                    "start": 5861,
                    "end": 5879,
                    "text": "HIV infection and,",
                    "ref_id": null
                },
                {
                    "start": 5880,
                    "end": 5887,
                    "text": "47:380,",
                    "ref_id": null
                },
                {
                    "start": 5888,
                    "end": 5892,
                    "text": "381,",
                    "ref_id": null
                },
                {
                    "start": 5893,
                    "end": 5897,
                    "text": "392,",
                    "ref_id": null
                },
                {
                    "start": 5898,
                    "end": 5930,
                    "text": "397 humoral immune response and,",
                    "ref_id": null
                },
                {
                    "start": 5931,
                    "end": 5937,
                    "text": "45:40,",
                    "ref_id": null
                },
                {
                    "start": 5938,
                    "end": 5944,
                    "text": "62 Ig,",
                    "ref_id": null
                },
                {
                    "start": 5945,
                    "end": 5973,
                    "text": "43:239 IgE biosynthesis and,",
                    "ref_id": null
                },
                {
                    "start": 5974,
                    "end": 6004,
                    "text": "47:16 Ig gene superfamily and,",
                    "ref_id": null
                },
                {
                    "start": 6005,
                    "end": 6010,
                    "text": "44:18",
                    "ref_id": null
                },
                {
                    "start": 6042,
                    "end": 6052,
                    "text": "genes and,",
                    "ref_id": null
                },
                {
                    "start": 6053,
                    "end": 6060,
                    "text": "44:174,",
                    "ref_id": null
                },
                {
                    "start": 6061,
                    "end": 6069,
                    "text": "195 and,",
                    "ref_id": null
                },
                {
                    "start": 6070,
                    "end": 6072,
                    "text": "44",
                    "ref_id": null
                },
                {
                    "start": 6073,
                    "end": 6081,
                    "text": "IBD and,",
                    "ref_id": null
                },
                {
                    "start": 6082,
                    "end": 6109,
                    "text": "42:289 Mitogenic signaling,",
                    "ref_id": null
                },
                {
                    "start": 6110,
                    "end": 6113,
                    "text": "Ig,",
                    "ref_id": null
                },
                {
                    "start": 6157,
                    "end": 6168,
                    "text": "tumors and,",
                    "ref_id": null
                },
                {
                    "start": 6169,
                    "end": 6175,
                    "text": "47:71,",
                    "ref_id": null
                },
                {
                    "start": 6176,
                    "end": 6179,
                    "text": "73,",
                    "ref_id": null
                },
                {
                    "start": 6180,
                    "end": 6211,
                    "text": "100 antinuclear antibodies and,",
                    "ref_id": null
                },
                {
                    "start": 6212,
                    "end": 6246,
                    "text": "44:107 autoimmune thyroiditis and,",
                    "ref_id": null
                },
                {
                    "start": 6247,
                    "end": 6254,
                    "text": "46:289,",
                    "ref_id": null
                },
                {
                    "start": 6255,
                    "end": 6284,
                    "text": "310 autoreactive T cells and,",
                    "ref_id": null
                },
                {
                    "start": 6285,
                    "end": 6313,
                    "text": "45:426 B cell formation and,",
                    "ref_id": null
                },
                {
                    "start": 6314,
                    "end": 6321,
                    "text": "41:192,",
                    "ref_id": null
                },
                {
                    "start": 6322,
                    "end": 6326,
                    "text": "200,",
                    "ref_id": null
                },
                {
                    "start": 6327,
                    "end": 6331,
                    "text": "228,",
                    "ref_id": null
                },
                {
                    "start": 6332,
                    "end": 6351,
                    "text": "231 CD5 B cell and,",
                    "ref_id": null
                },
                {
                    "start": 6352,
                    "end": 6359,
                    "text": "47:140,",
                    "ref_id": null
                },
                {
                    "start": 6360,
                    "end": 6364,
                    "text": "142,",
                    "ref_id": null
                },
                {
                    "start": 6365,
                    "end": 6386,
                    "text": "147 CD23 antigen and,",
                    "ref_id": null
                },
                {
                    "start": 6387,
                    "end": 6420,
                    "text": "49:170 complement receptor 2 and,",
                    "ref_id": null
                },
                {
                    "start": 6421,
                    "end": 6428,
                    "text": "46:206,",
                    "ref_id": null
                },
                {
                    "start": 6429,
                    "end": 6450,
                    "text": "208 cytotoxicity and,",
                    "ref_id": null
                },
                {
                    "start": 6451,
                    "end": 6458,
                    "text": "41:272,",
                    "ref_id": null
                },
                {
                    "start": 6459,
                    "end": 6490,
                    "text": "284. 285 donor lymphocytes and,",
                    "ref_id": null
                },
                {
                    "start": 6491,
                    "end": 6498,
                    "text": "38:283,",
                    "ref_id": null
                },
                {
                    "start": 6499,
                    "end": 6502,
                    "text": "284",
                    "ref_id": null
                },
                {
                    "start": 6517,
                    "end": 6530,
                    "text": "cytoknes and,",
                    "ref_id": null
                },
                {
                    "start": 6531,
                    "end": 6557,
                    "text": "46:122 IIIV infection and,",
                    "ref_id": null
                },
                {
                    "start": 6558,
                    "end": 6565,
                    "text": "47:390,",
                    "ref_id": null
                },
                {
                    "start": 6566,
                    "end": 6570,
                    "text": "391,",
                    "ref_id": null
                },
                {
                    "start": 6571,
                    "end": 6575,
                    "text": "398,",
                    "ref_id": null
                },
                {
                    "start": 6576,
                    "end": 6608,
                    "text": "399 human T cell activation and,",
                    "ref_id": null
                },
                {
                    "start": 6609,
                    "end": 6614,
                    "text": "41:7,",
                    "ref_id": null
                },
                {
                    "start": 6615,
                    "end": 6617,
                    "text": "8,",
                    "ref_id": null
                },
                {
                    "start": 6618,
                    "end": 6621,
                    "text": "11,",
                    "ref_id": null
                },
                {
                    "start": 6622,
                    "end": 6650,
                    "text": "humoral immune response and,",
                    "ref_id": null
                },
                {
                    "start": 6651,
                    "end": 6657,
                    "text": "45:67,",
                    "ref_id": null
                },
                {
                    "start": 6658,
                    "end": 6668,
                    "text": "49:314 12,",
                    "ref_id": null
                },
                {
                    "start": 6669,
                    "end": 6672,
                    "text": "26,",
                    "ref_id": null
                },
                {
                    "start": 6673,
                    "end": 6679,
                    "text": "27 70,",
                    "ref_id": null
                },
                {
                    "start": 6680,
                    "end": 6692,
                    "text": "72 antigens,",
                    "ref_id": null
                },
                {
                    "start": 6693,
                    "end": 6714,
                    "text": "45:23 helper T cells,",
                    "ref_id": null
                },
                {
                    "start": 6715,
                    "end": 6721,
                    "text": "45:26,",
                    "ref_id": null
                },
                {
                    "start": 6722,
                    "end": 6725,
                    "text": "29,",
                    "ref_id": null
                },
                {
                    "start": 6726,
                    "end": 6730,
                    "text": "[33]",
                    "ref_id": null
                },
                {
                    "start": 6731,
                    "end": 6735,
                    "text": "[34]",
                    "ref_id": null
                },
                {
                    "start": 6736,
                    "end": 6740,
                    "text": "[35]",
                    "ref_id": null
                },
                {
                    "start": 6741,
                    "end": 6747,
                    "text": "45:64,",
                    "ref_id": null
                },
                {
                    "start": 6748,
                    "end": 6751,
                    "text": "73,",
                    "ref_id": null
                },
                {
                    "start": 6752,
                    "end": 6776,
                    "text": "75 physical interaction,",
                    "ref_id": null
                },
                {
                    "start": 6777,
                    "end": 6805,
                    "text": "45:43 hybrid resistance and,",
                    "ref_id": null
                },
                {
                    "start": 6806,
                    "end": 6813,
                    "text": "41:350,",
                    "ref_id": null
                },
                {
                    "start": 6814,
                    "end": 6818,
                    "text": "393,",
                    "ref_id": null
                },
                {
                    "start": 6819,
                    "end": 6826,
                    "text": "44:154,",
                    "ref_id": null
                },
                {
                    "start": 6827,
                    "end": 6831,
                    "text": "168,",
                    "ref_id": null
                },
                {
                    "start": 6832,
                    "end": 6850,
                    "text": "189 human disease,",
                    "ref_id": null
                },
                {
                    "start": 6851,
                    "end": 6858,
                    "text": "44:192,",
                    "ref_id": null
                },
                {
                    "start": 6859,
                    "end": 6862,
                    "text": "194",
                    "ref_id": null
                },
                {
                    "start": 6863,
                    "end": 6870,
                    "text": "54:113,",
                    "ref_id": null
                },
                {
                    "start": 6871,
                    "end": 6889,
                    "text": "141 N K cells and,",
                    "ref_id": null
                },
                {
                    "start": 6890,
                    "end": 6897,
                    "text": "47:206,",
                    "ref_id": null
                },
                {
                    "start": 6898,
                    "end": 6902,
                    "text": "261,",
                    "ref_id": null
                },
                {
                    "start": 6903,
                    "end": 6937,
                    "text": "264 potential effector mechanisms,",
                    "ref_id": null
                },
                {
                    "start": 6938,
                    "end": 6954,
                    "text": "47:467 SCID and,",
                    "ref_id": null
                },
                {
                    "start": 6955,
                    "end": 6959,
                    "text": "387,",
                    "ref_id": null
                },
                {
                    "start": 6960,
                    "end": 6963,
                    "text": "398",
                    "ref_id": null
                },
                {
                    "start": 6964,
                    "end": 6970,
                    "text": "1 and,",
                    "ref_id": null
                },
                {
                    "start": 6971,
                    "end": 6978,
                    "text": "46:196,",
                    "ref_id": null
                },
                {
                    "start": 6979,
                    "end": 6983,
                    "text": "200,",
                    "ref_id": null
                },
                {
                    "start": 6984,
                    "end": 7010,
                    "text": "complement receptor 2 and,",
                    "ref_id": null
                },
                {
                    "start": 7011,
                    "end": 7018,
                    "text": "46:203,",
                    "ref_id": null
                },
                {
                    "start": 7019,
                    "end": 7023,
                    "text": "204,",
                    "ref_id": null
                },
                {
                    "start": 7024,
                    "end": 7032,
                    "text": "CTL and,",
                    "ref_id": null
                },
                {
                    "start": 7033,
                    "end": 7040,
                    "text": "41:169,",
                    "ref_id": null
                },
                {
                    "start": 7041,
                    "end": 7044,
                    "text": "170",
                    "ref_id": null
                },
                {
                    "start": 7062,
                    "end": 7072,
                    "text": "cells and,",
                    "ref_id": null
                },
                {
                    "start": 7073,
                    "end": 7080,
                    "text": "42:182;",
                    "ref_id": null
                },
                {
                    "start": 7081,
                    "end": 7088,
                    "text": "47:198,",
                    "ref_id": null
                },
                {
                    "start": 7089,
                    "end": 7098,
                    "text": "296 CD16,",
                    "ref_id": null
                },
                {
                    "start": 7099,
                    "end": 7106,
                    "text": "42:188,",
                    "ref_id": null
                },
                {
                    "start": 7107,
                    "end": 7112,
                    "text": "[190]",
                    "ref_id": null
                },
                {
                    "start": 7113,
                    "end": 7118,
                    "text": "[191]",
                    "ref_id": null
                },
                {
                    "start": 7119,
                    "end": 7135,
                    "text": "cell precursors,",
                    "ref_id": null
                },
                {
                    "start": 7136,
                    "end": 7143,
                    "text": "41:195,",
                    "ref_id": null
                },
                {
                    "start": 7144,
                    "end": 7179,
                    "text": "198 genetically detennined defects,",
                    "ref_id": null
                },
                {
                    "start": 7180,
                    "end": 7187,
                    "text": "41:224,",
                    "ref_id": null
                },
                {
                    "start": 7188,
                    "end": 7192,
                    "text": "226,",
                    "ref_id": null
                },
                {
                    "start": 7193,
                    "end": 7197,
                    "text": "228,",
                    "ref_id": null
                },
                {
                    "start": 7198,
                    "end": 7202,
                    "text": "231,",
                    "ref_id": null
                },
                {
                    "start": 7203,
                    "end": 7215,
                    "text": "232 B cells,",
                    "ref_id": null
                },
                {
                    "start": 7216,
                    "end": 7234,
                    "text": "59:300 box1 motif,",
                    "ref_id": null
                },
                {
                    "start": 7235,
                    "end": 7251,
                    "text": "60:12 Btk genes,",
                    "ref_id": null
                },
                {
                    "start": 7252,
                    "end": 7274,
                    "text": "195 CD4 molecules and,",
                    "ref_id": null
                },
                {
                    "start": 7275,
                    "end": 7282,
                    "text": "44:291,",
                    "ref_id": null
                },
                {
                    "start": 7283,
                    "end": 7302,
                    "text": "296 CD5 B cell and,",
                    "ref_id": null
                },
                {
                    "start": 7303,
                    "end": 7310,
                    "text": "47:132,",
                    "ref_id": null
                },
                {
                    "start": 7311,
                    "end": 7315,
                    "text": "146,",
                    "ref_id": null
                },
                {
                    "start": 7316,
                    "end": 7320,
                    "text": "154,",
                    "ref_id": null
                },
                {
                    "start": 7321,
                    "end": 7343,
                    "text": "155 CD5' B cell lines,",
                    "ref_id": null
                },
                {
                    "start": 7344,
                    "end": 7368,
                    "text": "55:330 CD23 antigen and,",
                    "ref_id": null
                },
                {
                    "start": 7418,
                    "end": 7424,
                    "text": "1 and,",
                    "ref_id": null
                },
                {
                    "start": 7425,
                    "end": 7432,
                    "text": "46:193,",
                    "ref_id": null
                },
                {
                    "start": 7433,
                    "end": 7437,
                    "text": "194,",
                    "ref_id": null
                },
                {
                    "start": 7438,
                    "end": 7464,
                    "text": "complement receptor 2 and,",
                    "ref_id": null
                },
                {
                    "start": 7465,
                    "end": 7480,
                    "text": "46:211 CTL and,",
                    "ref_id": null
                },
                {
                    "start": 7481,
                    "end": 7488,
                    "text": "41:138,",
                    "ref_id": null
                },
                {
                    "start": 7489,
                    "end": 7492,
                    "text": "169",
                    "ref_id": null
                },
                {
                    "start": 7493,
                    "end": 7509,
                    "text": "thyroiditis and,",
                    "ref_id": null
                },
                {
                    "start": 7510,
                    "end": 7517,
                    "text": "46:279,",
                    "ref_id": null
                },
                {
                    "start": 7518,
                    "end": 7522,
                    "text": "288,",
                    "ref_id": null
                },
                {
                    "start": 7523,
                    "end": 7527,
                    "text": "289,",
                    "ref_id": null
                },
                {
                    "start": 7528,
                    "end": 7553,
                    "text": "295 B cell formation and,",
                    "ref_id": null
                },
                {
                    "start": 7554,
                    "end": 7561,
                    "text": "41:192,",
                    "ref_id": null
                },
                {
                    "start": 7562,
                    "end": 7566,
                    "text": "199,",
                    "ref_id": null
                },
                {
                    "start": 7567,
                    "end": 7571,
                    "text": "225,",
                    "ref_id": null
                },
                {
                    "start": 7572,
                    "end": 7576,
                    "text": "231,",
                    "ref_id": null
                },
                {
                    "start": 7577,
                    "end": 7581,
                    "text": "236,",
                    "ref_id": null
                },
                {
                    "start": 7582,
                    "end": 7603,
                    "text": "237 CD23 antigen and,",
                    "ref_id": null
                },
                {
                    "start": 7604,
                    "end": 7622,
                    "text": "sulfasalazine and,",
                    "ref_id": null
                },
                {
                    "start": 7623,
                    "end": 7630,
                    "text": "42:187,",
                    "ref_id": null
                },
                {
                    "start": 7631,
                    "end": 7636,
                    "text": "[204]",
                    "ref_id": null
                },
                {
                    "start": 7637,
                    "end": 7642,
                    "text": "[205]",
                    "ref_id": null
                },
                {
                    "start": 7643,
                    "end": 7648,
                    "text": "[206]",
                    "ref_id": null
                },
                {
                    "start": 7649,
                    "end": 7656,
                    "text": "42:187,",
                    "ref_id": null
                },
                {
                    "start": 7657,
                    "end": 7662,
                    "text": "[194]",
                    "ref_id": null
                },
                {
                    "start": 7663,
                    "end": 7668,
                    "text": "[195]",
                    "ref_id": null
                },
                {
                    "start": 7669,
                    "end": 7674,
                    "text": "[196]",
                    "ref_id": null
                },
                {
                    "start": 7675,
                    "end": 7680,
                    "text": "[197]",
                    "ref_id": null
                },
                {
                    "start": 7681,
                    "end": 7686,
                    "text": "[198]",
                    "ref_id": null
                },
                {
                    "start": 7687,
                    "end": 7695,
                    "text": "205 CD3,",
                    "ref_id": null
                },
                {
                    "start": 7696,
                    "end": 7703,
                    "text": "42:187,",
                    "ref_id": null
                },
                {
                    "start": 7704,
                    "end": 7709,
                    "text": "[198]",
                    "ref_id": null
                },
                {
                    "start": 7710,
                    "end": 7715,
                    "text": "[199]",
                    "ref_id": null
                },
                {
                    "start": 7716,
                    "end": 7721,
                    "text": "[200]",
                    "ref_id": null
                },
                {
                    "start": 7722,
                    "end": 7727,
                    "text": "[201]",
                    "ref_id": null
                },
                {
                    "start": 7728,
                    "end": 7733,
                    "text": "[205]",
                    "ref_id": null
                },
                {
                    "start": 7734,
                    "end": 7739,
                    "text": "[206]",
                    "ref_id": null
                },
                {
                    "start": 7740,
                    "end": 7745,
                    "text": "[192]",
                    "ref_id": null
                },
                {
                    "start": 7746,
                    "end": 7751,
                    "text": "[193]",
                    "ref_id": null
                },
                {
                    "start": 7752,
                    "end": 7757,
                    "text": "[194]",
                    "ref_id": null
                },
                {
                    "start": 7758,
                    "end": 7765,
                    "text": "42:187,",
                    "ref_id": null
                },
                {
                    "start": 7766,
                    "end": 7771,
                    "text": "[190]",
                    "ref_id": null
                },
                {
                    "start": 7772,
                    "end": 7777,
                    "text": "[191]",
                    "ref_id": null
                },
                {
                    "start": 7778,
                    "end": 7781,
                    "text": "188",
                    "ref_id": null
                },
                {
                    "start": 7782,
                    "end": 7790,
                    "text": "IBD and,",
                    "ref_id": null
                },
                {
                    "start": 7791,
                    "end": 7798,
                    "text": "4228.5,",
                    "ref_id": null
                },
                {
                    "start": 7799,
                    "end": 7808,
                    "text": "286. 287,",
                    "ref_id": null
                },
                {
                    "start": 7809,
                    "end": 7812,
                    "text": "307",
                    "ref_id": null
                },
                {
                    "start": 7813,
                    "end": 7843,
                    "text": "and, 47:189, 190, 194, 201-204",
                    "ref_id": null
                },
                {
                    "start": 7844,
                    "end": 7858,
                    "text": "formation and,",
                    "ref_id": null
                },
                {
                    "start": 7859,
                    "end": 7866,
                    "text": "41:191,",
                    "ref_id": null
                },
                {
                    "start": 7867,
                    "end": 7871,
                    "text": "194,",
                    "ref_id": null
                },
                {
                    "start": 7872,
                    "end": 7876,
                    "text": "197,",
                    "ref_id": null
                },
                {
                    "start": 7877,
                    "end": 7895,
                    "text": "CD4 molecules and,",
                    "ref_id": null
                },
                {
                    "start": 7896,
                    "end": 7902,
                    "text": "44285,",
                    "ref_id": null
                },
                {
                    "start": 7903,
                    "end": 7922,
                    "text": "288 CD5 B cell and,",
                    "ref_id": null
                },
                {
                    "start": 7923,
                    "end": 7948,
                    "text": "47:144 CD8 molecules and,",
                    "ref_id": null
                },
                {
                    "start": 7949,
                    "end": 7955,
                    "text": "44274,",
                    "ref_id": null
                },
                {
                    "start": 7956,
                    "end": 7986,
                    "text": "276 complement receptor 2 and,",
                    "ref_id": null
                },
                {
                    "start": 7987,
                    "end": 8003,
                    "text": "46201 conjugate,",
                    "ref_id": null
                },
                {
                    "start": 8004,
                    "end": 8019,
                    "text": "58:322 CTL and,",
                    "ref_id": null
                },
                {
                    "start": 8020,
                    "end": 8029,
                    "text": "41:159 in",
                    "ref_id": null
                },
                {
                    "start": 8030,
                    "end": 8039,
                    "text": "CD45 and,",
                    "ref_id": null
                },
                {
                    "start": 8040,
                    "end": 8046,
                    "text": "66:24,",
                    "ref_id": null
                },
                {
                    "start": 8047,
                    "end": 8050,
                    "text": "37,",
                    "ref_id": null
                },
                {
                    "start": 8051,
                    "end": 8054,
                    "text": "39,",
                    "ref_id": null
                },
                {
                    "start": 8055,
                    "end": 8062,
                    "text": "44 p55,",
                    "ref_id": null
                },
                {
                    "start": 8063,
                    "end": 8090,
                    "text": "transcriptional regulation,",
                    "ref_id": null
                },
                {
                    "start": 8091,
                    "end": 8097,
                    "text": "p56'\",",
                    "ref_id": null
                },
                {
                    "start": 8140,
                    "end": 8149,
                    "text": "CD45 and,",
                    "ref_id": null
                },
                {
                    "start": 8150,
                    "end": 8156,
                    "text": "66:11,",
                    "ref_id": null
                },
                {
                    "start": 8157,
                    "end": 8160,
                    "text": "12,",
                    "ref_id": null
                },
                {
                    "start": 8161,
                    "end": 8165,
                    "text": "[19]",
                    "ref_id": null
                },
                {
                    "start": 8166,
                    "end": 8170,
                    "text": "[20]",
                    "ref_id": null
                },
                {
                    "start": 8171,
                    "end": 8175,
                    "text": "[21]",
                    "ref_id": null
                },
                {
                    "start": 8176,
                    "end": 8179,
                    "text": "26,",
                    "ref_id": null
                },
                {
                    "start": 8180,
                    "end": 8184,
                    "text": "[37]",
                    "ref_id": null
                },
                {
                    "start": 8185,
                    "end": 8189,
                    "text": "[38]",
                    "ref_id": null
                },
                {
                    "start": 8190,
                    "end": 8194,
                    "text": "[39]",
                    "ref_id": null
                },
                {
                    "start": 8195,
                    "end": 8232,
                    "text": "interaction with CD4 and CD8 phosphor",
                    "ref_id": null
                },
                {
                    "start": 8233,
                    "end": 8242,
                    "text": "CD45 and,",
                    "ref_id": null
                },
                {
                    "start": 8243,
                    "end": 8246,
                    "text": "37,",
                    "ref_id": null
                },
                {
                    "start": 8247,
                    "end": 8250,
                    "text": "38,",
                    "ref_id": null
                },
                {
                    "start": 8251,
                    "end": 8255,
                    "text": "[39]",
                    "ref_id": null
                },
                {
                    "start": 8256,
                    "end": 8260,
                    "text": "[40]",
                    "ref_id": null
                },
                {
                    "start": 8261,
                    "end": 8265,
                    "text": "[41]",
                    "ref_id": null
                },
                {
                    "start": 8266,
                    "end": 8270,
                    "text": "[42]",
                    "ref_id": null
                },
                {
                    "start": 8271,
                    "end": 8275,
                    "text": "[43]",
                    "ref_id": null
                },
                {
                    "start": 8329,
                    "end": 8344,
                    "text": "and, 61:188-190",
                    "ref_id": null
                },
                {
                    "start": 8354,
                    "end": 8363,
                    "text": "CD45 and,",
                    "ref_id": null
                },
                {
                    "start": 8364,
                    "end": 8366,
                    "text": "26",
                    "ref_id": null
                },
                {
                    "start": 8374,
                    "end": 8383,
                    "text": "CD45 and,",
                    "ref_id": null
                },
                {
                    "start": 8384,
                    "end": 8389,
                    "text": "6621,",
                    "ref_id": null
                },
                {
                    "start": 8390,
                    "end": 8394,
                    "text": "[23]",
                    "ref_id": null
                },
                {
                    "start": 8395,
                    "end": 8399,
                    "text": "[24]",
                    "ref_id": null
                },
                {
                    "start": 8400,
                    "end": 8402,
                    "text": "26",
                    "ref_id": null
                },
                {
                    "start": 8434,
                    "end": 8444,
                    "text": "virus and,",
                    "ref_id": null
                },
                {
                    "start": 8445,
                    "end": 8452,
                    "text": "45:350,",
                    "ref_id": null
                },
                {
                    "start": 8453,
                    "end": 8457,
                    "text": "352,",
                    "ref_id": null
                },
                {
                    "start": 8458,
                    "end": 8463,
                    "text": "[354]",
                    "ref_id": null
                },
                {
                    "start": 8464,
                    "end": 8469,
                    "text": "[355]",
                    "ref_id": null
                },
                {
                    "start": 8470,
                    "end": 8475,
                    "text": "[356]",
                    "ref_id": null
                },
                {
                    "start": 8476,
                    "end": 8481,
                    "text": "[357]",
                    "ref_id": null
                },
                {
                    "start": 8482,
                    "end": 8487,
                    "text": "[358]",
                    "ref_id": null
                },
                {
                    "start": 8488,
                    "end": 8493,
                    "text": "[359]",
                    "ref_id": null
                },
                {
                    "start": 8494,
                    "end": 8499,
                    "text": "[360]",
                    "ref_id": null
                },
                {
                    "start": 8500,
                    "end": 8505,
                    "text": "[361]",
                    "ref_id": null
                },
                {
                    "start": 8506,
                    "end": 8511,
                    "text": "[362]",
                    "ref_id": null
                },
                {
                    "start": 8512,
                    "end": 8524,
                    "text": "367 IRD and,",
                    "ref_id": null
                },
                {
                    "start": 8525,
                    "end": 8532,
                    "text": "42:289,",
                    "ref_id": null
                },
                {
                    "start": 8533,
                    "end": 8538,
                    "text": "[294]",
                    "ref_id": null
                },
                {
                    "start": 8539,
                    "end": 8544,
                    "text": "[295]",
                    "ref_id": null
                },
                {
                    "start": 8545,
                    "end": 8550,
                    "text": "[296]",
                    "ref_id": null
                },
                {
                    "start": 8551,
                    "end": 8556,
                    "text": "[297]",
                    "ref_id": null
                },
                {
                    "start": 8557,
                    "end": 8562,
                    "text": "47:6,",
                    "ref_id": null
                },
                {
                    "start": 8563,
                    "end": 8566,
                    "text": "7 ,",
                    "ref_id": null
                },
                {
                    "start": 8567,
                    "end": 8593,
                    "text": "9. 12. 38 binding factors,",
                    "ref_id": null
                },
                {
                    "start": 8594,
                    "end": 8599,
                    "text": "4721,",
                    "ref_id": null
                },
                {
                    "start": 8600,
                    "end": 8616,
                    "text": "22 ineasles and,",
                    "ref_id": null
                },
                {
                    "start": 8617,
                    "end": 8629,
                    "text": "45:338. 340,",
                    "ref_id": null
                },
                {
                    "start": 8630,
                    "end": 8634,
                    "text": "342,",
                    "ref_id": null
                },
                {
                    "start": 8635,
                    "end": 8653,
                    "text": "346 N K cells and,",
                    "ref_id": null
                },
                {
                    "start": 8659,
                    "end": 8667,
                    "text": "IRD and,",
                    "ref_id": null
                },
                {
                    "start": 8668,
                    "end": 8669,
                    "text": ",",
                    "ref_id": null
                },
                {
                    "start": 8670,
                    "end": 8690,
                    "text": "corticosteroids and,",
                    "ref_id": null
                },
                {
                    "start": 8691,
                    "end": 8697,
                    "text": "42:316",
                    "ref_id": null
                },
                {
                    "start": 8729,
                    "end": 8752,
                    "text": "MG and, 42:261 phagocl;",
                    "ref_id": null
                },
                {
                    "start": 8753,
                    "end": 8774,
                    "text": "tosis, IBD and, 42307",
                    "ref_id": null
                },
                {
                    "start": 8791,
                    "end": 8805,
                    "text": "formation and,",
                    "ref_id": null
                },
                {
                    "start": 8806,
                    "end": 8813,
                    "text": "41:212,",
                    "ref_id": null
                },
                {
                    "start": 8814,
                    "end": 8835,
                    "text": "213 CD23 antigen and,",
                    "ref_id": null
                },
                {
                    "start": 8836,
                    "end": 8842,
                    "text": "49:167",
                    "ref_id": null
                },
                {
                    "start": 8863,
                    "end": 8869,
                    "text": "1 and,",
                    "ref_id": null
                },
                {
                    "start": 8870,
                    "end": 8877,
                    "text": "46:183,",
                    "ref_id": null
                },
                {
                    "start": 8878,
                    "end": 8882,
                    "text": "186,",
                    "ref_id": null
                },
                {
                    "start": 8883,
                    "end": 8898,
                    "text": "by eosinophils,",
                    "ref_id": null
                },
                {
                    "start": 8899,
                    "end": 8928,
                    "text": "39:208 hybrid resistance and,",
                    "ref_id": null
                },
                {
                    "start": 8929,
                    "end": 8936,
                    "text": "41:340,",
                    "ref_id": null
                },
                {
                    "start": 8937,
                    "end": 8941,
                    "text": "357,",
                    "ref_id": null
                },
                {
                    "start": 8942,
                    "end": 8959,
                    "text": "370 Ir genes and,",
                    "ref_id": null
                },
                {
                    "start": 8960,
                    "end": 8990,
                    "text": "38:94 leukocyte integrins and,",
                    "ref_id": null
                },
                {
                    "start": 8991,
                    "end": 8998,
                    "text": "46:151,",
                    "ref_id": null
                },
                {
                    "start": 8999,
                    "end": 9002,
                    "text": "161",
                    "ref_id": null
                },
                {
                    "start": 9003,
                    "end": 9021,
                    "text": "B cell precursors,",
                    "ref_id": null
                },
                {
                    "start": 9022,
                    "end": 9029,
                    "text": "41:192,",
                    "ref_id": null
                },
                {
                    "start": 9030,
                    "end": 9043,
                    "text": "201 Ig genes,",
                    "ref_id": null
                },
                {
                    "start": 9044,
                    "end": 9051,
                    "text": "41:204,",
                    "ref_id": null
                },
                {
                    "start": 9052,
                    "end": 9082,
                    "text": "205 lymphahemopoietic tissues,",
                    "ref_id": null
                },
                {
                    "start": 9083,
                    "end": 9099,
                    "text": "41:187 NZB mice,",
                    "ref_id": null
                },
                {
                    "start": 9100,
                    "end": 9107,
                    "text": "41:227,",
                    "ref_id": null
                },
                {
                    "start": 9108,
                    "end": 9128,
                    "text": "229 WMI anemic mice,",
                    "ref_id": null
                },
                {
                    "start": 9129,
                    "end": 9162,
                    "text": "41:2a4 CD4 and CD8 molecules and,",
                    "ref_id": null
                },
                {
                    "start": 9163,
                    "end": 9170,
                    "text": "44:266,",
                    "ref_id": null
                },
                {
                    "start": 9171,
                    "end": 9175,
                    "text": "277,",
                    "ref_id": null
                },
                {
                    "start": 9176,
                    "end": 9191,
                    "text": "CD5 B cell and,",
                    "ref_id": null
                },
                {
                    "start": 9192,
                    "end": 9199,
                    "text": "47:120,",
                    "ref_id": null
                },
                {
                    "start": 9200,
                    "end": 9220,
                    "text": "122 279 mdignancies,",
                    "ref_id": null
                },
                {
                    "start": 9221,
                    "end": 9240,
                    "text": "47: 124 physiology,",
                    "ref_id": null
                },
                {
                    "start": 9241,
                    "end": 9248,
                    "text": "47:132,",
                    "ref_id": null
                },
                {
                    "start": 9249,
                    "end": 9253,
                    "text": "135,",
                    "ref_id": null
                },
                {
                    "start": 9254,
                    "end": 9258,
                    "text": "140,",
                    "ref_id": null
                },
                {
                    "start": 9259,
                    "end": 9280,
                    "text": "142 cytotoxicify and,",
                    "ref_id": null
                },
                {
                    "start": 9281,
                    "end": 9288,
                    "text": "41:273,",
                    "ref_id": null
                },
                {
                    "start": 9289,
                    "end": 9292,
                    "text": "287",
                    "ref_id": null
                },
                {
                    "start": 9349,
                    "end": 9363,
                    "text": "cytokines and,",
                    "ref_id": null
                },
                {
                    "start": 9364,
                    "end": 9371,
                    "text": "46:111,",
                    "ref_id": null
                },
                {
                    "start": 9372,
                    "end": 9376,
                    "text": "123,",
                    "ref_id": null
                },
                {
                    "start": 9377,
                    "end": 9396,
                    "text": "IIIV infection and,",
                    "ref_id": null
                },
                {
                    "start": 9397,
                    "end": 9417,
                    "text": "47:384 human B cell,",
                    "ref_id": null
                },
                {
                    "start": 9418,
                    "end": 9424,
                    "text": "44:70,",
                    "ref_id": null
                },
                {
                    "start": 9425,
                    "end": 9453,
                    "text": "139 B cell antigen receptor,",
                    "ref_id": null
                },
                {
                    "start": 9454,
                    "end": 9500,
                    "text": "rnodek and, 4664. 82, 94 N K cells and, 47292,",
                    "ref_id": null
                },
                {
                    "start": 9501,
                    "end": 9535,
                    "text": "CD4 and CD8 molecules and. 44:268,",
                    "ref_id": null
                },
                {
                    "start": 9536,
                    "end": 9556,
                    "text": "269 CD.5 B cell and,",
                    "ref_id": null
                },
                {
                    "start": 9557,
                    "end": 9564,
                    "text": "47:125,",
                    "ref_id": null
                },
                {
                    "start": 9565,
                    "end": 9569,
                    "text": "126,",
                    "ref_id": null
                },
                {
                    "start": 9570,
                    "end": 9600,
                    "text": "141 iniiiiiinoseiiescence and,",
                    "ref_id": null
                },
                {
                    "start": 9601,
                    "end": 9613,
                    "text": "46:224. 226,",
                    "ref_id": null
                },
                {
                    "start": 9614,
                    "end": 9618,
                    "text": "228,",
                    "ref_id": null
                },
                {
                    "start": 9619,
                    "end": 9619,
                    "text": "",
                    "ref_id": null
                },
                {
                    "start": 9661,
                    "end": 9696,
                    "text": "activation and, 41:8, 9, 11. 12, 14",
                    "ref_id": null
                },
                {
                    "start": 9708,
                    "end": 9753,
                    "text": "CTL and. 41:153 T cell activation and. 41:16,",
                    "ref_id": null
                },
                {
                    "start": 9754,
                    "end": 9764,
                    "text": "24 49:194,",
                    "ref_id": null
                },
                {
                    "start": 9765,
                    "end": 9770,
                    "text": "[236]",
                    "ref_id": null
                },
                {
                    "start": 9771,
                    "end": 9776,
                    "text": "[237]",
                    "ref_id": null
                },
                {
                    "start": 9777,
                    "end": 9781,
                    "text": "242,",
                    "ref_id": null
                },
                {
                    "start": 9782,
                    "end": 9785,
                    "text": "248",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "368"
        },
        {
            "text": "Phosphatidylcholine aPL antibodies and, 49259 biochemistry, 49:194, [196] [197] 248, 251 cytotoxicity and. 41:275, 44:175, 176, 185 I'liosphatidylethaiiolainine, aPL antibodies and hiochemistry. 49:194, [196] [197] 49:202 LA antibodies, [251] [252] 49:194, 229, Phosphatidylinositol \u20ac3 cell formation and, 41:197, 198, 202 47:lOl antinuclear antibodies and. 44:llS. 120, autoimniune thyroiditis and, 46:267 CD4 and CD8 molecules and, 44:269, 296. CD23 antigen and, 49:156 CD45, coinpletnent receptor 1 and, 46:187, 199 phosphorylation 124 300 complement receptor 2 and, 46:202, 208, CTL and. 41:135, 148 cytoplasmic tail of CD44, 54:281 cytotoxicity and, 588 IgE hiosynthesis and, 44:163, 184 iinmunosenescence and, 46:222 involvement, 46:155, 169 lvniphocyte homing and, , 58:127-128, 130 T cell activation, 41:4, 16, 18, 19, 23, 24; 48:269-285 threonine, 48:270- autoimmune thyroiditis and, 46:293, 310 B cell formation and, 41:198 CD23 antigen and, 49:150, 171 CTL and, 41:50 HIV infection and, 47:390, 398, 399, 401 hybrid resistance and, 41:359, 361 -polyclonal growth of hnman T cells, SCID and, 49 206, 224 isotype, 49:227 pathogenic potential, [244] [245] [247] [248] 47:132 genetically engineered antibodies, 4476 HIV infection and, 9, 13 NK cells and, 47:267 cells and, 4751. 68 antinuclear antibodies and, 44:109 Plasma membrane (continued) aPL antibodies and, 49:193, 197, 204, CD8 molecules and, 44:273 complement receptor 1 and, 46:191, 192, complement receptor 2 and, 46204, 209 HIV infection and, 44:163, 166, 175, 182, 184, 185 immuiiosenescence and, 46224, 226, 235 lymphocyte homing and, 44:319, 368 NK cells and, 199 Plasma Ig gene superfamily and, 44:39, 44, 44:153, 158, 164, 168, genes, evolutionaly relationship, Platelet factor 4 biological effects on neutrophils, 55:115 chemical properties, 55:97, 99-100 Platelet neutralization procedure, aPL antibodies and, 49:202, 244 Platelets aggregation, 49:193, 197 affinity purification, 49:231 binding to cell membranes, 49:200, [202] [203] 213 pathogenic potential, 49:239, [241] [242] [244] [245] [246] 49:161, 167 contact activation system, 665244 Fc receptors on, 54:309 IgE, 44:153, 167 SCID and, 49:382 surface antigens of human leukocytes and, see Cisplatin Platinum compounds, in cancer treatment, 56:329, 332 Pleckstrin homology domain, Btk, Pleiotropic effects, 185, [187] [188] [189] OSM, CNTF, reduction by coinpartnientalization, [196] [197] [198] 52:199 Polyc~oria~ B cell activation, resistance and, 41371-372, 388-390 Poly(l.-lysine) , synthetic T and B cell sites and, 45:198, 199 formation and, 41:193, 197, 223, CD1 proteins, 38:206, 49:365, [368] [369] 229 236 of C2, 38:208, 209 of C4, 38:223, 225, [229] [230] [231] 38:204 of' Factor B, 227 restriction fragment length, 38:215, 216 amino acid, 165 exon shuftling, 41:141, 142 HLA class I antigens, 41:151 mAbs, 41:158, 16#5 CTL and, 169 hybrid resistance and, 41:367, 400 leukocytes and, synthetic T and B cell sites and, 45:229 T cell receptor, 38:16; 45:108 45:388, 396, 92 TAP, [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] 45:149, 154, 156 homogeneity, 45: 129 MHC molecules, 45~112, [115] [116] [117] 45:132 residues, thyroiditis and, 46:272 B cell formation and, 41:190 CD4 and CD8 molecules and, 44:298 CD4 molecular biology, 44:284-287 CD8 molecular biology, 44:270-275, 277-280, 284 CD5 B cell and, 47:142 cell-mediated killing and, 41:291, 292, 298, complernent receptor 1 and, 46:184 complement receptor 2 and, 46:204 CTL and, 41:168 cytolysis and, 41276, 279, 285 cytotoxicity and, 41309, 319 genetically engineered antibody niolecrtles 313 and cloning, 44:73 expression, 44:79 fusion proteins, 44535, 86 production, 44:193 receptor, 44:180, 183 structure, 44:155 TNF, 44:185, inimunosenescence and, 46:229, 156 lymphocyte homing and, 44:342, :371 imps of Ig-like loci and, 46:2, 46 structure, 46:i. 12. 20 T cell receptor, 46:35, 41-43 N K cells and, 47202, 203. 208, 213 pore formers and, 41:316, 317 regulators of coinplement activation and, sporozoite inalaria vaccine and 45:392, 405 CS proteins, 45:294, 295, 300 human trials, 45:315 Pla.smo:liuni uivcix, 45:318 surface antigens of human leukocytes and, synthetic T and B cell sites and hacterial antigc, ns, 45:238 prediction, 45:251 vaccine, 45253, 255 viral antigens, 45221. 224 49:92, 94. 101, [112] [113] 41:lO. 17, 23 T cell receptor and accessory molecules, 45:109 antigen processing. 45:120 homogeneity, 45:130 MHC molecules, 45:112 T cell repertoire, 45:165 T cell subsets and. 41:41, 43, 50, 51, 75 Polyperforin 1, cytotoxicity and, 41:280, 288 Polperforin 2, cyfotoxicity and, 41:280 Pol~.phosphot~~onoester, lymphocyte homing Polyps. nasal, endothelial adhesion of Polyiihosomes. B cell formation and, 41:183 Polysaccharides and, :370 eosinophils, 49:162 lymphocyte homing and, 44:320, 356, 357. siirhice antigens of human leukocytes and. tumors and, antigen-presenting cells and, 47:65, 68, 49:308-310, 321, 325, 329-332 71-73, 75, 80 T cells, 47:82, 83, 85, 86, 94 tissue distribution, 4756 autoimmune demyelinating disease and, CD5 B cell and, 47:137, 139 hybrid resistance and, 47:6, 29, 30, 32, 33, binding factors, 26, 28 Primordial germ cells, LIF effects, 41:72, 74, 100 mechanisms, 49:300, 302, 304 principles, 49:289-290, 294, 298 49:325-330 autoimmune demyelinating disease and, 49359-360, 362, 364-366. 370 B cell formation and, 41:183, 184, 186, 187 B cell precursors, 41:192, 200, 202 bone marrow cultures, 41:210, 212 genetically determined defects, 41:225, 229, 231, 232, 234 inducible cell line, 41:220 population dynamics, 41:205-207 B cells, 40:6 antibody response and, 41:269 hybrid resistance and, 41:384, 390, 391, bone marrow cells, 41:335, 336, 338, lymphoid cells, 41:352, SClD and, [390] [391] 400 stein cell factor receptor-ligand interaction in, 55:39-40",
            "cite_spans": [
                {
                    "start": 24,
                    "end": 39,
                    "text": "antibodies and,",
                    "ref_id": null
                },
                {
                    "start": 40,
                    "end": 59,
                    "text": "49259 biochemistry,",
                    "ref_id": null
                },
                {
                    "start": 60,
                    "end": 67,
                    "text": "49:194,",
                    "ref_id": null
                },
                {
                    "start": 68,
                    "end": 73,
                    "text": "[196]",
                    "ref_id": null
                },
                {
                    "start": 74,
                    "end": 79,
                    "text": "[197]",
                    "ref_id": null
                },
                {
                    "start": 80,
                    "end": 84,
                    "text": "248,",
                    "ref_id": null
                },
                {
                    "start": 85,
                    "end": 114,
                    "text": "251 cytotoxicity and. 41:275,",
                    "ref_id": null
                },
                {
                    "start": 115,
                    "end": 122,
                    "text": "44:175,",
                    "ref_id": null
                },
                {
                    "start": 123,
                    "end": 127,
                    "text": "176,",
                    "ref_id": null
                },
                {
                    "start": 128,
                    "end": 161,
                    "text": "185 I'liosphatidylethaiiolainine,",
                    "ref_id": null
                },
                {
                    "start": 162,
                    "end": 202,
                    "text": "aPL antibodies and hiochemistry. 49:194,",
                    "ref_id": null
                },
                {
                    "start": 203,
                    "end": 208,
                    "text": "[196]",
                    "ref_id": null
                },
                {
                    "start": 209,
                    "end": 214,
                    "text": "[197]",
                    "ref_id": null
                },
                {
                    "start": 215,
                    "end": 236,
                    "text": "49:202 LA antibodies,",
                    "ref_id": null
                },
                {
                    "start": 237,
                    "end": 242,
                    "text": "[251]",
                    "ref_id": null
                },
                {
                    "start": 243,
                    "end": 248,
                    "text": "[252]",
                    "ref_id": null
                },
                {
                    "start": 249,
                    "end": 256,
                    "text": "49:194,",
                    "ref_id": null
                },
                {
                    "start": 257,
                    "end": 261,
                    "text": "229,",
                    "ref_id": null
                },
                {
                    "start": 291,
                    "end": 322,
                    "text": "formation and, 41:197, 198, 202",
                    "ref_id": null
                },
                {
                    "start": 323,
                    "end": 370,
                    "text": "47:lOl antinuclear antibodies and. 44:llS. 120,",
                    "ref_id": null
                },
                {
                    "start": 371,
                    "end": 399,
                    "text": "autoimniune thyroiditis and,",
                    "ref_id": null
                },
                {
                    "start": 400,
                    "end": 433,
                    "text": "46:267 CD4 and CD8 molecules and,",
                    "ref_id": null
                },
                {
                    "start": 434,
                    "end": 441,
                    "text": "44:269,",
                    "ref_id": null
                },
                {
                    "start": 442,
                    "end": 464,
                    "text": "296. CD23 antigen and,",
                    "ref_id": null
                },
                {
                    "start": 465,
                    "end": 477,
                    "text": "49:156 CD45,",
                    "ref_id": null
                },
                {
                    "start": 500,
                    "end": 518,
                    "text": "1 and, 46:187, 199",
                    "ref_id": null
                },
                {
                    "start": 563,
                    "end": 569,
                    "text": "2 and,",
                    "ref_id": null
                },
                {
                    "start": 570,
                    "end": 577,
                    "text": "46:202,",
                    "ref_id": null
                },
                {
                    "start": 578,
                    "end": 582,
                    "text": "208,",
                    "ref_id": null
                },
                {
                    "start": 583,
                    "end": 599,
                    "text": "CTL and. 41:135,",
                    "ref_id": null
                },
                {
                    "start": 600,
                    "end": 629,
                    "text": "148 cytoplasmic tail of CD44,",
                    "ref_id": null
                },
                {
                    "start": 630,
                    "end": 654,
                    "text": "54:281 cytotoxicity and,",
                    "ref_id": null
                },
                {
                    "start": 655,
                    "end": 680,
                    "text": "588 IgE hiosynthesis and,",
                    "ref_id": null
                },
                {
                    "start": 681,
                    "end": 688,
                    "text": "44:163,",
                    "ref_id": null
                },
                {
                    "start": 689,
                    "end": 715,
                    "text": "184 iinmunosenescence and,",
                    "ref_id": null
                },
                {
                    "start": 716,
                    "end": 735,
                    "text": "46:222 involvement,",
                    "ref_id": null
                },
                {
                    "start": 736,
                    "end": 743,
                    "text": "46:155,",
                    "ref_id": null
                },
                {
                    "start": 744,
                    "end": 771,
                    "text": "169 lvniphocyte homing and,",
                    "ref_id": null
                },
                {
                    "start": 772,
                    "end": 864,
                    "text": ", 58:127-128, 130 T cell activation, 41:4, 16, 18, 19, 23, 24; 48:269-285 threonine, 48:270-",
                    "ref_id": null
                },
                {
                    "start": 876,
                    "end": 892,
                    "text": "thyroiditis and,",
                    "ref_id": null
                },
                {
                    "start": 893,
                    "end": 900,
                    "text": "46:293,",
                    "ref_id": null
                },
                {
                    "start": 901,
                    "end": 926,
                    "text": "310 B cell formation and,",
                    "ref_id": null
                },
                {
                    "start": 927,
                    "end": 951,
                    "text": "41:198 CD23 antigen and,",
                    "ref_id": null
                },
                {
                    "start": 952,
                    "end": 959,
                    "text": "49:150,",
                    "ref_id": null
                },
                {
                    "start": 960,
                    "end": 972,
                    "text": "171 CTL and,",
                    "ref_id": null
                },
                {
                    "start": 973,
                    "end": 997,
                    "text": "41:50 HIV infection and,",
                    "ref_id": null
                },
                {
                    "start": 998,
                    "end": 1005,
                    "text": "47:390,",
                    "ref_id": null
                },
                {
                    "start": 1006,
                    "end": 1010,
                    "text": "398,",
                    "ref_id": null
                },
                {
                    "start": 1011,
                    "end": 1015,
                    "text": "399,",
                    "ref_id": null
                },
                {
                    "start": 1016,
                    "end": 1042,
                    "text": "401 hybrid resistance and,",
                    "ref_id": null
                },
                {
                    "start": 1043,
                    "end": 1050,
                    "text": "41:359,",
                    "ref_id": null
                },
                {
                    "start": 1051,
                    "end": 1054,
                    "text": "361",
                    "ref_id": null
                },
                {
                    "start": 1092,
                    "end": 1101,
                    "text": "SCID and,",
                    "ref_id": null
                },
                {
                    "start": 1102,
                    "end": 1104,
                    "text": "49",
                    "ref_id": null
                },
                {
                    "start": 1105,
                    "end": 1109,
                    "text": "206,",
                    "ref_id": null
                },
                {
                    "start": 1110,
                    "end": 1122,
                    "text": "224 isotype,",
                    "ref_id": null
                },
                {
                    "start": 1123,
                    "end": 1151,
                    "text": "49:227 pathogenic potential,",
                    "ref_id": null
                },
                {
                    "start": 1152,
                    "end": 1157,
                    "text": "[244]",
                    "ref_id": null
                },
                {
                    "start": 1158,
                    "end": 1163,
                    "text": "[245]",
                    "ref_id": null
                },
                {
                    "start": 1164,
                    "end": 1169,
                    "text": "[247]",
                    "ref_id": null
                },
                {
                    "start": 1170,
                    "end": 1175,
                    "text": "[248]",
                    "ref_id": null
                },
                {
                    "start": 1176,
                    "end": 1217,
                    "text": "47:132 genetically engineered antibodies,",
                    "ref_id": null
                },
                {
                    "start": 1218,
                    "end": 1241,
                    "text": "4476 HIV infection and,",
                    "ref_id": null
                },
                {
                    "start": 1242,
                    "end": 1244,
                    "text": "9,",
                    "ref_id": null
                },
                {
                    "start": 1245,
                    "end": 1261,
                    "text": "13 NK cells and,",
                    "ref_id": null
                },
                {
                    "start": 1262,
                    "end": 1268,
                    "text": "47:267",
                    "ref_id": null
                },
                {
                    "start": 1269,
                    "end": 1279,
                    "text": "cells and,",
                    "ref_id": null
                },
                {
                    "start": 1280,
                    "end": 1316,
                    "text": "4751. 68 antinuclear antibodies and,",
                    "ref_id": null
                },
                {
                    "start": 1317,
                    "end": 1351,
                    "text": "44:109 Plasma membrane (continued)",
                    "ref_id": null
                },
                {
                    "start": 1356,
                    "end": 1371,
                    "text": "antibodies and,",
                    "ref_id": null
                },
                {
                    "start": 1372,
                    "end": 1379,
                    "text": "49:193,",
                    "ref_id": null
                },
                {
                    "start": 1380,
                    "end": 1384,
                    "text": "197,",
                    "ref_id": null
                },
                {
                    "start": 1385,
                    "end": 1389,
                    "text": "204,",
                    "ref_id": null
                },
                {
                    "start": 1390,
                    "end": 1408,
                    "text": "CD8 molecules and,",
                    "ref_id": null
                },
                {
                    "start": 1409,
                    "end": 1442,
                    "text": "44:273 complement receptor 1 and,",
                    "ref_id": null
                },
                {
                    "start": 1443,
                    "end": 1450,
                    "text": "46:191,",
                    "ref_id": null
                },
                {
                    "start": 1451,
                    "end": 1455,
                    "text": "192,",
                    "ref_id": null
                },
                {
                    "start": 1456,
                    "end": 1482,
                    "text": "complement receptor 2 and,",
                    "ref_id": null
                },
                {
                    "start": 1483,
                    "end": 1489,
                    "text": "46204,",
                    "ref_id": null
                },
                {
                    "start": 1490,
                    "end": 1512,
                    "text": "209 HIV infection and,",
                    "ref_id": null
                },
                {
                    "start": 1513,
                    "end": 1520,
                    "text": "44:163,",
                    "ref_id": null
                },
                {
                    "start": 1521,
                    "end": 1525,
                    "text": "166,",
                    "ref_id": null
                },
                {
                    "start": 1526,
                    "end": 1530,
                    "text": "175,",
                    "ref_id": null
                },
                {
                    "start": 1531,
                    "end": 1535,
                    "text": "182,",
                    "ref_id": null
                },
                {
                    "start": 1536,
                    "end": 1540,
                    "text": "184,",
                    "ref_id": null
                },
                {
                    "start": 1541,
                    "end": 1567,
                    "text": "185 immuiiosenescence and,",
                    "ref_id": null
                },
                {
                    "start": 1568,
                    "end": 1574,
                    "text": "46224,",
                    "ref_id": null
                },
                {
                    "start": 1575,
                    "end": 1579,
                    "text": "226,",
                    "ref_id": null
                },
                {
                    "start": 1580,
                    "end": 1606,
                    "text": "235 lymphocyte homing and,",
                    "ref_id": null
                },
                {
                    "start": 1607,
                    "end": 1614,
                    "text": "44:319,",
                    "ref_id": null
                },
                {
                    "start": 1615,
                    "end": 1632,
                    "text": "368 NK cells and,",
                    "ref_id": null
                },
                {
                    "start": 1633,
                    "end": 1636,
                    "text": "199",
                    "ref_id": null
                },
                {
                    "start": 1652,
                    "end": 1668,
                    "text": "superfamily and,",
                    "ref_id": null
                },
                {
                    "start": 1669,
                    "end": 1675,
                    "text": "44:39,",
                    "ref_id": null
                },
                {
                    "start": 1676,
                    "end": 1679,
                    "text": "44,",
                    "ref_id": null
                },
                {
                    "start": 1680,
                    "end": 1687,
                    "text": "44:153,",
                    "ref_id": null
                },
                {
                    "start": 1688,
                    "end": 1692,
                    "text": "158,",
                    "ref_id": null
                },
                {
                    "start": 1693,
                    "end": 1697,
                    "text": "164,",
                    "ref_id": null
                },
                {
                    "start": 1698,
                    "end": 1702,
                    "text": "168,",
                    "ref_id": null
                },
                {
                    "start": 1703,
                    "end": 1709,
                    "text": "genes,",
                    "ref_id": null
                },
                {
                    "start": 1710,
                    "end": 1736,
                    "text": "evolutionaly relationship,",
                    "ref_id": null
                },
                {
                    "start": 1871,
                    "end": 1886,
                    "text": "antibodies and,",
                    "ref_id": null
                },
                {
                    "start": 1887,
                    "end": 1894,
                    "text": "49:202,",
                    "ref_id": null
                },
                {
                    "start": 1895,
                    "end": 1921,
                    "text": "244 Platelets aggregation,",
                    "ref_id": null
                },
                {
                    "start": 1922,
                    "end": 1929,
                    "text": "49:193,",
                    "ref_id": null
                },
                {
                    "start": 1930,
                    "end": 1956,
                    "text": "197 affinity purification,",
                    "ref_id": null
                },
                {
                    "start": 1957,
                    "end": 1990,
                    "text": "49:231 binding to cell membranes,",
                    "ref_id": null
                },
                {
                    "start": 1991,
                    "end": 1998,
                    "text": "49:200,",
                    "ref_id": null
                },
                {
                    "start": 1999,
                    "end": 2004,
                    "text": "[202]",
                    "ref_id": null
                },
                {
                    "start": 2005,
                    "end": 2010,
                    "text": "[203]",
                    "ref_id": null
                },
                {
                    "start": 2011,
                    "end": 2036,
                    "text": "213 pathogenic potential,",
                    "ref_id": null
                },
                {
                    "start": 2037,
                    "end": 2044,
                    "text": "49:239,",
                    "ref_id": null
                },
                {
                    "start": 2045,
                    "end": 2050,
                    "text": "[241]",
                    "ref_id": null
                },
                {
                    "start": 2051,
                    "end": 2056,
                    "text": "[242]",
                    "ref_id": null
                },
                {
                    "start": 2057,
                    "end": 2062,
                    "text": "[244]",
                    "ref_id": null
                },
                {
                    "start": 2063,
                    "end": 2068,
                    "text": "[245]",
                    "ref_id": null
                },
                {
                    "start": 2069,
                    "end": 2074,
                    "text": "[246]",
                    "ref_id": null
                },
                {
                    "start": 2075,
                    "end": 2082,
                    "text": "49:161,",
                    "ref_id": null
                },
                {
                    "start": 2083,
                    "end": 2113,
                    "text": "167 contact activation system,",
                    "ref_id": null
                },
                {
                    "start": 2114,
                    "end": 2137,
                    "text": "665244 Fc receptors on,",
                    "ref_id": null
                },
                {
                    "start": 2138,
                    "end": 2149,
                    "text": "54:309 IgE,",
                    "ref_id": null
                },
                {
                    "start": 2150,
                    "end": 2157,
                    "text": "44:153,",
                    "ref_id": null
                },
                {
                    "start": 2158,
                    "end": 2171,
                    "text": "167 SCID and,",
                    "ref_id": null
                },
                {
                    "start": 2172,
                    "end": 2178,
                    "text": "49:382",
                    "ref_id": null
                },
                {
                    "start": 2205,
                    "end": 2220,
                    "text": "leukocytes and,",
                    "ref_id": null
                },
                {
                    "start": 2221,
                    "end": 2254,
                    "text": "see Cisplatin Platinum compounds,",
                    "ref_id": null
                },
                {
                    "start": 2255,
                    "end": 2275,
                    "text": "in cancer treatment,",
                    "ref_id": null
                },
                {
                    "start": 2276,
                    "end": 2283,
                    "text": "56:329,",
                    "ref_id": null
                },
                {
                    "start": 2284,
                    "end": 2287,
                    "text": "332",
                    "ref_id": null
                },
                {
                    "start": 2316,
                    "end": 2320,
                    "text": "Btk,",
                    "ref_id": null
                },
                {
                    "start": 2321,
                    "end": 2341,
                    "text": "Pleiotropic effects,",
                    "ref_id": null
                },
                {
                    "start": 2342,
                    "end": 2346,
                    "text": "185,",
                    "ref_id": null
                },
                {
                    "start": 2347,
                    "end": 2352,
                    "text": "[187]",
                    "ref_id": null
                },
                {
                    "start": 2353,
                    "end": 2358,
                    "text": "[188]",
                    "ref_id": null
                },
                {
                    "start": 2359,
                    "end": 2364,
                    "text": "[189]",
                    "ref_id": null
                },
                {
                    "start": 2365,
                    "end": 2369,
                    "text": "OSM,",
                    "ref_id": null
                },
                {
                    "start": 2370,
                    "end": 2375,
                    "text": "CNTF,",
                    "ref_id": null
                },
                {
                    "start": 2413,
                    "end": 2418,
                    "text": "[196]",
                    "ref_id": null
                },
                {
                    "start": 2419,
                    "end": 2424,
                    "text": "[197]",
                    "ref_id": null
                },
                {
                    "start": 2425,
                    "end": 2430,
                    "text": "[198]",
                    "ref_id": null
                },
                {
                    "start": 2431,
                    "end": 2468,
                    "text": "52:199 Polyc~oria~ B cell activation,",
                    "ref_id": null
                },
                {
                    "start": 2469,
                    "end": 2519,
                    "text": "resistance and, 41371-372, 388-390 Poly(l.-lysine)",
                    "ref_id": null
                },
                {
                    "start": 2532,
                    "end": 2567,
                    "text": "T and B cell sites and, 45:198, 199",
                    "ref_id": null
                },
                {
                    "start": 2568,
                    "end": 2582,
                    "text": "formation and,",
                    "ref_id": null
                },
                {
                    "start": 2583,
                    "end": 2590,
                    "text": "41:193,",
                    "ref_id": null
                },
                {
                    "start": 2591,
                    "end": 2595,
                    "text": "197,",
                    "ref_id": null
                },
                {
                    "start": 2596,
                    "end": 2600,
                    "text": "223,",
                    "ref_id": null
                },
                {
                    "start": 2601,
                    "end": 2614,
                    "text": "CD1 proteins,",
                    "ref_id": null
                },
                {
                    "start": 2615,
                    "end": 2622,
                    "text": "38:206,",
                    "ref_id": null
                },
                {
                    "start": 2623,
                    "end": 2630,
                    "text": "49:365,",
                    "ref_id": null
                },
                {
                    "start": 2631,
                    "end": 2636,
                    "text": "[368]",
                    "ref_id": null
                },
                {
                    "start": 2637,
                    "end": 2642,
                    "text": "[369]",
                    "ref_id": null
                },
                {
                    "start": 2643,
                    "end": 2657,
                    "text": "229 236 of C2,",
                    "ref_id": null
                },
                {
                    "start": 2658,
                    "end": 2665,
                    "text": "38:208,",
                    "ref_id": null
                },
                {
                    "start": 2666,
                    "end": 2676,
                    "text": "209 of C4,",
                    "ref_id": null
                },
                {
                    "start": 2677,
                    "end": 2684,
                    "text": "38:223,",
                    "ref_id": null
                },
                {
                    "start": 2685,
                    "end": 2689,
                    "text": "225,",
                    "ref_id": null
                },
                {
                    "start": 2690,
                    "end": 2695,
                    "text": "[229]",
                    "ref_id": null
                },
                {
                    "start": 2696,
                    "end": 2701,
                    "text": "[230]",
                    "ref_id": null
                },
                {
                    "start": 2702,
                    "end": 2707,
                    "text": "[231]",
                    "ref_id": null
                },
                {
                    "start": 2708,
                    "end": 2728,
                    "text": "38:204 of' Factor B,",
                    "ref_id": null
                },
                {
                    "start": 2729,
                    "end": 2761,
                    "text": "227 restriction fragment length,",
                    "ref_id": null
                },
                {
                    "start": 2762,
                    "end": 2769,
                    "text": "38:215,",
                    "ref_id": null
                },
                {
                    "start": 2770,
                    "end": 2785,
                    "text": "216 amino acid,",
                    "ref_id": null
                },
                {
                    "start": 2786,
                    "end": 2805,
                    "text": "165 exon shuftling,",
                    "ref_id": null
                },
                {
                    "start": 2806,
                    "end": 2813,
                    "text": "41:141,",
                    "ref_id": null
                },
                {
                    "start": 2814,
                    "end": 2839,
                    "text": "142 HLA class I antigens,",
                    "ref_id": null
                },
                {
                    "start": 2840,
                    "end": 2852,
                    "text": "41:151 mAbs,",
                    "ref_id": null
                },
                {
                    "start": 2853,
                    "end": 2860,
                    "text": "41:158,",
                    "ref_id": null
                },
                {
                    "start": 2861,
                    "end": 2874,
                    "text": "16#5 CTL and,",
                    "ref_id": null
                },
                {
                    "start": 2875,
                    "end": 2878,
                    "text": "169",
                    "ref_id": null
                },
                {
                    "start": 2886,
                    "end": 2913,
                    "text": "resistance and, 41:367, 400",
                    "ref_id": null
                },
                {
                    "start": 2914,
                    "end": 2929,
                    "text": "leukocytes and,",
                    "ref_id": null
                },
                {
                    "start": 2930,
                    "end": 2963,
                    "text": "synthetic T and B cell sites and,",
                    "ref_id": null
                },
                {
                    "start": 2964,
                    "end": 2987,
                    "text": "45:229 T cell receptor,",
                    "ref_id": null
                },
                {
                    "start": 2988,
                    "end": 2994,
                    "text": "38:16;",
                    "ref_id": null
                },
                {
                    "start": 2995,
                    "end": 3009,
                    "text": "45:108 45:388,",
                    "ref_id": null
                },
                {
                    "start": 3010,
                    "end": 3014,
                    "text": "396,",
                    "ref_id": null
                },
                {
                    "start": 3015,
                    "end": 3022,
                    "text": "92 TAP,",
                    "ref_id": null
                },
                {
                    "start": 3023,
                    "end": 3027,
                    "text": "[65]",
                    "ref_id": null
                },
                {
                    "start": 3028,
                    "end": 3032,
                    "text": "[66]",
                    "ref_id": null
                },
                {
                    "start": 3033,
                    "end": 3037,
                    "text": "[67]",
                    "ref_id": null
                },
                {
                    "start": 3038,
                    "end": 3042,
                    "text": "[68]",
                    "ref_id": null
                },
                {
                    "start": 3043,
                    "end": 3047,
                    "text": "[69]",
                    "ref_id": null
                },
                {
                    "start": 3048,
                    "end": 3052,
                    "text": "[70]",
                    "ref_id": null
                },
                {
                    "start": 3053,
                    "end": 3057,
                    "text": "[71]",
                    "ref_id": null
                },
                {
                    "start": 3058,
                    "end": 3062,
                    "text": "[72]",
                    "ref_id": null
                },
                {
                    "start": 3063,
                    "end": 3067,
                    "text": "[73]",
                    "ref_id": null
                },
                {
                    "start": 3068,
                    "end": 3072,
                    "text": "[74]",
                    "ref_id": null
                },
                {
                    "start": 3073,
                    "end": 3077,
                    "text": "[75]",
                    "ref_id": null
                },
                {
                    "start": 3078,
                    "end": 3085,
                    "text": "45:149,",
                    "ref_id": null
                },
                {
                    "start": 3086,
                    "end": 3090,
                    "text": "154,",
                    "ref_id": null
                },
                {
                    "start": 3091,
                    "end": 3107,
                    "text": "156 homogeneity,",
                    "ref_id": null
                },
                {
                    "start": 3108,
                    "end": 3130,
                    "text": "45: 129 MHC molecules,",
                    "ref_id": null
                },
                {
                    "start": 3131,
                    "end": 3138,
                    "text": "45~112,",
                    "ref_id": null
                },
                {
                    "start": 3139,
                    "end": 3144,
                    "text": "[115]",
                    "ref_id": null
                },
                {
                    "start": 3145,
                    "end": 3150,
                    "text": "[116]",
                    "ref_id": null
                },
                {
                    "start": 3151,
                    "end": 3156,
                    "text": "[117]",
                    "ref_id": null
                },
                {
                    "start": 3157,
                    "end": 3173,
                    "text": "45:132 residues,",
                    "ref_id": null
                },
                {
                    "start": 3174,
                    "end": 3555,
                    "text": "thyroiditis and, 46:272 B cell formation and, 41:190 CD4 and CD8 molecules and, 44:298 CD4 molecular biology, 44:284-287 CD8 molecular biology, 44:270-275, 277-280, 284 CD5 B cell and, 47:142 cell-mediated killing and, 41:291, 292, 298, complernent receptor 1 and, 46:184 complement receptor 2 and, 46:204 CTL and, 41:168 cytolysis and, 41276, 279, 285 cytotoxicity and, 41309, 319",
                    "ref_id": null
                },
                {
                    "start": 3600,
                    "end": 3616,
                    "text": "313 and cloning,",
                    "ref_id": null
                },
                {
                    "start": 3617,
                    "end": 3634,
                    "text": "44:73 expression,",
                    "ref_id": null
                },
                {
                    "start": 3635,
                    "end": 3657,
                    "text": "44:79 fusion proteins,",
                    "ref_id": null
                },
                {
                    "start": 3658,
                    "end": 3664,
                    "text": "44535,",
                    "ref_id": null
                },
                {
                    "start": 3665,
                    "end": 3679,
                    "text": "86 production,",
                    "ref_id": null
                },
                {
                    "start": 3680,
                    "end": 3696,
                    "text": "44:193 receptor,",
                    "ref_id": null
                },
                {
                    "start": 3697,
                    "end": 3704,
                    "text": "44:180,",
                    "ref_id": null
                },
                {
                    "start": 3705,
                    "end": 3719,
                    "text": "183 structure,",
                    "ref_id": null
                },
                {
                    "start": 3720,
                    "end": 3731,
                    "text": "44:155 TNF,",
                    "ref_id": null
                },
                {
                    "start": 3732,
                    "end": 3739,
                    "text": "44:185,",
                    "ref_id": null
                },
                {
                    "start": 3740,
                    "end": 3762,
                    "text": "inimunosenescence and,",
                    "ref_id": null
                },
                {
                    "start": 3763,
                    "end": 3770,
                    "text": "46:229,",
                    "ref_id": null
                },
                {
                    "start": 3771,
                    "end": 3797,
                    "text": "156 lymphocyte homing and,",
                    "ref_id": null
                },
                {
                    "start": 3798,
                    "end": 3805,
                    "text": "44:342,",
                    "ref_id": null
                },
                {
                    "start": 3806,
                    "end": 3810,
                    "text": ":371",
                    "ref_id": null
                },
                {
                    "start": 3827,
                    "end": 3965,
                    "text": "loci and, 46:2, 46 structure, 46:i. 12. 20 T cell receptor, 46:35, 41-43 N K cells and, 47202, 203. 208, 213 pore formers and, 41:316, 317",
                    "ref_id": null
                },
                {
                    "start": 4028,
                    "end": 4047,
                    "text": "vaccine and 45:392,",
                    "ref_id": null
                },
                {
                    "start": 4048,
                    "end": 4064,
                    "text": "405 CS proteins,",
                    "ref_id": null
                },
                {
                    "start": 4065,
                    "end": 4072,
                    "text": "45:294,",
                    "ref_id": null
                },
                {
                    "start": 4073,
                    "end": 4077,
                    "text": "295,",
                    "ref_id": null
                },
                {
                    "start": 4078,
                    "end": 4095,
                    "text": "300 human trials,",
                    "ref_id": null
                },
                {
                    "start": 4096,
                    "end": 4124,
                    "text": "45:315 Pla.smo:liuni uivcix,",
                    "ref_id": null
                },
                {
                    "start": 4125,
                    "end": 4131,
                    "text": "45:318",
                    "ref_id": null
                },
                {
                    "start": 4158,
                    "end": 4173,
                    "text": "leukocytes and,",
                    "ref_id": null
                },
                {
                    "start": 4174,
                    "end": 4224,
                    "text": "synthetic T and B cell sites and hacterial antigc,",
                    "ref_id": null
                },
                {
                    "start": 4225,
                    "end": 4228,
                    "text": "ns,",
                    "ref_id": null
                },
                {
                    "start": 4229,
                    "end": 4247,
                    "text": "45:238 prediction,",
                    "ref_id": null
                },
                {
                    "start": 4248,
                    "end": 4263,
                    "text": "45:251 vaccine,",
                    "ref_id": null
                },
                {
                    "start": 4264,
                    "end": 4270,
                    "text": "45253,",
                    "ref_id": null
                },
                {
                    "start": 4271,
                    "end": 4290,
                    "text": "255 viral antigens,",
                    "ref_id": null
                },
                {
                    "start": 4291,
                    "end": 4308,
                    "text": "45221. 224 49:92,",
                    "ref_id": null
                },
                {
                    "start": 4309,
                    "end": 4317,
                    "text": "94. 101,",
                    "ref_id": null
                },
                {
                    "start": 4318,
                    "end": 4323,
                    "text": "[112]",
                    "ref_id": null
                },
                {
                    "start": 4324,
                    "end": 4329,
                    "text": "[113]",
                    "ref_id": null
                },
                {
                    "start": 4330,
                    "end": 4340,
                    "text": "41:lO. 17,",
                    "ref_id": null
                },
                {
                    "start": 4341,
                    "end": 4384,
                    "text": "23 T cell receptor and accessory molecules,",
                    "ref_id": null
                },
                {
                    "start": 4385,
                    "end": 4431,
                    "text": "45:109 antigen processing. 45:120 homogeneity,",
                    "ref_id": null
                },
                {
                    "start": 4432,
                    "end": 4453,
                    "text": "45:130 MHC molecules,",
                    "ref_id": null
                },
                {
                    "start": 4454,
                    "end": 4479,
                    "text": "45:112 T cell repertoire,",
                    "ref_id": null
                },
                {
                    "start": 4480,
                    "end": 4513,
                    "text": "45:165 T cell subsets and. 41:41,",
                    "ref_id": null
                },
                {
                    "start": 4514,
                    "end": 4517,
                    "text": "43,",
                    "ref_id": null
                },
                {
                    "start": 4518,
                    "end": 4521,
                    "text": "50,",
                    "ref_id": null
                },
                {
                    "start": 4522,
                    "end": 4525,
                    "text": "51,",
                    "ref_id": null
                },
                {
                    "start": 4526,
                    "end": 4528,
                    "text": "75",
                    "ref_id": null
                },
                {
                    "start": 4545,
                    "end": 4562,
                    "text": "cytotoxicity and,",
                    "ref_id": null
                },
                {
                    "start": 4563,
                    "end": 4570,
                    "text": "41:280,",
                    "ref_id": null
                },
                {
                    "start": 4571,
                    "end": 4589,
                    "text": "288 Polperforin 2,",
                    "ref_id": null
                },
                {
                    "start": 4590,
                    "end": 4607,
                    "text": "cyfotoxicity and,",
                    "ref_id": null
                },
                {
                    "start": 4608,
                    "end": 4639,
                    "text": "41:280 Pol~.phosphot~~onoester,",
                    "ref_id": null
                },
                {
                    "start": 4640,
                    "end": 4657,
                    "text": "lymphocyte homing",
                    "ref_id": null
                },
                {
                    "start": 4719,
                    "end": 4733,
                    "text": "formation and,",
                    "ref_id": null
                },
                {
                    "start": 4734,
                    "end": 4761,
                    "text": "41:183 Polysaccharides and,",
                    "ref_id": null
                },
                {
                    "start": 4762,
                    "end": 4779,
                    "text": ":370 eosinophils,",
                    "ref_id": null
                },
                {
                    "start": 4780,
                    "end": 4809,
                    "text": "49:162 lymphocyte homing and,",
                    "ref_id": null
                },
                {
                    "start": 4810,
                    "end": 4817,
                    "text": "44:320,",
                    "ref_id": null
                },
                {
                    "start": 4818,
                    "end": 4822,
                    "text": "356,",
                    "ref_id": null
                },
                {
                    "start": 4823,
                    "end": 4827,
                    "text": "357.",
                    "ref_id": null
                },
                {
                    "start": 4871,
                    "end": 4998,
                    "text": "tumors and, antigen-presenting cells and, 47:65, 68, 49:308-310, 321, 325, 329-332 71-73, 75, 80 T cells, 47:82, 83, 85, 86, 94",
                    "ref_id": null
                },
                {
                    "start": 5050,
                    "end": 5062,
                    "text": "disease and,",
                    "ref_id": null
                },
                {
                    "start": 5063,
                    "end": 5078,
                    "text": "CD5 B cell and,",
                    "ref_id": null
                },
                {
                    "start": 5079,
                    "end": 5086,
                    "text": "47:137,",
                    "ref_id": null
                },
                {
                    "start": 5087,
                    "end": 5090,
                    "text": "139",
                    "ref_id": null
                },
                {
                    "start": 5098,
                    "end": 5113,
                    "text": "resistance and,",
                    "ref_id": null
                },
                {
                    "start": 5114,
                    "end": 5119,
                    "text": "47:6,",
                    "ref_id": null
                },
                {
                    "start": 5120,
                    "end": 5123,
                    "text": "29,",
                    "ref_id": null
                },
                {
                    "start": 5124,
                    "end": 5127,
                    "text": "30,",
                    "ref_id": null
                },
                {
                    "start": 5128,
                    "end": 5131,
                    "text": "32,",
                    "ref_id": null
                },
                {
                    "start": 5132,
                    "end": 5135,
                    "text": "33,",
                    "ref_id": null
                },
                {
                    "start": 5136,
                    "end": 5152,
                    "text": "binding factors,",
                    "ref_id": null
                },
                {
                    "start": 5153,
                    "end": 5156,
                    "text": "26,",
                    "ref_id": null
                },
                {
                    "start": 5157,
                    "end": 5182,
                    "text": "28 Primordial germ cells,",
                    "ref_id": null
                },
                {
                    "start": 5183,
                    "end": 5195,
                    "text": "LIF effects,",
                    "ref_id": null
                },
                {
                    "start": 5196,
                    "end": 5202,
                    "text": "41:72,",
                    "ref_id": null
                },
                {
                    "start": 5203,
                    "end": 5206,
                    "text": "74,",
                    "ref_id": null
                },
                {
                    "start": 5207,
                    "end": 5210,
                    "text": "100",
                    "ref_id": null
                },
                {
                    "start": 5211,
                    "end": 5283,
                    "text": "mechanisms, 49:300, 302, 304 principles, 49:289-290, 294, 298 49:325-330",
                    "ref_id": null
                },
                {
                    "start": 5309,
                    "end": 5597,
                    "text": "disease and, 49359-360, 362, 364-366. 370 B cell formation and, 41:183, 184, 186, 187 B cell precursors, 41:192, 200, 202 bone marrow cultures, 41:210, 212 genetically determined defects, 41:225, 229, 231, 232, 234 inducible cell line, 41:220 population dynamics, 41:205-207 B cells, 40:6",
                    "ref_id": null
                },
                {
                    "start": 5607,
                    "end": 5620,
                    "text": "response and,",
                    "ref_id": null
                },
                {
                    "start": 5621,
                    "end": 5650,
                    "text": "41:269 hybrid resistance and,",
                    "ref_id": null
                },
                {
                    "start": 5651,
                    "end": 5658,
                    "text": "41:384,",
                    "ref_id": null
                },
                {
                    "start": 5659,
                    "end": 5663,
                    "text": "390,",
                    "ref_id": null
                },
                {
                    "start": 5664,
                    "end": 5668,
                    "text": "391,",
                    "ref_id": null
                },
                {
                    "start": 5669,
                    "end": 5687,
                    "text": "bone marrow cells,",
                    "ref_id": null
                },
                {
                    "start": 5688,
                    "end": 5695,
                    "text": "41:335,",
                    "ref_id": null
                },
                {
                    "start": 5696,
                    "end": 5700,
                    "text": "336,",
                    "ref_id": null
                },
                {
                    "start": 5701,
                    "end": 5705,
                    "text": "338,",
                    "ref_id": null
                },
                {
                    "start": 5706,
                    "end": 5721,
                    "text": "lymphoid cells,",
                    "ref_id": null
                },
                {
                    "start": 5722,
                    "end": 5729,
                    "text": "41:352,",
                    "ref_id": null
                },
                {
                    "start": 5730,
                    "end": 5739,
                    "text": "SClD and,",
                    "ref_id": null
                },
                {
                    "start": 5740,
                    "end": 5745,
                    "text": "[390]",
                    "ref_id": null
                },
                {
                    "start": 5746,
                    "end": 5751,
                    "text": "[391]",
                    "ref_id": null
                },
                {
                    "start": 5752,
                    "end": 5755,
                    "text": "400",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "368"
        },
        {
            "text": "T cell activation and. 41:1, 6, 7, 9, 10, 12-15, 26 T cell clone, 58:126-127 T cells, 51:106-110 anergy . , 47:382 IgE biosynthesis and, 44:175, 176, 179, see MAP kinase NK cells and, 47:249, 271 P34\"\" . cell cycle regulatory, blockade, stress-activated, 63:148 surface antigens of human leukocytes and, 49:77, 81, 83, 113 T cell, signal transduction, 48:284 T cell development and, 44:214, 226 58:267 Proteiu kinase Ia, interaction with CD3/\"CH Protein kinase A, inhibition, 63:51 Protein kinase B, 48:79, [270] [271] [272] [273] [274] complex, 46:296 B cell formation and, 41:222 CD45, 41:296, 297 complement receptor 1 and, 46:187, 199 complement receptor 2 and, 46:202, 208 49:283, 334-335 49:324, 331-332 antigen-presenting cells and, 47:46, 64-73, 77 antigen processing, 47:87, 88, 90, 91 cell surface, 47:60 immunogeneity, 47:104 T cells, 47:86, 94, 99, 101 autoantibodies, 44:125, 127, 137, 138 autoantigen, 44: 127- antibodies and, 4493, 94 scleroderma, 44:121, 122, 124, 125 Sjogren's syndrome, 44:112, 113, 115 SLE, 44:98, [100] [101] [102] [103] [104] [105] [106] 108, 109 aPL antibodies and, 49:195, 259 affinity purification, 49:200, 203, 213 pathogenic potential, specificity, [247] [248] [256] [257] 250-252 autoimmune dernyelinating disease and, autoimmune thyroiditis and, 46:265, 266, 49:369 315, 316 antigens, 46:268, 272 cellular immune responses, 46:294 experimental models, 46:276 B cell formation and, 41:205, 216, 239 B cell precursors, 41:191, 197, 198 inducible cell lines, 41:221, 222 biosynthesized, targeting to class I processing pathway, 52:19-21 CD4 and CD8 molecules and, 44:265, 266, 297, 298, 303 CD4 molecular biology, 44285, CD8 molecular biology, [288] [289] [290] [291] 284 CD5 B cell and, 47:126 Ig gene expression, 47:150, 153, 154, physiology 1 and, 46:185, 186, complement receptor 2 and, 46:201-203 CTL and, 41:135, 148, 153, 154, 159, 165, cytotoxicity and, 41:269, 270, 320 190, 194, 197, 199 168 cell-mediated killing, 41:289-295, 297, cytolysis, 41277-281, 316- genetically engineered antibody molecules and, 44:84, 85 chimeric antibodies, 44:79, 80, 82, 87 cloning, 4475 expression, 44:76, 78 fusion, 44:85, 86 lymphoid mammalian cells, 44:70 production, 79 granule eosinophil, [205] [206] [207] [208] 221 rule in DNA fragmentation, 60:300-301 Iielper T cell cytokines and, 46:115, 116, HIV infection and 123 activation, 384, 385 immune response, 409, 411 itnniunopathogenic mechanism, 47:387, 392 , 47:31, 32, 34, 39 binding factors, 20, 22, [24] [25] [26] [27] 44:43, 44 homology unit, 44:5, 6, 8 MHC complex, 44:24, 26, 28 nonirnmiine receptor members, 44:30, receptors, 44:10, 11, 14, 16, 17, 21 31, [34] [35] [36] [37] [39] [40] [41] Ig heavy-chain variable region genes and, 49:33 regulation, [49] [50] [51] [52] [53] [54] [55] [56] [57] 11, 15, 18 VH gene expression, 49:39, 41, 43, 46, 51 biological effects, 163 hunian disease, 44:192, 194 immunocotnpetent cells, 44:173, 177, receptor, 44:179, [182] [183] [184] properties, 563 iinmunogenicity, 43:2 iinmuno~ene~cence and, 46:222, 223, [227] [228] [229] [230] 234 interaction with Ig conserved octanucleotide, 43:254-255 isoforn-specific TGF-P-binding, 55:199 KB-dependent, inappropriate expression, leukocyte integrins and 44:154, 46:164, 165, 169 leukocyte adhesion deficiency disease, ligand molecules, 46:171 structure, 46:153, 154, 158, 159 carbohydrate, 44:354, 356, 364, 369, molecules, 44:342, [345] [346] [347] [348] [349] 351, 32 structure, 46:8, 10, 12, 13, 15, 17, 19 T cell receptor, 46 cells and, 47:284, 287, 291 liner sequences, 47:252, 255 effecter mechanisms, 47:241, 242, lymphokines, 47:263, 265 surface phenotype, 47:203, 205 octanucleotide, buried surfaces, 43:lOl oncogenic, 64:65 recognition by T cells, 58:420-421 outer membrane, Chlornydia, 60:136 posttranslational modification, 64:169 regulators of complement activation and, [244] [245] [246] 410, 411 expression, 45:403, 405, 408 interactions, 45:383, 384 roles, 45:409, 410 retroviral, 43:304 SCID and, spontaneous autoimmune thyroiditis and, sporozoite malaria vaccine and, 476, 479 antibodies, 45:300 CS proteins, 45:291, 45:306 Phsmodium zjiunx, 45317, 318 surface antigens of human leukocytes and, 49:85, 90, [115] [116] [117] 79 MIIC glycoproteins, 49:80, 82 in switch recombination. 54239-240 synthetic T and B cell sites and, 45:195, 197, [259] [260] [261] [262] [263] [264] 45:234 globular protein antigens, 45:201, parasitic antigens, 45:203, [230] [231] [232] [237] [238] [239] 45:218, 219, 221, 223, T cell development and, 44:232, 234, 241 T cell receptor and, 45:107 227, 228 accessory nrolecules, 45:llO alloreactivity, 45:149 antigen processing, 45:llR. 119, 124, epitopes, 45:131, 132, 137 homogeneity, 45:128, 129 MHC ~nolecules, 45:117 peptides, 45:138, 139 Proteoliposoines, cytotoxicity and, 41:274, 278, 303 Proteolysis, 64 :3 additional fkictors in selectivity, 52:34-35 antigen-presenting cells and, 47:66, 87, 88 in antigen processing, functional evidence, antinuclear antibodies and, 44:132, 135 hackground information, 47:130, 161 CD23 antigen and, 173 chemokines, 41:275. 276 leukocytes and, 49:90, 93, 112 T cell activation and, 41:18 T cell subsets and, 44:66, 44:158, 162, 164, 188, 192 selectivity, Prothroinbin. aPL antibodies and, 49:231, [242] [243] aPL antibodies and, 49:199 59:383; 62:276; 64:144, 145; phosphorylation, 355, 363, 367 cooperative ligand binding site, 64:148, 167 genetic studies, 64:194 ligands, 58:360; tumors and, 49:282, 320, 335 mechanisms, 49:292, 295 antinuclear antibodies and, 44:130 autoimmune thyroidltis and. 46:275 B cell formation and, 41:195, 233 CD4 and CD8 molecules and, 44:269, 284, endogenous, insertions 1 and, 44:191, [193] [194] [195] 54 models and, 4664, 91, 92, 98 N K cells and, 47:187, 283, 289, 290, 292 formation and, 41:181, 182, 184, 187, 206, 237 B cell precursors, 41:188, 191, 195, 199 formation and, 41:184, 185, 237, 238 B cell precursors, 41:198, 200 antibodies and, 49:193. 198, 209, 212, 219. 250, 257 conformation and recognition, 43:194, MHC interaction model, 43:201 processing, formation and, 41:194, 199, 225, 226, 237 C, domain. 43 formation and, 41:205, 212, 225, 236 B cell precursors, 41:189, 191, 192, 198 antibodies and, 49:194, 199, 257- MG and, 42:235, 256, 259, 270,  Thymoma cells 272 CD4 and CD8 molecules and, 44:179, 181, 194 T cell development and, 44:215 Thymopoietin, 47:47, 48, 81 antinuclear antibodies and, 44:106, 107, autoimmune thyroiditis and, 46:276, 286 autoreactive T cells and, 45:417, 421, 423, B cell formation and, 41:191, 223, Thyroid-stimulating hormone, see Thyrotropin Thyrotropin, 47:457, 458, 461; 272 experimental models, 46:275, 278, 279, 294 prevention, 46:279, 311 Thyroxine, 46:269, 278; 47:437, 439, 457 forination and, 41:192, 198, 204, 205, 221, 222. 226 CD1 gencs, 59:7, [9] [10] 44:275. 277, 279 CD23 antigen and, nniltiple products, 54278 cytotoaicity and. 41:271, 276, 277 activation and, 41:3, 5, 8, 11, 25 T cell development and, 44~210, 212 T cell subsets and, 41:58, 59, 62, 80, 47:89 B cell formation and, 41:193, 212 immunosenescence and, 46:222, 227 NK cells and, 47:209, 240 SCID and, Transforming growth factor p, 48:169; 52:173, 199; 55:181-183, 205-206; 59:235, 418, 419; 61:86, 87-90, 353, 374; 62:84-85, 90 55:188, 353, 374 55:182-183, 195 signaling, 55:200-202 functions, 55:203-204 194-195 binding of isoforms, 55:194 Transforming growth factor P receptor (continued ) cDNA cloning, 55:188-189, 192 structure, 55:190-193 soluble TGF-P-binding proteins, sources and structure, 52:183-184 type I, 55:195-196, 206 type I1 55:194 cDNA cloning, 205 signal transduction, 55:206 structural comparisons with actin receptor 11, 55:198 type V, antibodies and, 44:128 CD4 molecules and, 44:289, 290 CD8 inolecnles and, 44:275, 277, 44:155, [159] [160] [161] [162] 164, 42:176 T cell development and, 44:241 adoptive T cell therapy of tumors and, formation and, 41:186, 204, 230, 233,237 B cell precursors, 41:188, 193, 194, 196 CTL and, 41:135, 138, 139, 154 cytotoxicity and, 41:270, [284] [285] [286] 293 CTL and, 41:135, 142, 153, 154, 165 cytotoxicity and, 41:269, 270 helper T cell cytokines and, 46:127, 129, and host, role Ig heavy-chain variable region genes and,",
            "cite_spans": [
                {
                    "start": 18,
                    "end": 96,
                    "text": "and. 41:1, 6, 7, 9, 10, 12-15, 26 T cell clone, 58:126-127 T cells, 51:106-110",
                    "ref_id": null
                },
                {
                    "start": 106,
                    "end": 107,
                    "text": ",",
                    "ref_id": null
                },
                {
                    "start": 108,
                    "end": 136,
                    "text": "47:382 IgE biosynthesis and,",
                    "ref_id": null
                },
                {
                    "start": 137,
                    "end": 144,
                    "text": "44:175,",
                    "ref_id": null
                },
                {
                    "start": 145,
                    "end": 149,
                    "text": "176,",
                    "ref_id": null
                },
                {
                    "start": 150,
                    "end": 154,
                    "text": "179,",
                    "ref_id": null
                },
                {
                    "start": 155,
                    "end": 183,
                    "text": "see MAP kinase NK cells and,",
                    "ref_id": null
                },
                {
                    "start": 184,
                    "end": 191,
                    "text": "47:249,",
                    "ref_id": null
                },
                {
                    "start": 192,
                    "end": 195,
                    "text": "271",
                    "ref_id": null
                },
                {
                    "start": 288,
                    "end": 401,
                    "text": "leukocytes and, 49:77, 81, 83, 113 T cell, signal transduction, 48:284 T cell development and, 44:214, 226 58:267",
                    "ref_id": null
                },
                {
                    "start": 461,
                    "end": 463,
                    "text": "A,",
                    "ref_id": null
                },
                {
                    "start": 464,
                    "end": 475,
                    "text": "inhibition,",
                    "ref_id": null
                },
                {
                    "start": 476,
                    "end": 499,
                    "text": "63:51 Protein kinase B,",
                    "ref_id": null
                },
                {
                    "start": 500,
                    "end": 506,
                    "text": "48:79,",
                    "ref_id": null
                },
                {
                    "start": 507,
                    "end": 512,
                    "text": "[270]",
                    "ref_id": null
                },
                {
                    "start": 513,
                    "end": 518,
                    "text": "[271]",
                    "ref_id": null
                },
                {
                    "start": 519,
                    "end": 524,
                    "text": "[272]",
                    "ref_id": null
                },
                {
                    "start": 525,
                    "end": 530,
                    "text": "[273]",
                    "ref_id": null
                },
                {
                    "start": 531,
                    "end": 536,
                    "text": "[274]",
                    "ref_id": null
                },
                {
                    "start": 537,
                    "end": 545,
                    "text": "complex,",
                    "ref_id": null
                },
                {
                    "start": 546,
                    "end": 574,
                    "text": "46:296 B cell formation and,",
                    "ref_id": null
                },
                {
                    "start": 575,
                    "end": 587,
                    "text": "41:222 CD45,",
                    "ref_id": null
                },
                {
                    "start": 588,
                    "end": 595,
                    "text": "41:296,",
                    "ref_id": null
                },
                {
                    "start": 596,
                    "end": 626,
                    "text": "297 complement receptor 1 and,",
                    "ref_id": null
                },
                {
                    "start": 627,
                    "end": 634,
                    "text": "46:187,",
                    "ref_id": null
                },
                {
                    "start": 635,
                    "end": 665,
                    "text": "199 complement receptor 2 and,",
                    "ref_id": null
                },
                {
                    "start": 666,
                    "end": 673,
                    "text": "46:202,",
                    "ref_id": null
                },
                {
                    "start": 674,
                    "end": 677,
                    "text": "208",
                    "ref_id": null
                },
                {
                    "start": 678,
                    "end": 924,
                    "text": "49:283, 334-335 49:324, 331-332 antigen-presenting cells and, 47:46, 64-73, 77 antigen processing, 47:87, 88, 90, 91 cell surface, 47:60 immunogeneity, 47:104 T cells, 47:86, 94, 99, 101 autoantibodies, 44:125, 127, 137, 138 autoantigen, 44: 127-",
                    "ref_id": null
                },
                {
                    "start": 925,
                    "end": 940,
                    "text": "antibodies and,",
                    "ref_id": null
                },
                {
                    "start": 941,
                    "end": 946,
                    "text": "4493,",
                    "ref_id": null
                },
                {
                    "start": 947,
                    "end": 962,
                    "text": "94 scleroderma,",
                    "ref_id": null
                },
                {
                    "start": 963,
                    "end": 970,
                    "text": "44:121,",
                    "ref_id": null
                },
                {
                    "start": 971,
                    "end": 975,
                    "text": "122,",
                    "ref_id": null
                },
                {
                    "start": 976,
                    "end": 980,
                    "text": "124,",
                    "ref_id": null
                },
                {
                    "start": 981,
                    "end": 1004,
                    "text": "125 Sjogren's syndrome,",
                    "ref_id": null
                },
                {
                    "start": 1005,
                    "end": 1012,
                    "text": "44:112,",
                    "ref_id": null
                },
                {
                    "start": 1013,
                    "end": 1017,
                    "text": "113,",
                    "ref_id": null
                },
                {
                    "start": 1018,
                    "end": 1026,
                    "text": "115 SLE,",
                    "ref_id": null
                },
                {
                    "start": 1027,
                    "end": 1033,
                    "text": "44:98,",
                    "ref_id": null
                },
                {
                    "start": 1034,
                    "end": 1039,
                    "text": "[100]",
                    "ref_id": null
                },
                {
                    "start": 1040,
                    "end": 1045,
                    "text": "[101]",
                    "ref_id": null
                },
                {
                    "start": 1046,
                    "end": 1051,
                    "text": "[102]",
                    "ref_id": null
                },
                {
                    "start": 1052,
                    "end": 1057,
                    "text": "[103]",
                    "ref_id": null
                },
                {
                    "start": 1058,
                    "end": 1063,
                    "text": "[104]",
                    "ref_id": null
                },
                {
                    "start": 1064,
                    "end": 1069,
                    "text": "[105]",
                    "ref_id": null
                },
                {
                    "start": 1070,
                    "end": 1075,
                    "text": "[106]",
                    "ref_id": null
                },
                {
                    "start": 1076,
                    "end": 1080,
                    "text": "108,",
                    "ref_id": null
                },
                {
                    "start": 1081,
                    "end": 1104,
                    "text": "109 aPL antibodies and,",
                    "ref_id": null
                },
                {
                    "start": 1105,
                    "end": 1112,
                    "text": "49:195,",
                    "ref_id": null
                },
                {
                    "start": 1113,
                    "end": 1139,
                    "text": "259 affinity purification,",
                    "ref_id": null
                },
                {
                    "start": 1140,
                    "end": 1147,
                    "text": "49:200,",
                    "ref_id": null
                },
                {
                    "start": 1148,
                    "end": 1152,
                    "text": "203,",
                    "ref_id": null
                },
                {
                    "start": 1153,
                    "end": 1178,
                    "text": "213 pathogenic potential,",
                    "ref_id": null
                },
                {
                    "start": 1179,
                    "end": 1191,
                    "text": "specificity,",
                    "ref_id": null
                },
                {
                    "start": 1192,
                    "end": 1197,
                    "text": "[247]",
                    "ref_id": null
                },
                {
                    "start": 1198,
                    "end": 1203,
                    "text": "[248]",
                    "ref_id": null
                },
                {
                    "start": 1204,
                    "end": 1209,
                    "text": "[256]",
                    "ref_id": null
                },
                {
                    "start": 1210,
                    "end": 1215,
                    "text": "[257]",
                    "ref_id": null
                },
                {
                    "start": 1274,
                    "end": 1512,
                    "text": "thyroiditis and, 46:265, 266, 49:369 315, 316 antigens, 46:268, 272 cellular immune responses, 46:294 experimental models, 46:276 B cell formation and, 41:205, 216, 239 B cell precursors, 41:191, 197, 198 inducible cell lines, 41:221, 222",
                    "ref_id": null
                },
                {
                    "start": 1579,
                    "end": 1605,
                    "text": "CD4 and CD8 molecules and,",
                    "ref_id": null
                },
                {
                    "start": 1606,
                    "end": 1613,
                    "text": "44:265,",
                    "ref_id": null
                },
                {
                    "start": 1614,
                    "end": 1618,
                    "text": "266,",
                    "ref_id": null
                },
                {
                    "start": 1619,
                    "end": 1623,
                    "text": "297,",
                    "ref_id": null
                },
                {
                    "start": 1624,
                    "end": 1628,
                    "text": "298,",
                    "ref_id": null
                },
                {
                    "start": 1629,
                    "end": 1655,
                    "text": "303 CD4 molecular biology,",
                    "ref_id": null
                },
                {
                    "start": 1656,
                    "end": 1662,
                    "text": "44285,",
                    "ref_id": null
                },
                {
                    "start": 1663,
                    "end": 1685,
                    "text": "CD8 molecular biology,",
                    "ref_id": null
                },
                {
                    "start": 1686,
                    "end": 1691,
                    "text": "[288]",
                    "ref_id": null
                },
                {
                    "start": 1692,
                    "end": 1697,
                    "text": "[289]",
                    "ref_id": null
                },
                {
                    "start": 1698,
                    "end": 1703,
                    "text": "[290]",
                    "ref_id": null
                },
                {
                    "start": 1704,
                    "end": 1709,
                    "text": "[291]",
                    "ref_id": null
                },
                {
                    "start": 1710,
                    "end": 1729,
                    "text": "284 CD5 B cell and,",
                    "ref_id": null
                },
                {
                    "start": 1730,
                    "end": 1756,
                    "text": "47:126 Ig gene expression,",
                    "ref_id": null
                },
                {
                    "start": 1757,
                    "end": 1764,
                    "text": "47:150,",
                    "ref_id": null
                },
                {
                    "start": 1765,
                    "end": 1769,
                    "text": "153,",
                    "ref_id": null
                },
                {
                    "start": 1770,
                    "end": 1774,
                    "text": "154,",
                    "ref_id": null
                },
                {
                    "start": 1775,
                    "end": 1785,
                    "text": "physiology",
                    "ref_id": null
                },
                {
                    "start": 1786,
                    "end": 2010,
                    "text": "1 and, 46:185, 186, complement receptor 2 and, 46:201-203 CTL and, 41:135, 148, 153, 154, 159, 165, cytotoxicity and, 41:269, 270, 320 190, 194, 197, 199 168 cell-mediated killing, 41:289-295, 297, cytolysis, 41277-281, 316-",
                    "ref_id": null
                },
                {
                    "start": 2043,
                    "end": 2057,
                    "text": "molecules and,",
                    "ref_id": null
                },
                {
                    "start": 2058,
                    "end": 2064,
                    "text": "44:84,",
                    "ref_id": null
                },
                {
                    "start": 2065,
                    "end": 2088,
                    "text": "85 chimeric antibodies,",
                    "ref_id": null
                },
                {
                    "start": 2089,
                    "end": 2095,
                    "text": "44:79,",
                    "ref_id": null
                },
                {
                    "start": 2096,
                    "end": 2099,
                    "text": "80,",
                    "ref_id": null
                },
                {
                    "start": 2100,
                    "end": 2103,
                    "text": "82,",
                    "ref_id": null
                },
                {
                    "start": 2104,
                    "end": 2115,
                    "text": "87 cloning,",
                    "ref_id": null
                },
                {
                    "start": 2116,
                    "end": 2132,
                    "text": "4475 expression,",
                    "ref_id": null
                },
                {
                    "start": 2133,
                    "end": 2139,
                    "text": "44:76,",
                    "ref_id": null
                },
                {
                    "start": 2140,
                    "end": 2150,
                    "text": "78 fusion,",
                    "ref_id": null
                },
                {
                    "start": 2151,
                    "end": 2157,
                    "text": "44:85,",
                    "ref_id": null
                },
                {
                    "start": 2158,
                    "end": 2186,
                    "text": "86 lymphoid mammalian cells,",
                    "ref_id": null
                },
                {
                    "start": 2187,
                    "end": 2204,
                    "text": "44:70 production,",
                    "ref_id": null
                },
                {
                    "start": 2205,
                    "end": 2227,
                    "text": "79 granule eosinophil,",
                    "ref_id": null
                },
                {
                    "start": 2228,
                    "end": 2233,
                    "text": "[205]",
                    "ref_id": null
                },
                {
                    "start": 2234,
                    "end": 2239,
                    "text": "[206]",
                    "ref_id": null
                },
                {
                    "start": 2240,
                    "end": 2245,
                    "text": "[207]",
                    "ref_id": null
                },
                {
                    "start": 2246,
                    "end": 2251,
                    "text": "[208]",
                    "ref_id": null
                },
                {
                    "start": 2252,
                    "end": 2255,
                    "text": "221",
                    "ref_id": null
                },
                {
                    "start": 2309,
                    "end": 2323,
                    "text": "cytokines and,",
                    "ref_id": null
                },
                {
                    "start": 2324,
                    "end": 2331,
                    "text": "46:115,",
                    "ref_id": null
                },
                {
                    "start": 2332,
                    "end": 2336,
                    "text": "116,",
                    "ref_id": null
                },
                {
                    "start": 2337,
                    "end": 2370,
                    "text": "HIV infection and 123 activation,",
                    "ref_id": null
                },
                {
                    "start": 2371,
                    "end": 2375,
                    "text": "384,",
                    "ref_id": null
                },
                {
                    "start": 2376,
                    "end": 2396,
                    "text": "385 immune response,",
                    "ref_id": null
                },
                {
                    "start": 2397,
                    "end": 2401,
                    "text": "409,",
                    "ref_id": null
                },
                {
                    "start": 2402,
                    "end": 2435,
                    "text": "411 itnniunopathogenic mechanism,",
                    "ref_id": null
                },
                {
                    "start": 2436,
                    "end": 2443,
                    "text": "47:387,",
                    "ref_id": null
                },
                {
                    "start": 2444,
                    "end": 2447,
                    "text": "392",
                    "ref_id": null
                },
                {
                    "start": 2448,
                    "end": 2449,
                    "text": ",",
                    "ref_id": null
                },
                {
                    "start": 2450,
                    "end": 2456,
                    "text": "47:31,",
                    "ref_id": null
                },
                {
                    "start": 2457,
                    "end": 2460,
                    "text": "32,",
                    "ref_id": null
                },
                {
                    "start": 2461,
                    "end": 2464,
                    "text": "34,",
                    "ref_id": null
                },
                {
                    "start": 2465,
                    "end": 2484,
                    "text": "39 binding factors,",
                    "ref_id": null
                },
                {
                    "start": 2485,
                    "end": 2488,
                    "text": "20,",
                    "ref_id": null
                },
                {
                    "start": 2489,
                    "end": 2492,
                    "text": "22,",
                    "ref_id": null
                },
                {
                    "start": 2493,
                    "end": 2497,
                    "text": "[24]",
                    "ref_id": null
                },
                {
                    "start": 2498,
                    "end": 2502,
                    "text": "[25]",
                    "ref_id": null
                },
                {
                    "start": 2503,
                    "end": 2507,
                    "text": "[26]",
                    "ref_id": null
                },
                {
                    "start": 2508,
                    "end": 2512,
                    "text": "[27]",
                    "ref_id": null
                },
                {
                    "start": 2513,
                    "end": 2519,
                    "text": "44:43,",
                    "ref_id": null
                },
                {
                    "start": 2520,
                    "end": 2537,
                    "text": "44 homology unit,",
                    "ref_id": null
                },
                {
                    "start": 2538,
                    "end": 2543,
                    "text": "44:5,",
                    "ref_id": null
                },
                {
                    "start": 2544,
                    "end": 2546,
                    "text": "6,",
                    "ref_id": null
                },
                {
                    "start": 2547,
                    "end": 2561,
                    "text": "8 MHC complex,",
                    "ref_id": null
                },
                {
                    "start": 2562,
                    "end": 2568,
                    "text": "44:24,",
                    "ref_id": null
                },
                {
                    "start": 2569,
                    "end": 2572,
                    "text": "26,",
                    "ref_id": null
                },
                {
                    "start": 2573,
                    "end": 2605,
                    "text": "28 nonirnmiine receptor members,",
                    "ref_id": null
                },
                {
                    "start": 2606,
                    "end": 2612,
                    "text": "44:30,",
                    "ref_id": null
                },
                {
                    "start": 2613,
                    "end": 2623,
                    "text": "receptors,",
                    "ref_id": null
                },
                {
                    "start": 2624,
                    "end": 2630,
                    "text": "44:10,",
                    "ref_id": null
                },
                {
                    "start": 2631,
                    "end": 2634,
                    "text": "11,",
                    "ref_id": null
                },
                {
                    "start": 2635,
                    "end": 2638,
                    "text": "14,",
                    "ref_id": null
                },
                {
                    "start": 2639,
                    "end": 2642,
                    "text": "16,",
                    "ref_id": null
                },
                {
                    "start": 2643,
                    "end": 2646,
                    "text": "17,",
                    "ref_id": null
                },
                {
                    "start": 2647,
                    "end": 2653,
                    "text": "21 31,",
                    "ref_id": null
                },
                {
                    "start": 2654,
                    "end": 2658,
                    "text": "[34]",
                    "ref_id": null
                },
                {
                    "start": 2659,
                    "end": 2663,
                    "text": "[35]",
                    "ref_id": null
                },
                {
                    "start": 2664,
                    "end": 2668,
                    "text": "[36]",
                    "ref_id": null
                },
                {
                    "start": 2669,
                    "end": 2673,
                    "text": "[37]",
                    "ref_id": null
                },
                {
                    "start": 2674,
                    "end": 2678,
                    "text": "[39]",
                    "ref_id": null
                },
                {
                    "start": 2679,
                    "end": 2683,
                    "text": "[40]",
                    "ref_id": null
                },
                {
                    "start": 2684,
                    "end": 2688,
                    "text": "[41]",
                    "ref_id": null
                },
                {
                    "start": 2720,
                    "end": 2730,
                    "text": "genes and,",
                    "ref_id": null
                },
                {
                    "start": 2731,
                    "end": 2748,
                    "text": "49:33 regulation,",
                    "ref_id": null
                },
                {
                    "start": 2749,
                    "end": 2753,
                    "text": "[49]",
                    "ref_id": null
                },
                {
                    "start": 2754,
                    "end": 2758,
                    "text": "[50]",
                    "ref_id": null
                },
                {
                    "start": 2759,
                    "end": 2763,
                    "text": "[51]",
                    "ref_id": null
                },
                {
                    "start": 2764,
                    "end": 2768,
                    "text": "[52]",
                    "ref_id": null
                },
                {
                    "start": 2769,
                    "end": 2773,
                    "text": "[53]",
                    "ref_id": null
                },
                {
                    "start": 2774,
                    "end": 2778,
                    "text": "[54]",
                    "ref_id": null
                },
                {
                    "start": 2779,
                    "end": 2783,
                    "text": "[55]",
                    "ref_id": null
                },
                {
                    "start": 2784,
                    "end": 2788,
                    "text": "[56]",
                    "ref_id": null
                },
                {
                    "start": 2789,
                    "end": 2793,
                    "text": "[57]",
                    "ref_id": null
                },
                {
                    "start": 2794,
                    "end": 2797,
                    "text": "11,",
                    "ref_id": null
                },
                {
                    "start": 2798,
                    "end": 2801,
                    "text": "15,",
                    "ref_id": null
                },
                {
                    "start": 2802,
                    "end": 2824,
                    "text": "18 VH gene expression,",
                    "ref_id": null
                },
                {
                    "start": 2825,
                    "end": 2831,
                    "text": "49:39,",
                    "ref_id": null
                },
                {
                    "start": 2832,
                    "end": 2835,
                    "text": "41,",
                    "ref_id": null
                },
                {
                    "start": 2836,
                    "end": 2839,
                    "text": "43,",
                    "ref_id": null
                },
                {
                    "start": 2840,
                    "end": 2843,
                    "text": "46,",
                    "ref_id": null
                },
                {
                    "start": 2844,
                    "end": 2866,
                    "text": "51 biological effects,",
                    "ref_id": null
                },
                {
                    "start": 2867,
                    "end": 2886,
                    "text": "163 hunian disease,",
                    "ref_id": null
                },
                {
                    "start": 2887,
                    "end": 2894,
                    "text": "44:192,",
                    "ref_id": null
                },
                {
                    "start": 2895,
                    "end": 2922,
                    "text": "194 immunocotnpetent cells,",
                    "ref_id": null
                },
                {
                    "start": 2923,
                    "end": 2930,
                    "text": "44:173,",
                    "ref_id": null
                },
                {
                    "start": 2931,
                    "end": 2935,
                    "text": "177,",
                    "ref_id": null
                },
                {
                    "start": 2936,
                    "end": 2945,
                    "text": "receptor,",
                    "ref_id": null
                },
                {
                    "start": 2946,
                    "end": 2953,
                    "text": "44:179,",
                    "ref_id": null
                },
                {
                    "start": 2954,
                    "end": 2959,
                    "text": "[182]",
                    "ref_id": null
                },
                {
                    "start": 2960,
                    "end": 2965,
                    "text": "[183]",
                    "ref_id": null
                },
                {
                    "start": 2966,
                    "end": 2971,
                    "text": "[184]",
                    "ref_id": null
                },
                {
                    "start": 2972,
                    "end": 2983,
                    "text": "properties,",
                    "ref_id": null
                },
                {
                    "start": 2984,
                    "end": 3004,
                    "text": "563 iinmunogenicity,",
                    "ref_id": null
                },
                {
                    "start": 3005,
                    "end": 3032,
                    "text": "43:2 iinmuno~ene~cence and,",
                    "ref_id": null
                },
                {
                    "start": 3033,
                    "end": 3040,
                    "text": "46:222,",
                    "ref_id": null
                },
                {
                    "start": 3041,
                    "end": 3045,
                    "text": "223,",
                    "ref_id": null
                },
                {
                    "start": 3046,
                    "end": 3051,
                    "text": "[227]",
                    "ref_id": null
                },
                {
                    "start": 3052,
                    "end": 3057,
                    "text": "[228]",
                    "ref_id": null
                },
                {
                    "start": 3058,
                    "end": 3063,
                    "text": "[229]",
                    "ref_id": null
                },
                {
                    "start": 3064,
                    "end": 3069,
                    "text": "[230]",
                    "ref_id": null
                },
                {
                    "start": 3070,
                    "end": 3073,
                    "text": "234",
                    "ref_id": null
                },
                {
                    "start": 3234,
                    "end": 3241,
                    "text": "44:154,",
                    "ref_id": null
                },
                {
                    "start": 3242,
                    "end": 3249,
                    "text": "46:164,",
                    "ref_id": null
                },
                {
                    "start": 3250,
                    "end": 3254,
                    "text": "165,",
                    "ref_id": null
                },
                {
                    "start": 3255,
                    "end": 3297,
                    "text": "169 leukocyte adhesion deficiency disease,",
                    "ref_id": null
                },
                {
                    "start": 3298,
                    "end": 3315,
                    "text": "ligand molecules,",
                    "ref_id": null
                },
                {
                    "start": 3316,
                    "end": 3333,
                    "text": "46:171 structure,",
                    "ref_id": null
                },
                {
                    "start": 3334,
                    "end": 3341,
                    "text": "46:153,",
                    "ref_id": null
                },
                {
                    "start": 3342,
                    "end": 3346,
                    "text": "154,",
                    "ref_id": null
                },
                {
                    "start": 3347,
                    "end": 3351,
                    "text": "158,",
                    "ref_id": null
                },
                {
                    "start": 3352,
                    "end": 3369,
                    "text": "159 carbohydrate,",
                    "ref_id": null
                },
                {
                    "start": 3370,
                    "end": 3377,
                    "text": "44:354,",
                    "ref_id": null
                },
                {
                    "start": 3378,
                    "end": 3382,
                    "text": "356,",
                    "ref_id": null
                },
                {
                    "start": 3383,
                    "end": 3387,
                    "text": "364,",
                    "ref_id": null
                },
                {
                    "start": 3388,
                    "end": 3392,
                    "text": "369,",
                    "ref_id": null
                },
                {
                    "start": 3393,
                    "end": 3403,
                    "text": "molecules,",
                    "ref_id": null
                },
                {
                    "start": 3404,
                    "end": 3411,
                    "text": "44:342,",
                    "ref_id": null
                },
                {
                    "start": 3412,
                    "end": 3417,
                    "text": "[345]",
                    "ref_id": null
                },
                {
                    "start": 3418,
                    "end": 3423,
                    "text": "[346]",
                    "ref_id": null
                },
                {
                    "start": 3424,
                    "end": 3429,
                    "text": "[347]",
                    "ref_id": null
                },
                {
                    "start": 3430,
                    "end": 3435,
                    "text": "[348]",
                    "ref_id": null
                },
                {
                    "start": 3436,
                    "end": 3441,
                    "text": "[349]",
                    "ref_id": null
                },
                {
                    "start": 3442,
                    "end": 3446,
                    "text": "351,",
                    "ref_id": null
                },
                {
                    "start": 3447,
                    "end": 3460,
                    "text": "32 structure,",
                    "ref_id": null
                },
                {
                    "start": 3461,
                    "end": 3466,
                    "text": "46:8,",
                    "ref_id": null
                },
                {
                    "start": 3467,
                    "end": 3470,
                    "text": "10,",
                    "ref_id": null
                },
                {
                    "start": 3471,
                    "end": 3474,
                    "text": "12,",
                    "ref_id": null
                },
                {
                    "start": 3475,
                    "end": 3478,
                    "text": "13,",
                    "ref_id": null
                },
                {
                    "start": 3479,
                    "end": 3482,
                    "text": "15,",
                    "ref_id": null
                },
                {
                    "start": 3483,
                    "end": 3486,
                    "text": "17,",
                    "ref_id": null
                },
                {
                    "start": 3487,
                    "end": 3506,
                    "text": "19 T cell receptor,",
                    "ref_id": null
                },
                {
                    "start": 3507,
                    "end": 3509,
                    "text": "46",
                    "ref_id": null
                },
                {
                    "start": 3510,
                    "end": 3520,
                    "text": "cells and,",
                    "ref_id": null
                },
                {
                    "start": 3521,
                    "end": 3528,
                    "text": "47:284,",
                    "ref_id": null
                },
                {
                    "start": 3529,
                    "end": 3533,
                    "text": "287,",
                    "ref_id": null
                },
                {
                    "start": 3534,
                    "end": 3554,
                    "text": "291 liner sequences,",
                    "ref_id": null
                },
                {
                    "start": 3555,
                    "end": 3562,
                    "text": "47:252,",
                    "ref_id": null
                },
                {
                    "start": 3563,
                    "end": 3587,
                    "text": "255 effecter mechanisms,",
                    "ref_id": null
                },
                {
                    "start": 3588,
                    "end": 3595,
                    "text": "47:241,",
                    "ref_id": null
                },
                {
                    "start": 3596,
                    "end": 3600,
                    "text": "242,",
                    "ref_id": null
                },
                {
                    "start": 3601,
                    "end": 3613,
                    "text": "lymphokines,",
                    "ref_id": null
                },
                {
                    "start": 3614,
                    "end": 3621,
                    "text": "47:263,",
                    "ref_id": null
                },
                {
                    "start": 3622,
                    "end": 3644,
                    "text": "265 surface phenotype,",
                    "ref_id": null
                },
                {
                    "start": 3645,
                    "end": 3652,
                    "text": "47:203,",
                    "ref_id": null
                },
                {
                    "start": 3653,
                    "end": 3672,
                    "text": "205 octanucleotide,",
                    "ref_id": null
                },
                {
                    "start": 3673,
                    "end": 3689,
                    "text": "buried surfaces,",
                    "ref_id": null
                },
                {
                    "start": 3690,
                    "end": 3707,
                    "text": "43:lOl oncogenic,",
                    "ref_id": null
                },
                {
                    "start": 3708,
                    "end": 3713,
                    "text": "64:65",
                    "ref_id": null
                },
                {
                    "start": 3848,
                    "end": 3863,
                    "text": "activation and,",
                    "ref_id": null
                },
                {
                    "start": 3864,
                    "end": 3869,
                    "text": "[244]",
                    "ref_id": null
                },
                {
                    "start": 3870,
                    "end": 3875,
                    "text": "[245]",
                    "ref_id": null
                },
                {
                    "start": 3876,
                    "end": 3881,
                    "text": "[246]",
                    "ref_id": null
                },
                {
                    "start": 3882,
                    "end": 3886,
                    "text": "410,",
                    "ref_id": null
                },
                {
                    "start": 3887,
                    "end": 3902,
                    "text": "411 expression,",
                    "ref_id": null
                },
                {
                    "start": 3903,
                    "end": 3910,
                    "text": "45:403,",
                    "ref_id": null
                },
                {
                    "start": 3911,
                    "end": 3915,
                    "text": "405,",
                    "ref_id": null
                },
                {
                    "start": 3916,
                    "end": 3933,
                    "text": "408 interactions,",
                    "ref_id": null
                },
                {
                    "start": 3934,
                    "end": 3941,
                    "text": "45:383,",
                    "ref_id": null
                },
                {
                    "start": 3942,
                    "end": 3952,
                    "text": "384 roles,",
                    "ref_id": null
                },
                {
                    "start": 3953,
                    "end": 3960,
                    "text": "45:409,",
                    "ref_id": null
                },
                {
                    "start": 3961,
                    "end": 3976,
                    "text": "410 retroviral,",
                    "ref_id": null
                },
                {
                    "start": 3977,
                    "end": 3993,
                    "text": "43:304 SCID and,",
                    "ref_id": null
                },
                {
                    "start": 4053,
                    "end": 4065,
                    "text": "vaccine and,",
                    "ref_id": null
                },
                {
                    "start": 4066,
                    "end": 4070,
                    "text": "476,",
                    "ref_id": null
                },
                {
                    "start": 4071,
                    "end": 4086,
                    "text": "479 antibodies,",
                    "ref_id": null
                },
                {
                    "start": 4087,
                    "end": 4106,
                    "text": "45:300 CS proteins,",
                    "ref_id": null
                },
                {
                    "start": 4107,
                    "end": 4114,
                    "text": "45:291,",
                    "ref_id": null
                },
                {
                    "start": 4115,
                    "end": 4121,
                    "text": "45:306",
                    "ref_id": null
                },
                {
                    "start": 4177,
                    "end": 4192,
                    "text": "leukocytes and,",
                    "ref_id": null
                },
                {
                    "start": 4193,
                    "end": 4199,
                    "text": "49:85,",
                    "ref_id": null
                },
                {
                    "start": 4200,
                    "end": 4203,
                    "text": "90,",
                    "ref_id": null
                },
                {
                    "start": 4204,
                    "end": 4209,
                    "text": "[115]",
                    "ref_id": null
                },
                {
                    "start": 4210,
                    "end": 4215,
                    "text": "[116]",
                    "ref_id": null
                },
                {
                    "start": 4216,
                    "end": 4221,
                    "text": "[117]",
                    "ref_id": null
                },
                {
                    "start": 4222,
                    "end": 4244,
                    "text": "79 MIIC glycoproteins,",
                    "ref_id": null
                },
                {
                    "start": 4245,
                    "end": 4251,
                    "text": "49:80,",
                    "ref_id": null
                },
                {
                    "start": 4252,
                    "end": 4254,
                    "text": "82",
                    "ref_id": null
                },
                {
                    "start": 4300,
                    "end": 4323,
                    "text": "T and B cell sites and,",
                    "ref_id": null
                },
                {
                    "start": 4324,
                    "end": 4331,
                    "text": "45:195,",
                    "ref_id": null
                },
                {
                    "start": 4332,
                    "end": 4336,
                    "text": "197,",
                    "ref_id": null
                },
                {
                    "start": 4337,
                    "end": 4342,
                    "text": "[259]",
                    "ref_id": null
                },
                {
                    "start": 4343,
                    "end": 4348,
                    "text": "[260]",
                    "ref_id": null
                },
                {
                    "start": 4349,
                    "end": 4354,
                    "text": "[261]",
                    "ref_id": null
                },
                {
                    "start": 4355,
                    "end": 4360,
                    "text": "[262]",
                    "ref_id": null
                },
                {
                    "start": 4361,
                    "end": 4366,
                    "text": "[263]",
                    "ref_id": null
                },
                {
                    "start": 4367,
                    "end": 4372,
                    "text": "[264]",
                    "ref_id": null
                },
                {
                    "start": 4373,
                    "end": 4406,
                    "text": "45:234 globular protein antigens,",
                    "ref_id": null
                },
                {
                    "start": 4407,
                    "end": 4414,
                    "text": "45:201,",
                    "ref_id": null
                },
                {
                    "start": 4415,
                    "end": 4434,
                    "text": "parasitic antigens,",
                    "ref_id": null
                },
                {
                    "start": 4435,
                    "end": 4442,
                    "text": "45:203,",
                    "ref_id": null
                },
                {
                    "start": 4443,
                    "end": 4448,
                    "text": "[230]",
                    "ref_id": null
                },
                {
                    "start": 4449,
                    "end": 4454,
                    "text": "[231]",
                    "ref_id": null
                },
                {
                    "start": 4455,
                    "end": 4460,
                    "text": "[232]",
                    "ref_id": null
                },
                {
                    "start": 4461,
                    "end": 4466,
                    "text": "[237]",
                    "ref_id": null
                },
                {
                    "start": 4467,
                    "end": 4472,
                    "text": "[238]",
                    "ref_id": null
                },
                {
                    "start": 4473,
                    "end": 4478,
                    "text": "[239]",
                    "ref_id": null
                },
                {
                    "start": 4479,
                    "end": 4486,
                    "text": "45:218,",
                    "ref_id": null
                },
                {
                    "start": 4487,
                    "end": 4491,
                    "text": "219,",
                    "ref_id": null
                },
                {
                    "start": 4492,
                    "end": 4496,
                    "text": "221,",
                    "ref_id": null
                },
                {
                    "start": 4497,
                    "end": 4501,
                    "text": "223,",
                    "ref_id": null
                },
                {
                    "start": 4502,
                    "end": 4525,
                    "text": "T cell development and,",
                    "ref_id": null
                },
                {
                    "start": 4526,
                    "end": 4533,
                    "text": "44:232,",
                    "ref_id": null
                },
                {
                    "start": 4534,
                    "end": 4538,
                    "text": "234,",
                    "ref_id": null
                },
                {
                    "start": 4539,
                    "end": 4563,
                    "text": "241 T cell receptor and,",
                    "ref_id": null
                },
                {
                    "start": 4564,
                    "end": 4575,
                    "text": "45:107 227,",
                    "ref_id": null
                },
                {
                    "start": 4576,
                    "end": 4601,
                    "text": "228 accessory nrolecules,",
                    "ref_id": null
                },
                {
                    "start": 4602,
                    "end": 4624,
                    "text": "45:llO alloreactivity,",
                    "ref_id": null
                },
                {
                    "start": 4625,
                    "end": 4651,
                    "text": "45:149 antigen processing,",
                    "ref_id": null
                },
                {
                    "start": 4652,
                    "end": 4664,
                    "text": "45:llR. 119,",
                    "ref_id": null
                },
                {
                    "start": 4665,
                    "end": 4669,
                    "text": "124,",
                    "ref_id": null
                },
                {
                    "start": 4670,
                    "end": 4679,
                    "text": "epitopes,",
                    "ref_id": null
                },
                {
                    "start": 4680,
                    "end": 4687,
                    "text": "45:131,",
                    "ref_id": null
                },
                {
                    "start": 4688,
                    "end": 4692,
                    "text": "132,",
                    "ref_id": null
                },
                {
                    "start": 4693,
                    "end": 4709,
                    "text": "137 homogeneity,",
                    "ref_id": null
                },
                {
                    "start": 4710,
                    "end": 4717,
                    "text": "45:128,",
                    "ref_id": null
                },
                {
                    "start": 4718,
                    "end": 4737,
                    "text": "129 MHC ~nolecules,",
                    "ref_id": null
                },
                {
                    "start": 4738,
                    "end": 4754,
                    "text": "45:117 peptides,",
                    "ref_id": null
                },
                {
                    "start": 4755,
                    "end": 4762,
                    "text": "45:138,",
                    "ref_id": null
                },
                {
                    "start": 4763,
                    "end": 4766,
                    "text": "139",
                    "ref_id": null
                },
                {
                    "start": 4785,
                    "end": 4802,
                    "text": "cytotoxicity and,",
                    "ref_id": null
                },
                {
                    "start": 4803,
                    "end": 4810,
                    "text": "41:274,",
                    "ref_id": null
                },
                {
                    "start": 4811,
                    "end": 4815,
                    "text": "278,",
                    "ref_id": null
                },
                {
                    "start": 4816,
                    "end": 4832,
                    "text": "303 Proteolysis,",
                    "ref_id": null
                },
                {
                    "start": 4833,
                    "end": 4835,
                    "text": "64",
                    "ref_id": null
                },
                {
                    "start": 4903,
                    "end": 4927,
                    "text": "cells and, 47:66, 87, 88",
                    "ref_id": null
                },
                {
                    "start": 4984,
                    "end": 4999,
                    "text": "antibodies and,",
                    "ref_id": null
                },
                {
                    "start": 5000,
                    "end": 5007,
                    "text": "44:132,",
                    "ref_id": null
                },
                {
                    "start": 5008,
                    "end": 5035,
                    "text": "135 hackground information,",
                    "ref_id": null
                },
                {
                    "start": 5036,
                    "end": 5043,
                    "text": "47:130,",
                    "ref_id": null
                },
                {
                    "start": 5044,
                    "end": 5065,
                    "text": "161 CD23 antigen and,",
                    "ref_id": null
                },
                {
                    "start": 5066,
                    "end": 5081,
                    "text": "173 chemokines,",
                    "ref_id": null
                },
                {
                    "start": 5082,
                    "end": 5093,
                    "text": "41:275. 276",
                    "ref_id": null
                },
                {
                    "start": 5094,
                    "end": 5131,
                    "text": "leukocytes and, 49:90, 93, 112 T cell",
                    "ref_id": null
                },
                {
                    "start": 5132,
                    "end": 5147,
                    "text": "activation and,",
                    "ref_id": null
                },
                {
                    "start": 5148,
                    "end": 5173,
                    "text": "41:18 T cell subsets and,",
                    "ref_id": null
                },
                {
                    "start": 5174,
                    "end": 5180,
                    "text": "44:66,",
                    "ref_id": null
                },
                {
                    "start": 5181,
                    "end": 5188,
                    "text": "44:158,",
                    "ref_id": null
                },
                {
                    "start": 5189,
                    "end": 5193,
                    "text": "162,",
                    "ref_id": null
                },
                {
                    "start": 5194,
                    "end": 5198,
                    "text": "164,",
                    "ref_id": null
                },
                {
                    "start": 5199,
                    "end": 5203,
                    "text": "188,",
                    "ref_id": null
                },
                {
                    "start": 5204,
                    "end": 5220,
                    "text": "192 selectivity,",
                    "ref_id": null
                },
                {
                    "start": 5239,
                    "end": 5254,
                    "text": "antibodies and,",
                    "ref_id": null
                },
                {
                    "start": 5255,
                    "end": 5262,
                    "text": "49:231,",
                    "ref_id": null
                },
                {
                    "start": 5263,
                    "end": 5268,
                    "text": "[242]",
                    "ref_id": null
                },
                {
                    "start": 5269,
                    "end": 5274,
                    "text": "[243]",
                    "ref_id": null
                },
                {
                    "start": 5275,
                    "end": 5294,
                    "text": "aPL antibodies and,",
                    "ref_id": null
                },
                {
                    "start": 5295,
                    "end": 5301,
                    "text": "49:199",
                    "ref_id": null
                },
                {
                    "start": 5302,
                    "end": 5309,
                    "text": "59:383;",
                    "ref_id": null
                },
                {
                    "start": 5310,
                    "end": 5317,
                    "text": "62:276;",
                    "ref_id": null
                },
                {
                    "start": 5318,
                    "end": 5325,
                    "text": "64:144,",
                    "ref_id": null
                },
                {
                    "start": 5326,
                    "end": 5330,
                    "text": "145;",
                    "ref_id": null
                },
                {
                    "start": 5331,
                    "end": 5347,
                    "text": "phosphorylation,",
                    "ref_id": null
                },
                {
                    "start": 5348,
                    "end": 5352,
                    "text": "355,",
                    "ref_id": null
                },
                {
                    "start": 5353,
                    "end": 5357,
                    "text": "363,",
                    "ref_id": null
                },
                {
                    "start": 5358,
                    "end": 5394,
                    "text": "367 cooperative ligand binding site,",
                    "ref_id": null
                },
                {
                    "start": 5395,
                    "end": 5402,
                    "text": "64:148,",
                    "ref_id": null
                },
                {
                    "start": 5403,
                    "end": 5423,
                    "text": "167 genetic studies,",
                    "ref_id": null
                },
                {
                    "start": 5424,
                    "end": 5439,
                    "text": "64:194 ligands,",
                    "ref_id": null
                },
                {
                    "start": 5440,
                    "end": 5447,
                    "text": "58:360;",
                    "ref_id": null
                },
                {
                    "start": 5448,
                    "end": 5459,
                    "text": "tumors and,",
                    "ref_id": null
                },
                {
                    "start": 5460,
                    "end": 5467,
                    "text": "49:282,",
                    "ref_id": null
                },
                {
                    "start": 5468,
                    "end": 5472,
                    "text": "320,",
                    "ref_id": null
                },
                {
                    "start": 5473,
                    "end": 5488,
                    "text": "335 mechanisms,",
                    "ref_id": null
                },
                {
                    "start": 5489,
                    "end": 5496,
                    "text": "49:292,",
                    "ref_id": null
                },
                {
                    "start": 5497,
                    "end": 5528,
                    "text": "295 antinuclear antibodies and,",
                    "ref_id": null
                },
                {
                    "start": 5529,
                    "end": 5592,
                    "text": "44:130 autoimmune thyroidltis and. 46:275 B cell formation and,",
                    "ref_id": null
                },
                {
                    "start": 5593,
                    "end": 5600,
                    "text": "41:195,",
                    "ref_id": null
                },
                {
                    "start": 5601,
                    "end": 5631,
                    "text": "233 CD4 and CD8 molecules and,",
                    "ref_id": null
                },
                {
                    "start": 5632,
                    "end": 5639,
                    "text": "44:269,",
                    "ref_id": null
                },
                {
                    "start": 5640,
                    "end": 5644,
                    "text": "284,",
                    "ref_id": null
                },
                {
                    "start": 5645,
                    "end": 5656,
                    "text": "endogenous,",
                    "ref_id": null
                },
                {
                    "start": 5657,
                    "end": 5667,
                    "text": "insertions",
                    "ref_id": null
                },
                {
                    "start": 5668,
                    "end": 5674,
                    "text": "1 and,",
                    "ref_id": null
                },
                {
                    "start": 5675,
                    "end": 5682,
                    "text": "44:191,",
                    "ref_id": null
                },
                {
                    "start": 5683,
                    "end": 5688,
                    "text": "[193]",
                    "ref_id": null
                },
                {
                    "start": 5689,
                    "end": 5694,
                    "text": "[194]",
                    "ref_id": null
                },
                {
                    "start": 5695,
                    "end": 5700,
                    "text": "[195]",
                    "ref_id": null
                },
                {
                    "start": 5701,
                    "end": 5703,
                    "text": "54",
                    "ref_id": null
                },
                {
                    "start": 5704,
                    "end": 5774,
                    "text": "models and, 4664, 91, 92, 98 N K cells and, 47:187, 283, 289, 290, 292",
                    "ref_id": null
                },
                {
                    "start": 5775,
                    "end": 5862,
                    "text": "formation and, 41:181, 182, 184, 187, 206, 237 B cell precursors, 41:188, 191, 195, 199",
                    "ref_id": null
                },
                {
                    "start": 5863,
                    "end": 5930,
                    "text": "formation and, 41:184, 185, 237, 238 B cell precursors, 41:198, 200",
                    "ref_id": null
                },
                {
                    "start": 5931,
                    "end": 5983,
                    "text": "antibodies and, 49:193. 198, 209, 212, 219. 250, 257",
                    "ref_id": null
                },
                {
                    "start": 5984,
                    "end": 6013,
                    "text": "conformation and recognition,",
                    "ref_id": null
                },
                {
                    "start": 6014,
                    "end": 6021,
                    "text": "43:194,",
                    "ref_id": null
                },
                {
                    "start": 6022,
                    "end": 6044,
                    "text": "MHC interaction model,",
                    "ref_id": null
                },
                {
                    "start": 6045,
                    "end": 6063,
                    "text": "43:201 processing,",
                    "ref_id": null
                },
                {
                    "start": 6064,
                    "end": 6119,
                    "text": "formation and, 41:194, 199, 225, 226, 237 C, domain. 43",
                    "ref_id": null
                },
                {
                    "start": 6120,
                    "end": 6197,
                    "text": "formation and, 41:205, 212, 225, 236 B cell precursors, 41:189, 191, 192, 198",
                    "ref_id": null
                },
                {
                    "start": 6198,
                    "end": 6231,
                    "text": "antibodies and, 49:194, 199, 257-",
                    "ref_id": null
                },
                {
                    "start": 6232,
                    "end": 6239,
                    "text": "MG and,",
                    "ref_id": null
                },
                {
                    "start": 6240,
                    "end": 6247,
                    "text": "42:235,",
                    "ref_id": null
                },
                {
                    "start": 6248,
                    "end": 6252,
                    "text": "256,",
                    "ref_id": null
                },
                {
                    "start": 6253,
                    "end": 6257,
                    "text": "259,",
                    "ref_id": null
                },
                {
                    "start": 6258,
                    "end": 6262,
                    "text": "270,",
                    "ref_id": null
                },
                {
                    "start": 6263,
                    "end": 6263,
                    "text": "",
                    "ref_id": null
                },
                {
                    "start": 6282,
                    "end": 6308,
                    "text": "CD4 and CD8 molecules and,",
                    "ref_id": null
                },
                {
                    "start": 6309,
                    "end": 6316,
                    "text": "44:179,",
                    "ref_id": null
                },
                {
                    "start": 6317,
                    "end": 6321,
                    "text": "181,",
                    "ref_id": null
                },
                {
                    "start": 6322,
                    "end": 6349,
                    "text": "194 T cell development and,",
                    "ref_id": null
                },
                {
                    "start": 6350,
                    "end": 6370,
                    "text": "44:215 Thymopoietin,",
                    "ref_id": null
                },
                {
                    "start": 6371,
                    "end": 6377,
                    "text": "47:47,",
                    "ref_id": null
                },
                {
                    "start": 6378,
                    "end": 6381,
                    "text": "48,",
                    "ref_id": null
                },
                {
                    "start": 6382,
                    "end": 6412,
                    "text": "81 antinuclear antibodies and,",
                    "ref_id": null
                },
                {
                    "start": 6413,
                    "end": 6420,
                    "text": "44:106,",
                    "ref_id": null
                },
                {
                    "start": 6421,
                    "end": 6425,
                    "text": "107,",
                    "ref_id": null
                },
                {
                    "start": 6426,
                    "end": 6453,
                    "text": "autoimmune thyroiditis and,",
                    "ref_id": null
                },
                {
                    "start": 6454,
                    "end": 6461,
                    "text": "46:276,",
                    "ref_id": null
                },
                {
                    "start": 6462,
                    "end": 6491,
                    "text": "286 autoreactive T cells and,",
                    "ref_id": null
                },
                {
                    "start": 6492,
                    "end": 6499,
                    "text": "45:417,",
                    "ref_id": null
                },
                {
                    "start": 6500,
                    "end": 6504,
                    "text": "421,",
                    "ref_id": null
                },
                {
                    "start": 6505,
                    "end": 6509,
                    "text": "423,",
                    "ref_id": null
                },
                {
                    "start": 6510,
                    "end": 6531,
                    "text": "B cell formation and,",
                    "ref_id": null
                },
                {
                    "start": 6532,
                    "end": 6539,
                    "text": "41:191,",
                    "ref_id": null
                },
                {
                    "start": 6540,
                    "end": 6544,
                    "text": "223,",
                    "ref_id": null
                },
                {
                    "start": 6578,
                    "end": 6602,
                    "text": "Thyrotropin Thyrotropin,",
                    "ref_id": null
                },
                {
                    "start": 6603,
                    "end": 6610,
                    "text": "47:457,",
                    "ref_id": null
                },
                {
                    "start": 6611,
                    "end": 6615,
                    "text": "458,",
                    "ref_id": null
                },
                {
                    "start": 6616,
                    "end": 6620,
                    "text": "461;",
                    "ref_id": null
                },
                {
                    "start": 6621,
                    "end": 6645,
                    "text": "272 experimental models,",
                    "ref_id": null
                },
                {
                    "start": 6646,
                    "end": 6653,
                    "text": "46:275,",
                    "ref_id": null
                },
                {
                    "start": 6654,
                    "end": 6658,
                    "text": "278,",
                    "ref_id": null
                },
                {
                    "start": 6659,
                    "end": 6663,
                    "text": "279,",
                    "ref_id": null
                },
                {
                    "start": 6664,
                    "end": 6679,
                    "text": "294 prevention,",
                    "ref_id": null
                },
                {
                    "start": 6680,
                    "end": 6687,
                    "text": "46:279,",
                    "ref_id": null
                },
                {
                    "start": 6688,
                    "end": 6702,
                    "text": "311 Thyroxine,",
                    "ref_id": null
                },
                {
                    "start": 6703,
                    "end": 6710,
                    "text": "46:269,",
                    "ref_id": null
                },
                {
                    "start": 6711,
                    "end": 6715,
                    "text": "278;",
                    "ref_id": null
                },
                {
                    "start": 6716,
                    "end": 6723,
                    "text": "47:437,",
                    "ref_id": null
                },
                {
                    "start": 6724,
                    "end": 6728,
                    "text": "439,",
                    "ref_id": null
                },
                {
                    "start": 6729,
                    "end": 6732,
                    "text": "457",
                    "ref_id": null
                },
                {
                    "start": 6733,
                    "end": 6748,
                    "text": "forination and,",
                    "ref_id": null
                },
                {
                    "start": 6749,
                    "end": 6756,
                    "text": "41:192,",
                    "ref_id": null
                },
                {
                    "start": 6757,
                    "end": 6761,
                    "text": "198,",
                    "ref_id": null
                },
                {
                    "start": 6762,
                    "end": 6766,
                    "text": "204,",
                    "ref_id": null
                },
                {
                    "start": 6767,
                    "end": 6771,
                    "text": "205,",
                    "ref_id": null
                },
                {
                    "start": 6772,
                    "end": 6776,
                    "text": "221,",
                    "ref_id": null
                },
                {
                    "start": 6777,
                    "end": 6796,
                    "text": "222. 226 CD1 gencs,",
                    "ref_id": null
                },
                {
                    "start": 6797,
                    "end": 6802,
                    "text": "59:7,",
                    "ref_id": null
                },
                {
                    "start": 6803,
                    "end": 6806,
                    "text": "[9]",
                    "ref_id": null
                },
                {
                    "start": 6807,
                    "end": 6811,
                    "text": "[10]",
                    "ref_id": null
                },
                {
                    "start": 6812,
                    "end": 6824,
                    "text": "44:275. 277,",
                    "ref_id": null
                },
                {
                    "start": 6825,
                    "end": 6846,
                    "text": "279 CD23 antigen and,",
                    "ref_id": null
                },
                {
                    "start": 6847,
                    "end": 6866,
                    "text": "nniltiple products,",
                    "ref_id": null
                },
                {
                    "start": 6867,
                    "end": 6898,
                    "text": "54278 cytotoaicity and. 41:271,",
                    "ref_id": null
                },
                {
                    "start": 6899,
                    "end": 6903,
                    "text": "276,",
                    "ref_id": null
                },
                {
                    "start": 6904,
                    "end": 6907,
                    "text": "277",
                    "ref_id": null
                },
                {
                    "start": 6908,
                    "end": 6923,
                    "text": "activation and,",
                    "ref_id": null
                },
                {
                    "start": 6924,
                    "end": 6929,
                    "text": "41:3,",
                    "ref_id": null
                },
                {
                    "start": 6930,
                    "end": 6932,
                    "text": "5,",
                    "ref_id": null
                },
                {
                    "start": 6933,
                    "end": 6935,
                    "text": "8,",
                    "ref_id": null
                },
                {
                    "start": 6936,
                    "end": 6939,
                    "text": "11,",
                    "ref_id": null
                },
                {
                    "start": 6940,
                    "end": 6966,
                    "text": "25 T cell development and,",
                    "ref_id": null
                },
                {
                    "start": 6967,
                    "end": 6974,
                    "text": "44~210,",
                    "ref_id": null
                },
                {
                    "start": 6975,
                    "end": 6998,
                    "text": "212 T cell subsets and,",
                    "ref_id": null
                },
                {
                    "start": 6999,
                    "end": 7005,
                    "text": "41:58,",
                    "ref_id": null
                },
                {
                    "start": 7006,
                    "end": 7009,
                    "text": "59,",
                    "ref_id": null
                },
                {
                    "start": 7010,
                    "end": 7013,
                    "text": "62,",
                    "ref_id": null
                },
                {
                    "start": 7014,
                    "end": 7017,
                    "text": "80,",
                    "ref_id": null
                },
                {
                    "start": 7018,
                    "end": 7045,
                    "text": "47:89 B cell formation and,",
                    "ref_id": null
                },
                {
                    "start": 7046,
                    "end": 7053,
                    "text": "41:193,",
                    "ref_id": null
                },
                {
                    "start": 7054,
                    "end": 7079,
                    "text": "212 immunosenescence and,",
                    "ref_id": null
                },
                {
                    "start": 7080,
                    "end": 7087,
                    "text": "46:222,",
                    "ref_id": null
                },
                {
                    "start": 7088,
                    "end": 7105,
                    "text": "227 NK cells and,",
                    "ref_id": null
                },
                {
                    "start": 7106,
                    "end": 7113,
                    "text": "47:209,",
                    "ref_id": null
                },
                {
                    "start": 7114,
                    "end": 7127,
                    "text": "240 SCID and,",
                    "ref_id": null
                },
                {
                    "start": 7158,
                    "end": 7254,
                    "text": "48:169; 52:173, 199; 55:181-183, 205-206; 59:235, 418, 419; 61:86, 87-90, 353, 374; 62:84-85, 90",
                    "ref_id": null
                },
                {
                    "start": 7255,
                    "end": 7367,
                    "text": "55:188, 353, 374 55:182-183, 195 signaling, 55:200-202 functions, 55:203-204 194-195 binding of isoforms, 55:194",
                    "ref_id": null
                },
                {
                    "start": 7433,
                    "end": 7470,
                    "text": "55:188-189, 192 structure, 55:190-193",
                    "ref_id": null
                },
                {
                    "start": 7503,
                    "end": 7560,
                    "text": "sources and structure, 52:183-184 type I, 55:195-196, 206",
                    "ref_id": null
                },
                {
                    "start": 7569,
                    "end": 7589,
                    "text": "55:194 cDNA cloning,",
                    "ref_id": null
                },
                {
                    "start": 7590,
                    "end": 7614,
                    "text": "205 signal transduction,",
                    "ref_id": null
                },
                {
                    "start": 7615,
                    "end": 7668,
                    "text": "55:206 structural comparisons with actin receptor 11,",
                    "ref_id": null
                },
                {
                    "start": 7669,
                    "end": 7683,
                    "text": "55:198 type V,",
                    "ref_id": null
                },
                {
                    "start": 7684,
                    "end": 7699,
                    "text": "antibodies and,",
                    "ref_id": null
                },
                {
                    "start": 7700,
                    "end": 7725,
                    "text": "44:128 CD4 molecules and,",
                    "ref_id": null
                },
                {
                    "start": 7726,
                    "end": 7733,
                    "text": "44:289,",
                    "ref_id": null
                },
                {
                    "start": 7734,
                    "end": 7757,
                    "text": "290 CD8 inolecnles and,",
                    "ref_id": null
                },
                {
                    "start": 7758,
                    "end": 7765,
                    "text": "44:275,",
                    "ref_id": null
                },
                {
                    "start": 7766,
                    "end": 7770,
                    "text": "277,",
                    "ref_id": null
                },
                {
                    "start": 7771,
                    "end": 7778,
                    "text": "44:155,",
                    "ref_id": null
                },
                {
                    "start": 7779,
                    "end": 7784,
                    "text": "[159]",
                    "ref_id": null
                },
                {
                    "start": 7785,
                    "end": 7790,
                    "text": "[160]",
                    "ref_id": null
                },
                {
                    "start": 7791,
                    "end": 7796,
                    "text": "[161]",
                    "ref_id": null
                },
                {
                    "start": 7797,
                    "end": 7802,
                    "text": "[162]",
                    "ref_id": null
                },
                {
                    "start": 7803,
                    "end": 7807,
                    "text": "164,",
                    "ref_id": null
                },
                {
                    "start": 7808,
                    "end": 7838,
                    "text": "42:176 T cell development and,",
                    "ref_id": null
                },
                {
                    "start": 7839,
                    "end": 7845,
                    "text": "44:241",
                    "ref_id": null
                },
                {
                    "start": 7885,
                    "end": 7966,
                    "text": "formation and, 41:186, 204, 230, 233,237 B cell precursors, 41:188, 193, 194, 196",
                    "ref_id": null
                },
                {
                    "start": 7967,
                    "end": 7975,
                    "text": "CTL and,",
                    "ref_id": null
                },
                {
                    "start": 7976,
                    "end": 7983,
                    "text": "41:135,",
                    "ref_id": null
                },
                {
                    "start": 7984,
                    "end": 7988,
                    "text": "138,",
                    "ref_id": null
                },
                {
                    "start": 7989,
                    "end": 7993,
                    "text": "139,",
                    "ref_id": null
                },
                {
                    "start": 7994,
                    "end": 8015,
                    "text": "154 cytotoxicity and,",
                    "ref_id": null
                },
                {
                    "start": 8016,
                    "end": 8023,
                    "text": "41:270,",
                    "ref_id": null
                },
                {
                    "start": 8024,
                    "end": 8029,
                    "text": "[284]",
                    "ref_id": null
                },
                {
                    "start": 8030,
                    "end": 8035,
                    "text": "[285]",
                    "ref_id": null
                },
                {
                    "start": 8036,
                    "end": 8041,
                    "text": "[286]",
                    "ref_id": null
                },
                {
                    "start": 8042,
                    "end": 8045,
                    "text": "293",
                    "ref_id": null
                },
                {
                    "start": 8046,
                    "end": 8054,
                    "text": "CTL and,",
                    "ref_id": null
                },
                {
                    "start": 8055,
                    "end": 8062,
                    "text": "41:135,",
                    "ref_id": null
                },
                {
                    "start": 8063,
                    "end": 8067,
                    "text": "142,",
                    "ref_id": null
                },
                {
                    "start": 8068,
                    "end": 8072,
                    "text": "153,",
                    "ref_id": null
                },
                {
                    "start": 8073,
                    "end": 8077,
                    "text": "154,",
                    "ref_id": null
                },
                {
                    "start": 8078,
                    "end": 8099,
                    "text": "165 cytotoxicity and,",
                    "ref_id": null
                },
                {
                    "start": 8100,
                    "end": 8107,
                    "text": "41:269,",
                    "ref_id": null
                },
                {
                    "start": 8108,
                    "end": 8111,
                    "text": "270",
                    "ref_id": null
                },
                {
                    "start": 8126,
                    "end": 8168,
                    "text": "cytokines and, 46:127, 129, and host, role",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "368"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "48:288 PV, see Pemphigus vulgaris Pyridostigmine, for MG",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Putrescine",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "42",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "224 Pyrrolidine dithiocarbamate",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "42",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Quantitative matrices algorithms based on",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "66",
            "issn": "",
            "pages": "72--76",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Q region gene products",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "52",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Quantitative regulatory mechanism",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "48",
            "issn": "",
            "pages": "12--15",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Rabbit anti-mouse Ig, see Immunoglobulin, Rabies, synthetic T and B cell sites and, Rabies virus rabbit anti-mouse",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Ra",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Rabbit",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "infection with HIV-1",
            "volume": "52",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Race, see also Ethnicity as RA susceptibility factor",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "56",
            "issn": "",
            "pages": "109--111",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "IgE biosynthesis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "47",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Radoreceptor assay",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "42",
            "issn": "",
            "pages": "166--167",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Radioresistance. hybrid resistance and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "41",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Sepsis anticytokine therapies, 66:151 anti-TNF-a therapy",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "64",
            "issn": "",
            "pages": "149--150",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "150 IFN-y and",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Gm-Csf",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "66",
            "issn": "",
            "pages": "142--145",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "142-151 pulmonary inflammation, 62271-275 therapeutic regulation of complement system in, 56281-282 Septic shock complement cascade, 62271 contact cascade in, 66:235 experimental treatment",
            "authors": [],
            "year": null,
            "venue": "66:lOl and IL-lra animal models",
            "volume": "66",
            "issn": "",
            "pages": "281--282",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "collective responses of different species, critical residue",
            "authors": [],
            "year": null,
            "venue": "replaceability matrix",
            "volume": "43",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Sequential switching, switch recombination",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "61",
            "issn": "",
            "pages": "105--107",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "lll-112, 155 CD4 and CD8 molecules and, 44:269 CTL and, 41:135. 148 genetically engineered antibody molecules IL-1 and",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ars",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "42",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "202 Serine proteinases, 64:297 complement components and C2",
            "authors": [
                {
                    "first": "Inhibitor",
                    "middle": [],
                    "last": "Serine Proteinase",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "61",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Factor B, 38209, 211, 214 cytotoxicity and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "41",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "hinding of isoforms, 55:194 cDNA cloning",
            "authors": [],
            "year": null,
            "venue": "Serine/threonine kinase receptors",
            "volume": "55",
            "issn": "",
            "pages": "190--193",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "as p56'ri targets in T cell signaling. 56:160 in analysis of MHC class I-deficient cells",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "37--44",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Seriidthreonine phosphatases",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "63",
            "issn": "",
            "pages": "385--386",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "antithymocyte, hybrid resistance and",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Serraticl",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "42",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Serum aniyloid A, lymphocyte adhesion and, Serum sickness, IFN-y and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "62",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Servomodulator, regulating functional tolerance",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "50",
            "issn": "",
            "pages": "167--170",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "237 DNA repair defects",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "41",
            "issn": "",
            "pages": "61310--311",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "SCID mouse, 50:303 EBV-associated lymphoproliferative disease in hu-PBL-SCID mice",
            "authors": [
                {
                    "first": ",",
                    "middle": [],
                    "last": "V(d)j Recombination",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Scid-Hu Mouse",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "63",
            "issn": "",
            "pages": "299--301",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Scid syndromes, with V(D)J recombination defects",
            "authors": [],
            "year": null,
            "venue": "lack of",
            "volume": "58",
            "issn": "",
            "pages": "398--399",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "HIV-infection of hn-PBL-SCID mice, other tumor models in SCID mice, transfer of normal or autoimmune with fetal tissue",
            "authors": [],
            "year": null,
            "venue": "J joining of antigen receptor",
            "volume": "49",
            "issn": "",
            "pages": "393--396",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Sex steroids, spontaneous autoimmune thyroiditis and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "47",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "SH1 domain, BTK",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "61",
            "issn": "",
            "pages": "13--14",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Stat activation specificity in, 60:23 Stat proteins, 6018-20 SH2 and IRSl NPXY (SA1N)-binding SH2-PTP",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "63",
            "issn": "",
            "pages": "283--285",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "IL-2-induced Ras activation",
            "authors": [],
            "year": null,
            "venue": "signal transduction",
            "volume": "61",
            "issn": "",
            "pages": "262--164",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Shedding lymphocytes, 64:170 in regulation of CD44 receptors",
            "authors": [
                {
                    "first": "Tyrosine",
                    "middle": [],
                    "last": "Shc",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Phosphorylation",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "60",
            "issn": "",
            "pages": "317--318",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "293 humoral immune response and, 451, 2, 68, hybrid resistance and, 41:3S2 T cell subsets and",
            "authors": [],
            "year": null,
            "venue": "Sheep red blood cells cytotoxicity and",
            "volume": "41",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "Sheet-sheet packing, schematic",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "43",
            "issn": "",
            "pages": "102--103",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "42:213, see also Cachectin Shope fibroma virus, T2 ORF product Short consensus repeats",
            "authors": [],
            "year": null,
            "venue": "Shock",
            "volume": "70",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "202, 203, regulators of complement activation and common structural motif, 45:391, 392 genes, 45404-408 localization, 45392-394 protein expression, 45:399 protein utilization",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Resemblance To Tnf-R Domain",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "61:lO complement receptor 1 and",
            "volume": "46",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Sialic acid, 64:162, 168 CD23 antigen and",
            "authors": [],
            "year": null,
            "venue": "lSS-156 lymphocyte homing and",
            "volume": "60",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "CD34, and selectin ligaird",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Sialoiniicins",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "64",
            "issn": "",
            "pages": "359--360",
            "other_ids": {}
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "Side chain contribution to solvent-exposed surface hydrophobic, 43:42, 80-81 sequential epitope role, 43:40 65363 area",
            "authors": [
                {
                    "first": "Ynrlronie",
                    "middle": [],
                    "last": "Sicca-Cd8&apos; Lymphocytosis S",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "65",
            "issn": "",
            "pages": "36--38",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "Signal binding proteins. recombination, Signaling, see Negative signaling",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF67": {
            "ref_id": "b67",
            "title": "ahortive, and second signals in adult R cells",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "54",
            "issn": "",
            "pages": "407--410",
            "other_ids": {}
        },
        "BIBREF68": {
            "ref_id": "b68",
            "title": "iintigenic, constraints to hiochemical study of, 52994-295 cytokines in, 58:369 differential, between CD4 and CD8",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "3--9",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "p:ithwvays, controling positive selection",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "53",
            "issn": "",
            "pages": "85--91",
            "other_ids": {}
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "64:40, 41 Signal sequence recognition. V(D)J Signal transditcers and activators of recombination. 64:54 transcription, 59261",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Signal Joints",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "V( D) J Recombination",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "see O~O Stat activation hy ECF",
            "volume": "60",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "IFN signaling",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "60",
            "issn": "",
            "pages": "17--19",
            "other_ids": {}
        },
        "BIBREF74": {
            "ref_id": "b74",
            "title": "adoptive T cell therapy of tumors and, Bi-1 and B7-2",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "62",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "cachectin and",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Btk",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "60",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF76": {
            "ref_id": "b76",
            "title": "Signal transdiiction",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "59",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "CD4 and CD8 molecules antl, 44267, 270, CD23 antigen and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "49",
            "issn": "",
            "pages": "36--37",
            "other_ids": {}
        },
        "BIBREF79": {
            "ref_id": "b79",
            "title": "Ig production",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "300",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "CD44-ligand interactions",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "54",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF81": {
            "ref_id": "b81",
            "title": "cjtokines tidapter niokcules",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "60",
            "issn": "",
            "pages": "164--165",
            "other_ids": {}
        },
        "BIBREF82": {
            "ref_id": "b82",
            "title": "nuclear transcription factor NF-KH, Px-I. 63:167 plrospliatidyliriositol 3-kin;isc~. phosphoprotein phosphatases. protein kinase C, 63:154-157 protein-tyrosine kinases",
            "authors": [
                {
                    "first": "Jak-Stat",
                    "middle": [],
                    "last": "Pathway",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "ncgative regulation",
            "volume": "63",
            "issn": "",
            "pages": "6--166",
            "other_ids": {}
        },
        "BIBREF85": {
            "ref_id": "b85",
            "title": "Hlio protein. 63:lilY Src family",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "63",
            "issn": "",
            "pages": "133--137",
            "other_ids": {}
        },
        "BIBREF86": {
            "ref_id": "b86",
            "title": "Stats role",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "60",
            "issn": "",
            "pages": "19--22",
            "other_ids": {}
        },
        "BIBREF87": {
            "ref_id": "b87",
            "title": "Syk family",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "63",
            "issn": "",
            "pages": "208--210",
            "other_ids": {}
        },
        "BIBREF93": {
            "ref_id": "b93",
            "title": "89-90 mechanism",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "57",
            "issn": "",
            "pages": "57231--83",
            "other_ids": {}
        },
        "BIBREF94": {
            "ref_id": "b94",
            "title": "Signal transduction (continued) second messenger interactions, structural factors",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "57",
            "issn": "",
            "pages": "77--79",
            "other_ids": {}
        },
        "BIBREF95": {
            "ref_id": "b95",
            "title": "GPI hydrolysis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "59",
            "issn": "",
            "pages": "264--265",
            "other_ids": {}
        },
        "BIBREF96": {
            "ref_id": "b96",
            "title": "Grb2, 59:262 IFN-y binding",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "62",
            "issn": "",
            "pages": "67--71",
            "other_ids": {}
        },
        "BIBREF97": {
            "ref_id": "b97",
            "title": "Ig gene superfamily and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "44",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF98": {
            "ref_id": "b98",
            "title": "IgR-mediated cascade functionill molecules",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "54",
            "issn": "",
            "pages": "378--379",
            "other_ids": {}
        },
        "BIBREF99": {
            "ref_id": "b99",
            "title": "1L-1 and, 44:183 IL-2/IL-2\u20ac3 system",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "63",
            "issn": "",
            "pages": "171--173",
            "other_ids": {}
        },
        "BIBREF100": {
            "ref_id": "b100",
            "title": "IL-2-induced",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "59",
            "issn": "",
            "pages": "265--266",
            "other_ids": {}
        },
        "BIBREF102": {
            "ref_id": "b102",
            "title": "IL-2H-triggered proximal signaling events, IL-6R complex chain",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "54",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF103": {
            "ref_id": "b103",
            "title": "IL-9 receptors and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "54",
            "issn": "",
            "pages": "262--263",
            "other_ids": {}
        },
        "BIBREF104": {
            "ref_id": "b104",
            "title": "mechanism of IL-2H-mediated, 50:152 in neutrophil regulation by 1L-8, new molecules",
            "authors": [],
            "year": null,
            "venue": "PI3-K, 59:263 pituitary hormones",
            "volume": "54",
            "issn": "",
            "pages": "263--264",
            "other_ids": {}
        },
        "BIBREF105": {
            "ref_id": "b105",
            "title": "kinase",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "59",
            "issn": "",
            "pages": "262--263",
            "other_ids": {}
        },
        "BIBREF106": {
            "ref_id": "b106",
            "title": "regulators of complement activation and, S6 kinase, 59:264 SCID and",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Ras",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "59",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF107": {
            "ref_id": "b107",
            "title": "262 surface antigens of human leukocytes and",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Shc",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "IL-2H",
            "volume": "59",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF108": {
            "ref_id": "b108",
            "title": "Simian immunodeficiency virus type 1, Simian virus 40",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "63",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF109": {
            "ref_id": "b109",
            "title": "Ig heavy-chain variable region genes and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "49",
            "issn": "",
            "pages": "56--57",
            "other_ids": {}
        },
        "BIBREF110": {
            "ref_id": "b110",
            "title": "Single strand annealing model, 6L:lll sis-inducible element, in c7fU.s gene. 60:24 Sister chromatid exchange",
            "authors": [],
            "year": null,
            "venue": "Sindbis virus, cytotoxic T cells and",
            "volume": "38",
            "issn": "",
            "pages": "234--235",
            "other_ids": {}
        },
        "BIBREF111": {
            "ref_id": "b111",
            "title": "Site-specific tolerance, peripheral lymphocytes",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "53",
            "issn": "",
            "pages": "201--203",
            "other_ids": {}
        },
        "BIBREF112": {
            "ref_id": "b112",
            "title": "lll-11:3, 115-118 autoantihodies",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Sjogren&apos;s Syndrome",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "62",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF113": {
            "ref_id": "b113",
            "title": "SLE",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "44",
            "issn": "",
            "pages": "209--210",
            "other_ids": {}
        },
        "BIBREF114": {
            "ref_id": "b114",
            "title": "invariant intraepithelid y/S T cells, invariant yS T cell receptors of inurine suppressor antigen-presenting cell",
            "authors": [],
            "year": null,
            "venue": "infections, immunity",
            "volume": "58",
            "issn": "",
            "pages": "167--169",
            "other_ids": {}
        },
        "BIBREF116": {
            "ref_id": "b116",
            "title": "93 B cell formation and, 41:225 CTL and, 41:158 hybrid resistance and, 41:369, 376, 383 in MHC class I-deficient mouse",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "55",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF119": {
            "ref_id": "b119",
            "title": "Crohn's disease and. Skin window chamber technique, 42:307 SLE. see Systemic lupus erythematosus S1 locus",
            "authors": [],
            "year": null,
            "venue": "Skin test antigens",
            "volume": "55",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF120": {
            "ref_id": "b120",
            "title": "Smoking, related lung disease",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "60",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF121": {
            "ref_id": "b121",
            "title": "Spbp-2, biiiding site, switch recombination, Snake venom toxin, MG and, 42:237 Sodium azodisalicylate",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "42",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF122": {
            "ref_id": "b122",
            "title": "Sodium dodecyl sulfate, denatured AChR suhunits",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "42",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF123": {
            "ref_id": "b123",
            "title": "Sodium dodecyl sulfate-polyac3.lamide gel electrophoresis, see SDS-PAGE Sodium salicylate. inhibition of NF-KB activation at high doses",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "58",
            "issn": "",
            "pages": "19--20",
            "other_ids": {}
        },
        "BIBREF124": {
            "ref_id": "b124",
            "title": "affinity purification, 49230-231 antibody subsets, 49:232 clinical aspects",
            "authors": [],
            "year": null,
            "venue": "Solid-phase immunoassay, aPL antibodies and",
            "volume": "49",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF125": {
            "ref_id": "b125",
            "title": "Solid-phase synthesis, multiple antigen Soluble costimulators. EC production of, Sohbk mediators",
            "authors": [],
            "year": null,
            "venue": "IBD",
            "volume": "42",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF126": {
            "ref_id": "b126",
            "title": "Somatic cell genetics peptides",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "60",
            "issn": "",
            "pages": "272--274",
            "other_ids": {}
        },
        "BIBREF127": {
            "ref_id": "b127",
            "title": "320 human I? cell neoplasia and Somatic cell hybridization Burkitt 1,yniphoma cells. 38257, 259 chromosomal translocation, 38:248, 265 c-myc activation, 38:263 c-tnyc oneogene, 38:248, 249, 259 1ymphot)lastoid cells, 38:260 lymphocyte hybridonias and, 38:275 B cell iinmortalization, 38:306 geneticdly engineered antibodies",
            "authors": [],
            "year": null,
            "venue": "204, 233 human H cell neoplasia and",
            "volume": "38",
            "issn": "",
            "pages": "287--289",
            "other_ids": {}
        },
        "BIBREF129": {
            "ref_id": "b129",
            "title": "Ig gene siiperfainily and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "44",
            "issn": "",
            "pages": "12--20",
            "other_ids": {}
        },
        "BIBREF131": {
            "ref_id": "b131",
            "title": "Somatic fusion, B cell hybridization and, Somatic hypermutation Somatic diversification 38:279 in germinal centers",
            "authors": [],
            "year": null,
            "venue": "T cell subsets",
            "volume": "53",
            "issn": "42",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF132": {
            "ref_id": "b132",
            "title": "adoptive T cell therapy of tumors and, and antibody repertoire generation in Somatic mutation",
            "authors": [],
            "year": null,
            "venue": "evolution of repeats",
            "volume": "4296",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF133": {
            "ref_id": "b133",
            "title": "CS-specific T cells",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "45",
            "issn": "",
            "pages": "310--313",
            "other_ids": {}
        },
        "BIBREF134": {
            "ref_id": "b134",
            "title": "endemic areas",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "45",
            "issn": "",
            "pages": "319--322",
            "other_ids": {}
        },
        "BIBREF137": {
            "ref_id": "b137",
            "title": "11s protein",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "61",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF138": {
            "ref_id": "b138",
            "title": "SPTII",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "60",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF139": {
            "ref_id": "b139",
            "title": "Src family",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "55",
            "issn": "",
            "pages": "133--137",
            "other_ids": {}
        },
        "BIBREF140": {
            "ref_id": "b140",
            "title": "src homology 2, see SH2 domain Src tyrosine kinases",
            "authors": [],
            "year": null,
            "venue": "cytokine signaling",
            "volume": "60",
            "issn": "",
            "pages": "253--255",
            "other_ids": {}
        },
        "BIBREF142": {
            "ref_id": "b142",
            "title": "Staphylococcal 6-toxin, cytolysis and",
            "authors": [],
            "year": null,
            "venue": "Staphylococcal enterotoxin A action on TCR, 58:323 deletion of VP3+ and VPll'R lymphocytes",
            "volume": "41",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF143": {
            "ref_id": "b143",
            "title": "thymocyte apoptosis, 58:216 VP8' thymocyte depletion",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "58",
            "issn": "",
            "pages": "219--224",
            "other_ids": {}
        },
        "BIBREF145": {
            "ref_id": "b145",
            "title": "alternative activation molecule",
            "authors": [],
            "year": null,
            "venue": "accessory activation molecule",
            "volume": "57",
            "issn": "",
            "pages": "258--260",
            "other_ids": {}
        },
        "BIBREF146": {
            "ref_id": "b146",
            "title": "cell cycle progression, 48:290 cell surface molecules",
            "authors": [],
            "year": null,
            "venue": "CD8a role",
            "volume": "53",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF148": {
            "ref_id": "b148",
            "title": "de nova-induced genes, 48:290 gene products, 48:290 gene regulation",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "41",
            "issn": "",
            "pages": "26--30",
            "other_ids": {}
        },
        "BIBREF149": {
            "ref_id": "b149",
            "title": "intracellular signals, 41:26 in n i w",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Il-I Receptor",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "48",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF150": {
            "ref_id": "b150",
            "title": "104-108 competitive inhibition",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Ir",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "38",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF152": {
            "ref_id": "b152",
            "title": "15-22, 30-32 nuclear scaffold, 63:201 regulator proteins in nucleus",
            "authors": [],
            "year": null,
            "venue": "lymphokine production by FcsRI+ cells, NF-KB family",
            "volume": "65",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF154": {
            "ref_id": "b154",
            "title": "see also assembly, role in gene rearrangements, B cell development, 63:5 B cell development and function IFN-dP",
            "authors": [],
            "year": null,
            "venue": "Transcription complex, ISGF3, induction by Transcription factors",
            "volume": "63",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF157": {
            "ref_id": "b157",
            "title": "EZA gene",
            "authors": [],
            "year": null,
            "venue": "homeodomain proteins",
            "volume": "63",
            "issn": "",
            "pages": "267--271",
            "other_ids": {}
        },
        "BIBREF158": {
            "ref_id": "b158",
            "title": "58:14 phosphorylation, activation by DNA-PK, 5860-62 topography",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Dif",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "re1 family, characterization",
            "volume": "63",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF159": {
            "ref_id": "b159",
            "title": "$5' ;~lleles, and c-kit alleles",
            "authors": [],
            "year": null,
            "venue": "relationship WEHI-3 cells between",
            "volume": "55",
            "issn": "",
            "pages": "6--7",
            "other_ids": {}
        },
        "BIBREF160": {
            "ref_id": "b160",
            "title": "lS-16 WEHI-SB, 48:77 WEHI-231 B cell line, growth arrest",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "39",
            "issn": "",
            "pages": "64--65",
            "other_ids": {}
        },
        "BIBREF161": {
            "ref_id": "b161",
            "title": "Weibel-Palade bodies, P-selectin stored in",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "58",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF162": {
            "ref_id": "b162",
            "title": "Western blotting, I1LA class 11",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "48",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF163": {
            "ref_id": "b163",
            "title": "B cell formation Wiskott-Aldrich syndrome",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Whitlock-Witte",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "59",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF166": {
            "ref_id": "b166",
            "title": "Xanthine, genetically engineered antibody X-chromosome, mosaicism, 59:159, 195 Xenograft rnodets HIV-I disease",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "63",
            "issn": "",
            "pages": "79--82",
            "other_ids": {}
        },
        "BIBREF169": {
            "ref_id": "b169",
            "title": "Xeroderma pigmentosum",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "61",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF170": {
            "ref_id": "b170",
            "title": "Xd mutation",
            "authors": [],
            "year": null,
            "venue": "B cells",
            "volume": "59",
            "issn": "",
            "pages": "317--318",
            "other_ids": {}
        },
        "BIBREF171": {
            "ref_id": "b171",
            "title": "niitogenic signaling",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "59",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF172": {
            "ref_id": "b172",
            "title": "niotiels. human-to-mouse",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "50",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF173": {
            "ref_id": "b173",
            "title": "XLA, .we X-linked aganlmaglobnlinemia X-linked againinaglobu~inemia",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "59",
            "issn": "",
            "pages": "312--314",
            "other_ids": {}
        },
        "BIBREF175": {
            "ref_id": "b175",
            "title": "178-196 carrier detection",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Btk",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "B cell development",
            "volume": "59",
            "issn": "",
            "pages": "194--195",
            "other_ids": {}
        },
        "BIBREF176": {
            "ref_id": "b176",
            "title": "with growth honnoiie deficiency. 59:149 and HIGMX-1, imniunodeficiency diseases",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "59",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF177": {
            "ref_id": "b177",
            "title": "incidence and prognosis, 59:142 and SCID mice",
            "authors": [],
            "year": null,
            "venue": "X-linked againmaglobulinemid (continued) history",
            "volume": "59",
            "issn": "",
            "pages": "150--151",
            "other_ids": {}
        },
        "BIBREF178": {
            "ref_id": "b178",
            "title": "hyper-IgM syndrome, 59:248 CD40-L role",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "61",
            "issn": "",
            "pages": "92--93",
            "other_ids": {}
        },
        "BIBREF179": {
            "ref_id": "b179",
            "title": "X-linked immunodeficiency, see also Xid mutation diseases",
            "authors": [],
            "year": null,
            "venue": "Btk implicated in",
            "volume": "59",
            "issn": "",
            "pages": "41--42",
            "other_ids": {}
        },
        "BIBREF180": {
            "ref_id": "b180",
            "title": "X-linked lyrnphoproliferative disorder",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF181": {
            "ref_id": "b181",
            "title": "X-linked severe combined immunodeficiency",
            "authors": [],
            "year": null,
            "venue": "cells and",
            "volume": "59",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF182": {
            "ref_id": "b182",
            "title": "IL-2Ry mutations",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "59",
            "issn": "",
            "pages": "248--250",
            "other_ids": {}
        },
        "BIBREF183": {
            "ref_id": "b183",
            "title": "X-ray analysis, antibody, 43:121 X-ray crystallography",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "43",
            "issn": "",
            "pages": "8--9",
            "other_ids": {}
        },
        "BIBREF184": {
            "ref_id": "b184",
            "title": "X-ray structures, antibody-antigen interaction",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "43",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "molecules, 52:92-104 characteristics of individual class Ib general aspects of structure and function,",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "-1 , 4 1 :401-403 marrow ahgraft reactivity, 41:408-410 transplanted cells, 41:403",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "of human basophils in teferons, 52355-356 transforming growth factors, and mast cells, 52:355-357 52:356-357 receptors for activating peptides, 52:366-375 receptors for formyl-methionine peptides and related compounds, 52:371-372 receptors for IL-8 and related integrins, 52:367-371 receptors for substance P and other neuropeptides, 52:372-375 receptors for growth and differentiating hemopoietic growth factor receptor superfamily, HHS, 52:340-351 factors, 52:339-355 receptors for low-molecular-weight regulators and pharmacological compounds, 52:396-404 receptors for adenosine, 52:396-398 receptors for antiinflammatory drugs,receptors for arachidonic acid metabolites, 52:398-402 52:402-404 HTK family, c-kit, and related oncogenes, 52:351-355 neuropeptide production, 39:316-317 phenotypic properties, 53:l-2 precursors, 532 properties, 53:l-2 role in inflammatory reactions, 53:2 secretions, 5 3 2 BBlO antibody, 43:306-307 bcl-2 oncogene, immunological memory and, bcl-2 transgenic mice, pre-B cell B cell activation factor 1, humoral immune B cell activators, isotype specificity, 61:90-92 B cell antigen receptor, 52:136-138, anti-Ig in study of, 52:185-188 53241 differentiation into B cells, 53:143-144 response and, 45:67 185-188; 55282 Branhamella cntarrhalis and others, inhibitory effects of anti-Ig antibodies, Staphylococcus aurais Strain Cowan, stirnulatory effects, 52:185-186 52: 188 52~186-187 52: 187-188 cytoskeletal attachment, 55:262 Ig-a, tyrosine phosphorylation, 55946-248 Ig-P, tyrosine phosphorylation, 55246-248",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "and, 41:273 delineation of responsive subsets, 40:4-5 development, 59:151-162: 63:l-3, bursa of Fahricius, 48:42v i m activated plasmablasts,",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "J558 V,, gene family. see Arsonate idiotypic system, A/] mouse, 1558 V, gene family and J774.1 cell line, specific binding of' LPS, 53277-278 yak, and JAK, 602-4 JAK-1, 62:68-69, 106; 63:139, 168 JAK-lILV(D)J, antigen receptor genes, see V(D)J joining, antigen receptor genes Joints morphology of, 64:287-288 NO-induced destruction, 60:344 open-and-shut, V(D)J recon~bination,",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": "CDS B cell expression in, 55:314 MRUMp-lprflpr, recombinant IL-Uvaccina virus construct on, 50:193-203 Mtv-7' and Mtv-7-, 58222 mutations affected by stem cell factor or neomtally thymectomized, effect of IL-Nulnu, effect of IL-2.W on, 50:204-206 p53-deficient, 58:169 perforin gene mutation, 60:292-296 retention of Vbse sequences, 50:41-42 scirl, 60:34-343 model, 60:348-349 self-reactive T cells, 58:274-277 a, -p, -y, and -6 loci, 58:118response, 65:192-194 humoral response, 65:188-192 neonatd response, 65:171-175, 203 receptors for, 65:11 molecules, interartion \\vi th, 65:164-165 MIS identification 3s product, 54:lOO-102 protein structure, 65: 157-lM role in life cycle of viivs arid host, structure-frinction studies, 54: 103-106 TCH Vp. interaction with, 65:165-167 titinor fortnation md, 65:152, 15.5 ;implification ;ind spread. 65: 180-188 infection and transmission, 65: 148-151 life cycle. 6521 1 stnictiirr. 65:146-148 tissue distribution, 65:lSl-1.52 tmnscription;il regulntioir, 65: 148 Mouse inan~inary tumor cirus receptors. 65: 194-196 MPL units, aPL aiitihodies and. 49:203-204 niHNA. S w Messenger HNA a-MSH. in ~i t r t i IgE synthesis, 61:371-372 mTOR, 61:181, 188-190 m f p genes. ;itoiny of Peyer's patches, utiidies on disassociated Peyer's patclies and immunity, 58:297-298; 59372 lymphocyte hoiniiig into, 64:175helniinthic diseases, 60:124-128 mono-, di-. and triepitope. 60:120-123 [INAAG),], MAP. iinininiized inouse, for in protozoan diseases, 60: 108-124 sporozoite malaria vaccine and, 45:32 1 (TlB), MAP construct, inimunogenicity, for viral and bacterial diseases, 60:128-136 P. ~~d [~r i a c , , 42:224: 64:219. see czlso Myeloma adhrsion moleriiles, 64:246-249 CD40, 61:12, 39 cell identification, 64:242-246 chromosome and oncogene abnormalities cytokinrs, 64:252-260 11,-6 signal transcluction therapies, 64960-263 in, 64:250-251",
            "latex": null,
            "type": "figure"
        },
        "TABREF6": {
            "text": "anti-Id antibody as mediator of, 395279 hronchoconstrictive response to LTCl leukotrienes in neutrophils, dietary EPA",
            "latex": null,
            "type": "table"
        },
        "TABREF7": {
            "text": "TCR V region, antibodies to molecules, TCR V region, vaccination to,",
            "latex": null,
            "type": "table"
        },
        "TABREF8": {
            "text": "Autoimmune manifestations lack of, in mice transgenic for human LL-2 after in cico applications of recombinant or",
            "latex": null,
            "type": "table"
        },
        "TABREF9": {
            "text": "Autologous plaque-forming B cell response, Autonomous model, interaction of Clq and Arsonate idiotypic system, A/J mouse",
            "latex": null,
            "type": "table"
        },
        "TABREF15": {
            "text": "TIIl and TH2 CD4+ helper T cells, 52: 185 52: 175-177 i n oiuo aspects, 52:221-230 cytokines and B cells, a s,ptliesis,",
            "latex": null,
            "type": "table"
        },
        "TABREF21": {
            "text": "BCH triggering, CD40 signaling differs from, Bence-Jones proteins, structural analyses, Beta cells, islet, see Islet beta cells P chain, 52:379-380, see also T cell receptor",
            "latex": null,
            "type": "table"
        },
        "TABREF22": {
            "text": "CD23 antigen antl, 49:155 cells lrorn, transplantion i n ino~ise. derived B cells, clonal deletion, 58:257 derived cells. and deletion of thymocytes, FcaWI' cells. lymphokine production by forbidden dBT cells, 53:166",
            "latex": null,
            "type": "table"
        },
        "TABREF23": {
            "text": "NK cells, 41:372, 373, 375 normal henlopoetic cells, 41:335-351 syigeneic stern cell functions. 41:388, Ig Iie:r\\?..-cliain variable region genes m d ,",
            "latex": null,
            "type": "table"
        },
        "TABREF25": {
            "text": "264Biiriiet's clonal selection theory, Ars A",
            "latex": null,
            "type": "table"
        },
        "TABREF27": {
            "text": "IgEbiosynthesis and, 229.    influx, atid cNOS phosphorylation. 60:324.",
            "latex": null,
            "type": "table"
        },
        "TABREF35": {
            "text": "DP fl allele, 48:145 DP a-DQwl p, 48:146-147 DP (Y polymorphism, 48:145 DP fl polymorphism, 48:145 HLA class 11, 48:144 HLA class I1 antigen, 48:147 hybrid HLA-DQ molecule, 48:147",
            "latex": null,
            "type": "table"
        },
        "TABREF37": {
            "text": "Cell lines, see nLso spec$. cell lines CD44 expression and hyahranon binding,",
            "latex": null,
            "type": "table"
        },
        "TABREF38": {
            "text": ");te hoinirig and, 44:320 stem cell factor-ligantl interaction in, see cilso specific agents adoptive T cell therapy of tnmors and.Cholinergic nerve differentiation factor, seeChondroitin sulfate A, cell-mediated killing orphan Vl,and DII loci, 19,",
            "latex": null,
            "type": "table"
        },
        "TABREF39": {
            "text": "Chronic inyeloid leukemia, B cell formation Chronic obstructive pulmonary disease, MTV superantigen-reactive T cells, nascent bone marrow B cells, 58:257 and peripheral tolerance to cancer, putative interference of IL-Z.With, Clonal dominance, PIG-A mutant cells, Clonal expansion, and V gene expression, Clonal inactivation, by V/3 selective elements,Clonality, definition based onIg and T cell",
            "latex": null,
            "type": "table"
        },
        "TABREF42": {
            "text": "Colitis colon-hound antibody, IgC. levels in,",
            "latex": null,
            "type": "table"
        },
        "TABREF50": {
            "text": "Deoxypanosine. T cellsubsets and, 41:104,",
            "latex": null,
            "type": "table"
        },
        "TABREF51": {
            "text": "Endoglin, see Transforming growth factor p and regulatory mechanisms of other surfice antigens of human leukocytes and, Frrritin. complement receptor 1 and.Fetal calf scrim, autoreactive T cells and.Genetic chimerisni, 59:106, 109-111, see also Genetic defects, in B lineage cells leading to Genetic drift, Ir genes, 38:87, 148 CD23antigen and, 49:15G, 165-166    Ig heay-chain variable region genes and, Xid mutation. 59:175XLA gene,[194][195] 59: 159,  195   Gencltic recombination, see Recombination Cieiietics adoptive T cell therapy oftumors and,    aPLantibodies and, 49:222. 255  B cell progenitors, 59:152  Btk gene, 184, 196    CD1 family, 59:2-10 CD23antigen and, 49:162  and diabetes, 51:290-294   mutations, 59:185-192, 195, 317 M IIC-linked diabetogenic genes, non-MNC-linked genes, 51:293-TCK S gene segments, 43:155-156 Genomic structure, CD23 antigen and, Genotype, autoimmune deniyelinating disease PIC-A mutations, 60:81, 87 Plastru,diuni vivax malaria, 60:122 PNH, 60:74 Germ cells, development, stem cell factor receptor effect on, 55:66-69 Germinal center cells, 62:146-148, 150 Germinal center reaction, responses to VH segment, 42:113-115 V d O family, 42:144-148 Ig heavy-chain variable region genes, J558 VH gene, 42:127-128 see Granulocyte functional antigen GH-N gene, 63:384-385 Glial cells, retinal, T helper lymphocyte, Glid growth-promoting factor, 48:173 Glioblastoma cells, immunological mediator, 48: 168 -169 Gliotoxin, 65:126-127 Globular protein antigens, synthetic T and B Glucagon, spontaneous autoimmune P-Glucan receptor, phagocytosis and thyroiditis and, 47:440 alternative complenient pathway activators. and antigen-driven T cell deletion, interaction with NF-IL6, 65:21-22, 23 linomide effects, 58:2M-265 NF-KB and, 65:118-120 and T cell fate determination, 58:137-138 Ig gene superfamily and, 44:39, 40, 42 IL-1 and, 44:165, 166 leukocyte integrins and, 46:149, 151, 153 210 ligand molecules, 46:171, 172 structure, 46:157, 159 lymphocyte homing and, 44:317, 341, 350, maps of Ig-like loci and, 46:34 myelin-associated, see Myelin-associated glycoprotein NK cells and, 47:298 Ig gene superfamily and, 44:35, 39 IL-1 and, 44:179, 183, 194 leukocyte integrins and, 46:154, 170, 174 lymphocyte homing and, 44:342 maternally transmitted antigen and, 38:331 patterns, cell-type specific, 54:314 regulators of complement activation and, surface antigens of human leukocytes and, T cell development and, 44:233 T cell receptor proteins, 38:4, 5, 10, 18 T cell subsets and, 41:41, 50 GPI-H, 60~72-73 GPL, aPL antibodies and, 49:203-204 G proteins, see also Coupling proteins in chemokine activation of integrin, 58:379 coupling to chemokine receptors, TNF-related polypeptides, 41298 eosinophil, 60:191-194, 205-208, 221 role in DNA fragmentation, 60:300-301 eosinophil, 60:155-162, 191-194 exocytosis GM-CSF, in immune response, sepsis and, 66:104, 149-150 single receptor chain, 60:10 58:lO-11 mediated killing and, 41312 coloriy-stiiiiulatitiR factor, 48:75 helper T cell cytokines and, 46:115, 117 h y l d resistance and. 41:336, 370, 380 I1,-4. 48:75 IL-6, 48:75 leukocyte integrins and, 46:151, 161-163, leukocyte surf'ace antigens and, 49:88. 90, nonrecirculating, 58:350-051 opioid receptor. human, 48:180 pituitary hormones, 63:411-412 PNH, clonal origin. 60:81 with two PNH clones, 60:89 in Crohn's disease, 42:297 oil. plastnacyt~magenes~s and, 64:224-225 in pullnonary inflammation. 62:280-283 Granulopoiesis, hybrid resistance and. 4 1:336 as effector molecules in CTL cytotoxicity, or fragmentins. cytotoxic T cells containing, GRB2, recruitment of ras exchange factor, G reactive protein, NK cells and, 47946, mutations, 58:161 peptide antigens bound to, 58:330 Growth, B c~lls, and differentiation, in uiuo Growth arrest, and apoptosis induced by anti-GVHD, see Graft-versus-host disease p2microglobulin, 4 1 : 155, 156 carbohydrate moieties, 41:152-154 exon shuming, 41:138-148 HLA class I antigens, 41:149, 152 monoclonal antibodies, 41:156, 157, 166, mutant strains, 41:158-163, 165 Ig heavy-chain variable region genes and, MIIC, HA susceptibility associated with, tniirine lupus models and, 46:99 563438-446Ig germline, 4666, 67, 69, 71, 72  T cell antigen receptor, 88, 90  T cell subsets and, 41:47, 48, 78, 79. 102    Haptotaxis, stern cell factor receptor-ligand Hay fever, IgE biosynthesis and, 47:1, 28 H-CAM, multiple myeloma and, 64:247, 248 Heart, iiiyxoma, and IL-6. 54:39-40 Heart disease 293 coronary, dietary fish oil and, 39:14-5-146 eosinophil degranulation and, 39:226 eosinophil localization and, 39:226-227 ;intinuclear antibodies and, 44:90, 96, 109, 132 hsp70, 62:244 MHC class I peptide loading, 64:128 niycobacterial, recognition, 58:321-322 surface antigens of human leukocytes and, Heat-stable antigen, for B and T cells, Heavy chain variable region, see also Variable Ars A response and, 42:99-105, see ulso region, gene expression Arsonate idiotypic system, A/J mouse cross-reactive idiotype-positive kinetics, 42~108-109 repetitive substitutions, 42:IlO-111 serine, 42:lll-112 molecules, 42:109-110 Heavy chain vitriable region, genes, 43:237-238: 49:l-3, 61. 63 and antibody repertoire generation in rabbit allotype,",
            "latex": null,
            "type": "table"
        },
        "TABREF52": {
            "text": "genes, 49:20-21 D segments, 49:28-33 expression, see Variable region, gene YH families, 49:6-11, 14-20 Heliogosomiodes polygjnrs, 54:94 Helix, movement, 43:104 Helix-loop-helix oncogenes, in chromosome",
            "latex": null,
            "type": "table"
        },
        "TABREF53": {
            "text": "NK cells and, 42:182, 183 physiological experiments implying role for pituitary hormones, 63:404-40.5 stem cell factor receptor effect on, transcription factors, 63:216-250 VBV, 63:142 CD23 antigen and, 49:150, 169 CD44 expression. 54:291-296 induction of positive selection, 58:164-165 leukocyteintegrins and, 46:160, 166  NK cells and, 473187, 198, 303 TGF-P effect on, 55:186-187 Hemolytic anemia, 59:146-147, 343 Hemolytic overlay, 38:208 Hemophiliacs, HIV-infected, 65:291-292 Hemopoiesis, see Hematopoiesis Hemopoietic growth factor receptor factor receptor, 52:351 granulocyte-macrophage colony-stimulating superfamily, HRS, 52:340-351 Hemopoietin 1, B cell formation and, 41:234 Hen egg lysozyme, synthetic T and B cell sites and globular protein antigens, 45:204, 211-214 peptides, 45:240 Hen egg lysozyine model, clonal anergy, acute-phase protein synthesis, 54:25-27 grafts in MHC class I-deficient mouse, helper T cell cytokines and, 46:116 IL-lra production, 54:188 iNOS production, 60:351-352 interaction with IgA, 40:171, 177-184 leukocyte integrins and, 46:162 T cell activation and, 41:16 Herpesvirus type 6, human, and HIV-1, exacerhation of AIDS disease progression, 58:16 5-IIETE, see 5-Hydroxyeicosatetraenoic acid Heterogeneity autoimmune thyroiditis and, 46274, 281, B cell formation and. 41:196, 216, 217 CTL and. 41:138, 139. 152 helper T cell cytokines and, 46:125, 126 hybrid resistmce and, 41:372 leukocyte integrins and, 46:151, 154, 174, T cell activation and, 41:27 T cell subsets and, 41:43, 79, 98 175 Heterohybridoma antibodies, 38288-290. Heterohybridomas, human-mouse, 38:300, Heterokaryons, hybridomas and, 38:287, 291, Heterozygosity, Ig gene superfamily and, High endothelial binding factors, lymphoc).te Zr genes and, 38:107 T cell subsets and, 4153, 58 HIV, .see Human immunodeficiency virus HIVENRGA, 48:298 HLA autoimmune demyelinating disease and, synthetic T and B cell sites and, 45:219, T cell receptor and 223, 231, 235 alloreactivity, 45:150, 151, 153, 155, 156 epitopes, 45142. 144 homogeneit): 45:129 MIIC molecules, 45:111, 112, 115, I16 peptides, 45:137, 138 polyniorphic residues, 45:158, 160, 161 sinictrrre-fur~ctiori relatiottsliips, 45: 139-141 IILA-A2.1, 62234 HLA-AS, niriltiple sclerosis. 48:148-150 HLA-B7, multiple sclerosis. 48:148-150 NLAB8, HIV and, 65:285 f 1 LA-B27 HIV and, 65:285 spondyloarthritic diseases, 65:94 IlLA-B35, HIV progressioii to AIDS and. DQ, 48:109, 110-111 DQ gene, 48:120-121 UQ haplotype, 48:120-121 DQ molecule. 48:120-121 restriction fragment length polymorphism, supertypic specificity localization, 37:47-50 biochemistry, 37:43-47 serology/HTC, 37: 14-1 5 HLA-DQ hybrid molecule, 48:119-124 HLA-DR HLADR3-DQ2, 65286HLA-DR5, 65:286 HLA-DR13, 65:286 HLA-D region, 48:108 HLA-D region products, monoclonal HLA-D region specificity, 48:113-114 antibodies to, 37:18-21 IILA DR specificity, HLA D typing, HLA-Dwl4, T cell clone reactivity, 48:129 HLA factor, IDDM, 48:133-144 HLA markers, MG and, 42251 mHNA expression in patients, 57:158 Holoricin-AChR conjugates, MC and, 42265 Homeobox domain, Ig heavy-chain variable N K cells and, 47:252, 254 antinuclear antibodies and, 44:129 ;iutoimini~nedeniyelinating disease and, CD4 molecules and. 44:285. 28fi, 288, 295, CD8 molecules and, 44:272. 276. 278. 302 CD23 antigen and, 49:162-164. 166 CTL and, 41:136 ~2-microglobiilin, 41:154. 155 exon shuffling, 41:140-142, 144-146 nionoclonal antibodies, 41:156, 158 cytotoxicity and, 41:285, 307, 309. 314, 316 genetically engineered antibody molecules human T cell activation and, 41:s antibodies from combinatorial libraries, see Antibodies, human, from combinatorial libraries antibody effector function, see Antibody effector function, human common mucosal systems in, 40:199-204 K light chain genes of, 40:249-251 lymphoid neoplasms, Ig and T cell receptor gene rearrangements and, 40:264-270 and mouse, heavy chain locus organization. CTL decline in late disease, 65:300 CTL exhaustion, 65:304-305 disease progression, 65297-298 epitopes, 65:291-293, 301, 312, 313 escape mutation, 65:311-317, 322-323 infection, 65:290-307 long-term nonprogressors, 65:298-300 lysis of infected cells, 65:280-281 measurement of HIV-specific CTLs, ininiinie response, 47:406. 407, 409 inirr~i~nopatho~r~iic mechanism, 47:391 in seronegatives, 65:287. 307-309 inhihitioii of lymphocyte death, 58279 integrases of. 64:57 Iynphoc.\\tic tendency to undergo I'CD, Humoral memory, germinal center B cells, Hu-PBL-SCID mouse in, 50:310-313 60:283 EBV-associated lymphoproliferative disease HIV infection of, 50:314-317 binding regulation, evidence, 54:302-308 CD44 as receptor for, 54:284-287 Hybrid hyperreactivity. 4 1:360. 379 Hybridization, see d s o Somatic cell hybridization antigen-presenting cells and, 47:65-67, 70, Ig heavychain variable region genes and polymorphism of V, gene segments, cell receptor and, 45:135, 139, 140 T cell receptors and, 38:15 T cell subsets and, 41:41, 100, 101 virus-induced in~munosuppression and, Hybrid joints, V(D)j recombination, 64:41 autoimmune demyelinating disease and, autoimmune thyroiditis and, 46:289, 296, autoreactive T cells and. 45:420, 424-426 B cell formation and. 41:223, 225, 237 CD4 and CD8 molecules and, 44:268, 270. leukemia/lymphoma cells, 41:358-369 antinuclear antibodies and, 44:108, 129 B cell formation and, 190, 41:226 CD4 molecules and, 44:285, 296 CD8 molecules and, 44:272, 273, 282 CTL and, 41:169 Hybrids /3~-microglohulin, 41: 156 exon shuffling, 41:139, 142, 144, 145, 147 IJLA class I antigens, 41:150, 151 resistance phenomenon, NK cells in, 2l-I-Iydroxylase, maps of Ig-like loci and, 4-Hydroxy-:3-1iitrophenyl acetyl, genetically Hyperimmunization, secondary B cells and, Hypophysis, IFN-.), effect on, 62:93 Hypothalamic-pituita~y-adrenal axis, Hypothalamus, NK cells and, 47:266 Ia-like molecules, expression by T cells 156, I-A molecules, role in VP selective element Idio9ic deterininants. Ars A response :nd,",
            "latex": null,
            "type": "table"
        },
        "TABREF56": {
            "text": "differentiation after antigenic stimulation, effector T cell function, 53:227-228 memory T cell fnnctions, 53227-228 naive T cell function, 53:227-228",
            "latex": null,
            "type": "table"
        },
        "TABREF57": {
            "text": "athymic mice by IL-2/vaccina virus, 50:203-206 effect of IL-2.W on neonatally effect of IL-2.W on n d n u mice, lack of autoimmune manifestations in mice transgenic for human IL-2 or IL-2R components, 50:192-193 recombinant IL-2/vaccina virus construct effect on SLE of MRL/Mp-lpr/lpr mice, 50:193-203 effect of IL-2.W on life expectancy effect of IL-2.W on T cell mechanism of beneficial effect of IL-2",
            "latex": null,
            "type": "table"
        },
        "TABREF58": {
            "text": "Leukemia virus, cytotoxic T cells and, 38:173,",
            "latex": null,
            "type": "table"
        },
        "TABREF59": {
            "text": "Light chain, see ubo K light chain; A light LNGFR, see Low-affinity nerve growth factor",
            "latex": null,
            "type": "table"
        },
        "TABREF64": {
            "text": "AB-Mu1 V-transformed mast cells,",
            "latex": null,
            "type": "table"
        },
        "TABREF68": {
            "text": "I1 a chain, 48:141-142 class I1 p chain, 48:141-142 class I1 loci, corneal graft, 48:199-200 conipieinentcomponents and, 38:203, 207,",
            "latex": null,
            "type": "table"
        },
        "TABREF70": {
            "text": "cytotoxic T cells and, seeCytotoxic T cells deficient mouse, .we Mouse ently into processing pathwiiys, 52:13-14 euogenoiis P2ni association with. exogenous peptide association with, site export to cell surface. control of', N K cell recognition, 55363, 36s i n NK cell-specific fiinctioris. Melanoma-derived lipoprotein lipase a-Melanotropin. in uitro IgE synthesis, Memory. .see (dso Immitnological memory Memory B cells, 59:340-041. :393. 412 humoral, germinal center B cells, 60:283 adhesion molecules affecting niigration.",
            "latex": null,
            "type": "table"
        },
        "TABREF73": {
            "text": "Mixed leukocyte cultures, NK cells arid, Mixed-leukocyte reaction, see Mixed-MLA-144 leukemic cell line, 42:172 MLR, see Mixed-l?mphocyte reaction inls identification as product of MMTV,",
            "latex": null,
            "type": "table"
        },
        "TABREF90": {
            "text": ".",
            "latex": null,
            "type": "table"
        },
        "TABREF101": {
            "text": "Population studies. RA susceptibility.",
            "latex": null,
            "type": "table"
        },
        "TABREF103": {
            "text": "adoptive T cell therapy of tumors and,",
            "latex": null,
            "type": "table"
        },
        "TABREF114": {
            "text": ", inseparable from B cell neoplasia in avian bursa of fabricius, see Bursa of fabricius infection, as substrate introduction method in V(D)J joining, 56:50-51 iutegration of viral DNA, 65:168 NK cells and, 47:303 origin of endogenous superantigens, 54: 101-102 SCID and, 49:400 surface antigens of human leukocytes and, transformed tumors, adoptive T cell virus-induced immunosuppression and Heverse-phase high-perfonnance liquid Reverse transcriptase, virus-induced 46: 153 ligand molecules, 46:171-173 structure, 46:158, 159 HGL, 63:144 Hhe, 43:112-113 Rhesus monkey, coinplement components Rlieumatoid arthritis, 38:284, 298; and, 38:207-209 54:137-140, 187; 59~146, 343: 61:367 109 D6 mAb, 48:128 anemia in, 64:321-322 animal models, 64288, 298 antinuclearantibodies and, 44:99, 111   anti-TNF-a! antibodies and goldcompounds and, 64:289, 293,[333][334] 47:136, 147,[148][149][150] fl gene, 48:131 DRw53 molecule, 48:128 Dw4, 48:126-127 DW14, 48:126-127 DwlO, 48:126-127 etiology, 48:126-132; 64283 HLA, 48:126 HLA-B27 and, 65:94 IILA class I1 peptide binding and, Ig heavy-chain variable region genes and, IL-",
            "latex": null,
            "type": "table"
        },
        "TABREF115": {
            "text": "Hheurriatoitl spovial tissue. 54:170 Rhinitis 54: 193 allergic, 60:221 seasonal allergic and perennial, 60:172-173 Rho, 63:149, IT1 RIB1 adjuvaut, with MAP, 60:131-132 Ribonucleic wid, in suppressed cells, Hibonucleoprotein, antinuclear antibodies 40: 140-14 1 and, 4493, 94 autoantibodies, 44:138 autoantigen. 44:129-131 autoimmune response, 44:131-134, 136 mixed connective tissue disease, 44: 11 1 SLE, 4436, 97, 100-102. 104-106 cell formation and, 41:191, 198, 221 double-stranded, induction of NF-KB, 58:6, IgE biosynthesis and, 47:21 Ig gene siiperfamily and, 44:10, 12, 34, 39, Ig heavy-chain variable region genes and, Ig-like loci, imps, 46:8, 1.3, 25 IL-1 and, 44:156, 159-161 iininunosenescence and, 46:227 leukocyte integrins and, 46:174-176 murine lupus models and negative strand transcript, 58:15-16 N K cells and, 47:203, 241, 242, 284 regulators of complement activation and, SCID and, 49:383, 385 sporozoite malaria vaccine and, 45:302 T cell activation and, 41:27 T cell development and, 44:217 T cell receptor and, 45:116 translation inhibition, 58:240 virus-induced immunosuppression and 45:396, 398, 399, 407 HIV, 45:348, 354, 355, 366 measles, 45:33fi, 344, 346 HNA colony blot hybridizations, Ars A response and, 42:132-133 RNA-duplex DNA complex, 61:114-116 RNA polymerases, antinuclear antibodies and, RSal class I1 fragment, 4-kDa, celiac disease, HSS, see Hecombination signal sequences RT-6, 48:241 KU-38486, effect on CD4'8+ thymocyte Runt domain, AML1, 65:24, 25 Sy3 regions, binding site, switch recombination, 61:117-118 S6 kinase, signal transduction, 59:264 Saccharomyces cereoisiae, cytolysis, 41:319 SAgs, sce Superantigens Salicylates NF-KB and, 65:121-122 PCHS, 62:187 Salicylic acid, 62:184-187 Saliva, S-IgA antibodies in, 40201-202 Salmonella adelride, 54:395 Schistosomiasis. immunugen selection, 60:124-12S Schi~osacchommyc~s purrhe, maps of Ig-like loci and, 46:s Schlepper experiment, Zr genes and, 38:39, PACE, 42~166-168, 167-172, 172, 188 T cell receptor, 43:150 SEB, see Staphylrwoccd enterotoxin B Secondary B cell lineage, 42:83, see nlso B cell repertoire expression environment and, 4268-79 Secondary B cell repertoire expression, somatic mutation and, 426-12, see also T cell aiitigeii receptor and, 412, 26, 27 Secretion. helper T cell cytokines, 46:111-114, 127. 136 Secretol?; antibodies, 65249, 250 Secretory component, IgA binding of. 40:165-166, 167, 186 epithelial cells and, 40:175-177 hepatocytes and, 40:179-180, 182 structure and function. 40:160-163 Secretory glands, mechanisnis of Iioming of 367, see also E-Selectin; L-Selectin; P-Selectin CD23 antigen and, 49:163 characterization. 60:165-167 genetic studies, 64:193-195 interactions with eosinophils, 60:167-169 monospecific ligands, 58:362 multistep adhesion cascades, 64:183-184 and related recognition molecules, surface antigens of human leukocytes and, Selection, see nlso Negative selection; Positive Ig heavy-chain variable region genes and, intracellular, 58:120-121 intrathymic, T cells, 58:139-174 phenotypic, in germinal centers, 60:280 T cell, processes, 51:164-189 vs two kinds of death, 51:175-177 positive selection, molecular basis of CD4 vs CD8 down-regulation, four-way 51:185-186 developmental choice, 51:180-186 positive vs negative selection, signaling pathways that control positive Self-peptides, positive selection, 59: 122-128 Self-reactive cells, elimination, 59:288-295 Self-reactive clones, 58:213 Self-reactive immune cells, clonal deletion, cytotoxic T cells and, 38:163, 164, 167 responses in MHC class I-deficient mouse, T cell receptor and, 45:llO cup TCH complex, 58: 124-128 leading to NF-KB activation by TNFcu, TCR-mediated, relation of Apo-l/Fas, 58:136 SIINFEKL, 59:122, 124 SIIKFEKL, 59:125 Silica, hybridresistance and, 41:350, 368,   Vt, gene expression, 49:37, 39, 41, 46,  49, 52  neonatal hybridoma and, 42:79   and terminal differentiation, apoptosis and,   Somatic variation, T cell receptors and, 38:16  Somatostatin, 48:169; 63:385,387 cells of origin, 39:317 histamine release by mast cells and, 39:305-306 immunosuppressive properties, 39:310-311 secretion regulation by, 39:302-303 50:65-66 SOS, 63:143, 144, 146 SOS, signal transduction, 59262 Southern blot analysis 49:363 autoimmune demyelinating disease and, clonally rearranged genes, 40:267-268 complement components, 38:212, 215, 229, human B cell neoplasia, 38:248, 266, 267 hybridomas, 38:299 I r genes, 38:lI7 SCID and, 49385-386 T cell receptors, 38:11, 13, 15, 16 Southern filter hybridization analysis Ars A VH gene segment and, 42:101 of BALBIc liver, 42:121 of VFI complex, 42:130 V.10 family of germline genes and, 42:144 CD8 molecules and, 44:271, 282 c o n i p h e n t receptor 2 and, 46:204-206 CTL aid, 41:138 delayed-type h,yprrsensiti\\<ty, 48:211 -212 FceHI + cells, Iymiphokine production by, forbidden alp T cells. 53:166 helper T cellcytokines and, 46:122. 123.  128, 129, 137, 138  histolop, 60:268-272",
            "latex": null,
            "type": "table"
        },
        "TABREF116": {
            "text": "effector mechanisms, 47:234, 260, 262 genetic control, 47:223 hematopoiesis, 47:274, 276 identification, 47:199 indigriant expansion, 47:228 surface phenotype, 47:210, 211, 213 tissue distribution. 47:220, 221 regulators of complement activation and, spontaneous autoinmwie thyroiditis and 45:384, 388, 389, 410 cellular immune reactions, 47:450, 452. disturbed irnrnunoregulation, 47:471, humoral immune reactions, 47:446, 447 sporozoitr malaria vaccine and, 45287, synthetic T and B cell sites and, 45199 T cell development and, 44:250, 251 T cell populations, 53:161-163 T cell receptor and, 45:134 T cell subsets and :305 306 H-2 alloantigen recognition, 41:78, 86. H-2 molecules in thymus. 41:95, 102 1 I-2-restricted antigen recognition, vints-induced immunosuppression and, Spontaneous cellular cytotoxicty, 47:451, Spontaneous neoplasm, immune regulation, Sporozoite malaria vaccine, 45:283, 284 assays, IBD and, 42:295 Staphylococcus aurais, 52:160: 54:108, 109 antinuclear antibodies and, 44:115, 118, genetically engineered antibody molecules infection-associated autoimmune disease, pulmonary infection, 59:397 B cells responsive to, 40:20, 21 cell response and. 40:14-15, 16, Staphylococcus auracs B 41-44 Statl, 59:261: 62:69; 63:141 State, 59:261: 62:69 STAT3, 65:19 Stat3, 59:261; 61:177: 63:141, 399 STAT5, 65:20 Stat5, 63:141, 399 STAT family, interaction with NF-IL6. 65:19-21 Stat proteins, 59261; 62:68, 69; 63:14O, 398, see al.ro Signal transducers and activators of transcription Stem cell factor receptork-kit, 52:352-354,",
            "latex": null,
            "type": "table"
        },
        "TABREF117": {
            "text": "infection, membrane cofactor protein, tumor necrosis and, 42:215 Streptococcus mnutans, subunit vaccines, Streptococcus pnetmonias, mouse infection 60:135-136 anti-Id antibodies as vaccines against, 39:283 Streptococcus pyogenes, 54:109, 114 vp specificity for, 54:109, 110-112 Streptococcus zooepidemicus, and Fc of IgG, Streptolysin 0. 317, 41:318 Streptomyces tsukobarnsis, 52:403 Streptozotocin, diabetes induced by, 62:lOO Stress-activated protein kinases, 63:148 Stroke, aPL antibodies and, 49:218, 221, 258 Stroma, hybrid resistance and, 41:336, 404 Stromal cells",
            "latex": null,
            "type": "table"
        },
        "TABREF118": {
            "text": "contacts with pre-B cells, 53:133-134 immunosenescence and, 46:241 pre-B cell nonproliferation on, 53:134-135 proand pre-B cells reactive to, thymic, autoreactive T cells and, uterine, IL-lra production, 54:188 Subtilisin, site-directed mutants, 43:23 Subtractive hybridization, 43: 135 N-Succiniinidyl 3-(2-pyridyldithio) propionate, endogenous inurine, 54: 100-108 cellular expression of MMTV antigens, identification of MIS antigens as MMTV role i n life cycle of MMTV and host. direct non-T cell effects, 54:127 involvement of accessory C D 4 or CD8 molecules, 54:124-125 recognition by T cell receptors, T cell deletion and anergy in adult streptococcal infection, 54~140-141 H C class I1 molecules, interaction with, 65:164-165 protein structure, 65:157-164 TCR Vp, interaction with, 65:165-167 tumor formation and, 65:155, 156 T cell signaling in response to interaction with NO, 60:324-325 relatioil to P-selectin, 58:355 allotypic and anti-idiotypic. Fc region and, hybrid resistance and, 41:380, 381, 384, IDDM, 48:143-144 in uitro, induced by Vfi selective elements, 50:37 Suppressor T cells, 43:266; 50:176-177, see also Suppression, T cell-mediated AChR-specific, 42:258-259 adoptive T cell therapy of tumors and, 49287-289, 293 antigen-specific inhibition of MOPC-315 by, 40:143-144 autoreactive T cells and, 45:431, 432 covert, in Crohn's disease, 42:300, 301 historical background, 40:135-136 hybrid resistance and, 41:379, 386, 410 idiotype-specific inhibition of B cells by, immunosenescence and, 46:251, 252 isotype-specific inhibition of B cells by, lymphocytotoxic antibodies and, MG therapy and, 42:269 T cell subsets and, 41:102, 107, 110 Surface area, exposed, MHr, 43:s-36 Surface markers, for memory B cells, Surface receptors, alternative, death induction Surface variability analysis, 43:11, 14 Surrogate heavy chain, 63:8, 25 B cell development, 632-4, 15-25, 29-31 expression, 63:s-12, 13-15 genes, 63:4-5 transduction in complex, 63:25-29 Switched memory B cells, 59:340-341 control during cell cycle, 61:116-117 in DNA replication, 54:237-238 experimental systems for studying, 54:237 fine sequence specificity, 61:107-108 germline transcripts, 61:111-116 homeologous recombination similarity, Ig production, 63:58-59 illegitimate priming model, 61:108-111 intrachromosomal deletion, 61:99 looping out and deletion, 54:234 mutations, 61:108 poly(ADP-ribose) polymerase, 61:llO protein-binding sites, 61:117, 120 NF-Sp, 61:119 Pax& 61:120-122 NF-KB/P~O, 61~117, 118-119 sy3 regions, 61:117-118 spbp-2, 61:119 54:239-240 proteins involved in switch recombination, HNA splicing, 61:101-102 sequential switching, 54:238-239; sister chromatoid exchange, 54:234-235 sites, 61:102-105 substrates, 61:123-129 transchroinosomal switching, 61:lOO-102 vectors. 61:123-129 IL-2H coupling, 61:159-160, 190",
            "latex": null,
            "type": "table"
        },
        "TABREF119": {
            "text": "CD23 antigen and. 49:174-175 human idio%iic network and, 39277-278 Ig heavy-chain variable region genes and, Systemic lupus erythematosus (continued) overexpression of Fas variant, 58:274 patients, low IL-1 production in, pituitary hormones, 63:420-421 transfer to hu-PBL-SCID mouse, 50:307 Systemic lupus erythematosus, murine, 46:61, 50: 175-176, 186-187 62, 65, 71, 99, 100, see also Liipus mouse aPL antibodies and, 49:219, 248 EPA and docosahexaenoic acid in diet and, fish oil in diet and, 39:163-165 functional abnormalities in 39:163-164 B cells, 37:309-316 macrophage defects, 37:324-326 natural killer cells, 37:327 other cellular and humoral abnormalities, T cells, 37:316-324 treatment of, 37:350-355 viruses in, 37:348-349 Systemic lupus erythematosus-like BMiFl mouse, 53:144-147 autoimmune disease, 54: 141 -142 T3, T cell receptor and, 38:18, 22 T3 membrane proteins, 43:116 T9, positive lymphocytes, in Crohn's dsease, T11, see CD2 T15' B cells in mice, 42:72 Tac antigen, 59:228 Tachykinin receptor, 48:181 Tachyzoite antigen, 65:208 Talin, leukocyte integrins and, 46:169 T-ALL cell line (YT), 42:171 TAM, see Tyrosine-containing sequence NK cells and, 47~292, 294 spontaneoiis autoimmune thyroiditis and, T cell activation and, 41:1, 14, 30 T cell subsets and, 41:76, 94, 95 Targeted chemotherapy, concept of, thyroiditis and defect, 47:456-465 genetics. 47:482, 485. 487 Target recognition, T cell receptors and, TATA box, TAP genes, 65:60 Tau, 65:29 TBAM, 63:47 T cell-activating protein, 48:240-241 T cell activation, 41:1, 4, 8, 10, 17, 19, 21, 38:22-24 HTLV-I, activation of NF-KB, 58:17-18 Ras proteins, 63:144-145 receptor-mediated signal transduction, recognition phase, 63:43-44 signal transduction, 48:251-252 synergy, 41:15-19 T cell antigen receptor-CD3 complex, 48:232-235 two stages of, 51:107 tyrosine kinase ~5 6 \"~ role, 53:78-82 T cell antigen receptor, see T cell receptor T cell-B cell collaboration, antigens and, competitive inhibition, 38:109, 110 cross-reactive lysis, 38:187 cytotoxic T cells 165, 38:170 gene dosage, 38:81 gene function, 38:92 germline repertoire, 38:116-118 GM-CSF preferential synthesis, 48:91 immunizing, 38:3 immunodominance, 38:184, 185 lines, 43:196 lyrnphokine mHNA expression, 4887-88 macrophages, 38: 11 1-1 14 reactivity, HLA-Dwl4, 48:129 suppression, 38:134, 143, 152 T cell selection, 38:131, 134 T cell-T cell interactions, 38:160 tolerance, 38:119-121, 124, 126, 129 T cell cytokines. see T helper cells, cytoldnes T cell development, 44:207, 255; 58:90-101; CD4 vs CD8 down-regulation. positive selection vs two kinds of death, positive vs negative selection, signaling pathways that control positive 51:185-186 thymocyte suhpopulation. 44:225-245 in thymus, 51:112 autoimmune diseases and, 66238-91 circumsporozoite protein-derived, computational identification, 66:77-84 nonmalarial protein-derived, 60:110-112 T cell growth factor, 46:112, 114; 61:147 T cell hybridomas, Ir genes and, 38:40 T cell epitopes, 43:4, 60, 73, 78 60:108-120 antigen binding, 3839. 107 antigen processing, 38:95 competitive inhibition, 38:109, 110 germline repertoire, 38:116 suppression, 38:151 T cell-T cell interactions, 38:156, 157, specific B cells and, 39:56-57 anti-Id antibody therapy. 39:288 development, 50:141-142 mature, receptor gene rearrangements in, 43:115; 59:100-105 antigen receptor dimer, 43:116-117 CD3 complex, 43:135 chain alignment, 43:221 compared to T cell receptor Ad, 43:175 developmental control, 58:157 expression, 43:146-147, 165 genes, 43:136 heterodimers, 43:221, 266 induction of CD8+ T cell apoptosis, 58:223 loci, 43:140 lymphocytes, ontogeny, 43:169 mo~ecules, 43:134 mRNA, 43:146-147 protein complex, 43:134-135 role i n signal transduction, 58:125-127 specificity, 58:124-125, 174 transcripts, 43:168 variable region sequences, 43:221 complexes, 58: 113-128 diversified a@ and y8 in human, 58:305-306 in mouse, 58:304-305 c.P lineage, 51:118-124 adoptive T cell therapy of tumors and, allelic exclusion, 38:17, 18 alloreactivity, 45:148-157 amino acid conservation, 43:221-222 amphipathicity, 43:204 antigen, 38:2",
            "latex": null,
            "type": "table"
        },
        "TABREF120": {
            "text": "antigen binding, 38:98, 99, 104-107 antigen processing class I1 molecules, 45:117, 118 class I molecules, 45:118, 119 exceptions, 45:119, 120 factors, 45: 122-124 molecular mechanisms, 45:127, 128 pathways, 45:124-127 peptides, 45:120, 121 recycling, 45:121, 122 antigen-specific, 38:115-117 autoimmune demyelinating disease and, myelin basic protein, 49:358-360 usage restriction, 49:363-366 autoimmunethyroiditis and, 46:2f3, 318,",
            "latex": null,
            "type": "table"
        },
        "TABREF121": {
            "text": "CTL and. 41:136, 137, 139, 152, 167, 168,   cytotoxic, 38:17O, 173  cytotoxicity and, 41:271, 272, 274  defined, 64:1  encoding, 45:131, 132,   expression, peripheral T cells, expression at different anatomical sites, gene defects, in hereditary primary peripheral T cells. 38:13-15 putative transcription signals, 43:267 during T cell ontogeny, 43:266-267 tissue specific, 43:235 trans-acting negative regilation, 43:267 transcriptional regulatory elements, 43:267-269 gene organization, 40:259-262 gene rearrangements, 58:31, 36-41, 63, 68-69 applications to clinical medcine, definition of clonality based on, developmentally programmed, and expression, thymus, 38:lO-13 d e h c exclusion, 38:17-18 a enhancer, 43:268 Ig fold, 43:221 Ig heay-chain variable region genes and, IL-2 and, 42:173-174 immediate responses, mediators for, interaction with antigen bound to MHC, intracellular selection, 58:120-121 J gene segment, 43:115 ligands indncing deletion of thymocytes, mAb,SFI, 43:161 male-specific, CD4-8 thymocytes maps of Ig-like loci and, 46:1, 5, 34-45 antigen presentation, 45:115-117 class I1 molecules, 45:112-115 HLA-A2, 45:111 models, 45:111, 112 cell receptor V gene, 48:166 mediators, 51:140-146 thymus, 38:lO-13 tolerance, 38:127 transgenes, 59:107-108, 113-116, 124-127 transgenic, 58:154-156, 159, 166-167 triggered CTL-mediated killing, 60291 molecular basis of' action, 50:16-22 non-MIS, in niurine genome. 5O:ll-14 general nomenclature. 50: 13-14 not stimii1;cting primary T cell multiple sclerosis and, 49:372-375 V and C domains. 43:115 V(D)J joining of antigeu receptor genes expressions of Mtv in B cells with Vbse expression, 5039 mice transgenic for given Mtv, 50:40 mouse niaminary tumor virus. 50:39 mouse retention of Vbse sequences, Mtv transcripts expressed in activated other retroviruses, 50:40-41 retroviral sequences bearing no homology to bacterial toxic mitogen, 50:41 role of MHC molecules, 5O:l'i-22 I-A molecules, 50:20-21 I-E molecules, 50:18-19 T cell receptor, 50:23-24 V p region of TCR, 5024-25 T cell development and function, T cell development and function in 50:25-27 50:32-37. 35-37 periphery, 50:35-37 clonal inactivation, 50:35-36 enhancement of responses to antigen, suppression induced in oitro, working model, evidence, 50:28-29 VB-specific antibodies. 58:275 V-V interface edge strands, 43:115-116 V-V pnirings, 43:116 what it sees, 52:lO-11 cell receptor I, 43:169 T cell replacement Factors, huinoral immune T cell-replacing factor, interfering and, 40:38 T cells, 43:134; 48:70, 71 response and, 4565, 66, 68 cup CD4-8-, expression of Vp8 TCR chains, CD4+8-, heterogeneity, function, and CD4-8+, heterogeneity, function, and extrathymically derived, 58:lll-112 negative and positive selection, 58:311 reactivities, 58:318-319 differences, 58:300 lineage divergence, 58:141 extrathyrnically derived, 58:110-111 function, 58:104-105 heterogeneity, 58:102-103 niurine, properties of classes of, 51:128 reactivities, 583319-324 self-tolerance, 58:313 specificity, 58:103-104 differentiation and, 39~26-31 IL-3-i induced 2, 39:5, 18-19, 23-24 in Thy-l+, 39:21-22, 24, 26-29 58:109-110 specificity, 58:105-108 specificity, 58:108-109 (YP and y6 endothelium and tissue-specific homing of lymphocytes, 50:284-285 extravasation of T cells, 50:285-287 migration of memory T cells to inflaininatory sites, 50:278-284 endothelid leukocyte adhesion expression of endothelial leukocyte molecules, 50:279-281 adhesion molecules in uiuo, 50:283-284 role of endothrlial leukocyte adhesion molecules in lymphocyte binding in uitro, 50:281-283 migration of naive T celIs to lymph migration of pre-T cells to thymus, autoimmunity, theories, 56:453 autoreactive, see Autoreactive T cells BALU, 59:386 B cell activation, 40:2-4, 12-13; 63:43, 46 B cell differentiation and, 4 0 3 -3 5 B cell",
            "latex": null,
            "type": "table"
        },
        "TABREF122": {
            "text": ", genetically determined defects, 41:226. Ig genes, 41:204 soluble mediators, 41233-235 -B cell interactions antigen bridging, 3951 antigen presentation by B cells, see B cells and B cells, interphase death and bone marrow, characterization, 53:171-173cachectin and, 42:220, 222  CD1 proteins, CD3, T cellreceptor and, 45:109, 110   CD4+, 198; 114, lymphokine production patterns, malignancies, 47: 123-125 marker for activation, 47:125-128 ontogeny, 47:121, 122 physiology 53:17-19 48:85-86 autoantibody production, 47:130-136 helper B cells, 47:137-141 monocytoid features, 47:141-143 primordial immune network, 47:159-161 role in Vp selective element action, sporozoite malariavaccine and, 45:303,   surface antigen, 47:143-147  T cell receptor and, 45:109, 110, 127  T helper, 48:163    virus-induced immunosuppression and,CD4 and CD8 molecules and,   role  in Vp selective element action, sporozoite malaria vaccine and, 45:319 CS-specific T cells, 45:312 interferon-y, 45:303-306 T cell receptor and, 45:109, 110 TH responses, 61:358-360 virus-induced immunosuppression and HIV, 45:352,353,356-358, 366 measles, 45:339 what it recognizes, 52:6-11 CD23 antigen and, 49149, 151-153, 176 see T cell clones colony-stimulating factor monoclonal antibody studies, 66:6-12 CTL and, 41:16,5 cytotoxic, sev Cytotoxic T cells cytotoxicity, islet beta cell, 48:142 cytotoxicity and, 41:271-273, 277, 297 dependent autoimmunity. 51:294-296 dependent l3 cell responses, 62:131-157, B7-UB7-2 ligand family, 62:135-138, 140-142 CD28-B7 costimiilation. 62:142-144. 148-1.57 CD28/CTLA-4 receptor Family, 62:132-135, 138-140 costimulation. 62:138-144, 148-154 hvo-signal model, 62: 131-132 dependent isotype switching, role of IL-4, depleted haploidentical bone marrow, depletion. immune reconstitution and, derived colony-stimulating factor. 48:69-98 derived lyniphokine. in vivo studies, development, see T cell development rliffrrentiation. CD4 and CD8 roles, in negative selection, 53:101-103 in positive selection. 53:97-100 epitopes, ,we T cell epitopes experimental autoiinmuiie uveitis, 48:216 expressing Epo receptor, 60:14 facilitation of hematopoietic engraftrnent factors. Ig-secreting cell differentiation and, development role. 57:137 expression in cpotoxic T cells, 57:138 fate deterinination, 58:lX-139 Fce receptors, 43:301, 303 Fc receptors on, 40:67-68 forhiddrn, in peripheral immune system, fusion, 38:283, 286 genetically engineered antibody molecules and, 44:86 C : protein, 48267-269 i n graft-versus-host diseases, rat, itliotypie network and, 39:281 and growth requirements, 53:167 helper. see T helper cells hcterogeneity, 48:8:3-92 higli-affinity self-reactive, deletion, 43:219 HI\\'-l disease, 63:87-89, 90 isotype response and, 40:212-216 53: 164-166 39:280-281 SC1D-hu thy/liv xenograft model, interactions with rabbit anti-Id antibodies human binding to, 39:265-267 suppression by, 39:267-269 met-enkephalin receptors, 39:312 SP receptors, 39:313 T8', Id determinants. 39:266-267 IELs as, 58:298-300 IFN-y production, 6263-66, 105 IgE-binding factors, 43:301-303 IgE biosynthesis and, 47:1, 28-30, 32-39 antibody response, 47:4-12 binding factors, 47:12. 13, 15-24, 26-28 IGF-I, 63:406 IGF-I-R, 63:402 receptors, 44:9-12, 14, 16, 17, 20-24 Ig heavy-chain variable region genes and, IL-1 and, 44:154, 156, 164, 190 44:179, 181-183 TNF, 44:185, I86 IL-2 receptor and, 42:165-166, 177, see IL-6 effects, 54:21-22 IL-10 biological effects, 56:8-10 immune, transfer of idiotypic-suppression immunosenescence and, 46:221 also Interleukin-2 receptor by, 40139 lymphocyte activation, 46:221, 222, lymphocyte subsets, 46:236-239 regulatory changes, 46:250-252 stem cells, 46240, 243-247 224-232, 234, 236 intermitotic life span of, 53:237-241 intestinal intraepithelial lymphocytes, intrathymic development, 58:139-174 53:163-167 control of apoptosis during, 58:168-174 pre-T cell receptor control, 58:142-151 role of Vp selective elements in, 50:33 negative selection, 50:34-35 positive selection, 50:34 and selection, 58:139-174 cup TCR control, 58:151-165 intrathymic transitions, 51:117-139 ontogeny of major thymic lineages, 51:133-138 ontogeny of minor thymic lineages, 51:138-139 summary, 51:139 TCRaP lineage, 51:118-124 TCRy8 lineage, 51:124-133 female reproductive tract), 53:167-169 invariant intraepithelial y/S T cells (skin, ion channel, 48:285-288 conihinatorial regulation of, 51:105 IL-2 gene regulation. C' BSC study, T cell subset characteristics, 51:lOO T cell subsets, 51:98-103 signaling via TCWCD3 and coreceptors, 51: 103-105 51:92-98 cell-mediated mediated suppression. see Suppression, T memory. .YPF Memory T cells MG and, 42:241-245, 273 MIIC class I-deficient mouse CD4+, 55:393-394 TCRaP' CD4-CD8-T cells. TCRaP' CD8+ CD4-T cells, MHC class I-restricted, antigen processing and presentation to, SPY Antigen processing and presentation MHC class I[-restricted, 60:305-306 MHC recognition, 43:224: 55:364 M HC-restricted recognition I 59: 100 migration to periphery, avian, 50536-I01 homing preferences, 50:96-97 interstitial T cell surface glycoprotein, 50:97-101 migration of TCR1. TCR2 and TCR3 sub-populations, 50:96 inurine. 54:88-93 deletion and anergy in adult animals injected with superantigens, 54:125-127 inurine lupus models and, 4664, 66, 67, adhesion molecules affecting migration, enclothelium and migration of to lymph fimctional differences with memory and effector cells, 53:227-228 adhesion molecules and, 53:248basic pattern, 53:242-244 tissue tcipic sirhsets, 53:244-247 migration pattern, 53:242-244 TCR and signal transduction. negative selection, 58:166-168 networks in secretory immune system, N K cells and, 47:188, 190. 197, 294 manipulation, 50:102-105 T cells (continued) embryonic treatment with anti-TCRI, -TCR2. -TCH3 antibodies, 50: 103-105 thymectomy, 50:102 T cell migration to periphery, 50:96-101 cell tumors, 5O:lOS-108 tumors, 50:10,5-107 tumors, 50:107-108 capnbili ties, 50: 10 1-102 conserved structural features, genoinic organization, 50: 108-109 TCRP diversity, 50:109-111 thymic attraction and origin, 50:89-90 thymus, diversification in, 50:SO-96 embryonic waves of thymocyte development, 50:95-96 intrathymic clonal selection, 50:94 ontogeny of TCHI, TCR2, and TCR3, ontogeny, T cell receptor gene expression, potential effecter mechanisms, 47:465-469 precursors, migration to thymus, 58:347, pre-T cells, endothelium and migration of IL-2, 39:1, 3, 10-15 GM-CSF, 39:2, 3, 10-15 IL-3 2-3, 39:lO-15 programmed cell death, 50:66-69 CTL targets, death, 5069 deprived of growth factors, 50:68-69 hybridomas, activation-induced death, Ras proteins, 63:144-145 receptor-like genes and, 38:10 recognition, antigen processing for, 58:420 recognition and finiction, overview, 52:l-4 regulation, 48:285, 286 regulation of IgA response and, TII-1-TH-2 concept, 61:346-347 germline limitations, 38: 115-1 18 positive T cell selection. 38:130-134 suppression, 38:134-152 tolerance, 38:119-130 repertoire, and RA susceptibility exogenous events. 56:452-455 formation, 56:450-452 cytottrxic T cells arid, 65:279-280 to M M T V stein cell engraftment, 49:388-391 tolerance, 49:398-399 transplantation. 49:393-396 SCID-hu thy/liv xenograft model, 63:82-83 secondar). B cell lineage and, 42:73 selection, 43:217; 51: 164-189 negative selection, 51:165-175 intrathytnic cloiial deletion, positive selection. 51:175-189 51: 165-173 functional divergence, 51:186-189 ligends and receptors in positive selection, 51:178-180 vs two kinds of death, 51:175-177 CD4 vs CD8 dowi-regulation, developmental choice, 51: 180-186 positive selection, fou r-way 51:185-186 positive vs negative selection, signaling pathways controling, 51 : 180-183 51:183-185 selective defect, 59:247 self-MHC class I recognition by cytotoxic T cell effector cells, 57314-315 self-vs nonself-discriininIltinn, 43:223 signaling response to superantigens and site-dependent tolerance, 53:201-203 soluble factors, B cell responses and, specific antigen presentation by vascular alloantigen presentation, 50:266-267 protein antigen presentation, 50:265-266 regulation of MIIC molecule expression, 40:13-14, 1.5, 26-29 EC, 50:261-267 50:262-265 specific for foreign antigens, 43:219-220 specificity for peptide antigens, 43:197-206 approidies, 43: 197-198 cytochrome c, 43:198-200 hen egg lyswzytne, 43:201 liner sequences, naturally occurring proteins, 43:198-201 minitnum fragment size, 43:197 specific tyrosine protein kinase, CD4. 48:243-244 splenic, 53:161-163 spontaneous autoimmune thyroiditis and. altered thyroid function, 47:461, 462 cellular immune reactions, 47:449-452, tlisturbed iininunoregulation. genetics, 47:488-490 histopathology, 47:442, 444 Iiumoral immune reactions, 47:445, potential effecter mechanisms. \u20ac3 cells, 39:83-85 \u20ac3 cell tinnors, 39:84 T cells (continued) macrophages, 39:84 n-specific B cells, 39:57-58 subsets, 41:44; 5198-103 characteristics defined by cloned lines, 'triggering of activated T cells and hybridomas, 4152-59 triggering of unprirned and resting T cells, 41:62-75 substrates, 482281-283 supernatants, 54:247 suppressor, see Suppressor T cells surface activation molecule, 48:228-253 surface antigens of humanleukocytes and,  49:86, 98, 112, 114, 116-117, 125    surface molecules, in communication with APCs, 58:112-139 target, specific binding and, 38:20 target interaction, 3821-23 as target molecules in trimolecular complex anti-CD3 antibody, 56:220-223 anti-CD4 antibody, 56:223-228 anti-culp T cell receptor antibody, anti-T cell receptor VP antibody, cell tumors, avian, 50:105-108 Mareks disease (MDV) virus-induced tumors, 50:105-107 reticuloendotheliosis virus-induced tumors, 50: 107-108 TCR, see T cell receptor T-dependent and T-independent B cells, TdT, see Terminal deoxynucleotidyl-Tec, association with c-kit, 60:5-6 Telencephalin, 64:157 Tel protein, 64:65 Temperature, and apoptosis, 58:237-240 TEMPO-amine spin label, 48:27-28 TEPITOPE (software), T cell epitope prediction, 66:82-84, 86, 90-91 Terminal deoxynucleotidyltransferase, 58:117; T cell-T cell interactions, Zr genes and 4263-65 transferase 62:43, 52; 64:51 in cortical thymocytes, 39:23, 25 Ig heavy-chain variable region genes and, V-D-J recombination, 61:296-298 as V(D)J recombination product as carrier for (NANP)3 vaccine, 60:112-113 derived epitopes, 60:121-122 donor lymphocytes and, 38:283-285 heterohybridoma antibodies, 38:288,human-human hybridomas, 38:293, 294, humoral immune response and, 45:13 sporozoite malaria vaccine and Tetrahydrobiopterin, IFN-y, 62:72 Tetrahyma, maternally transmitted antigen TFIIIA, concentration, 43:266 TGF, see Transforming growth factor TH cell receptor Tethering and, 38:315 experimental autoimmune encephalomyelitis, 48:166 T cell receptor V gene, 48:166 TH domain, Btk, 59:183, 187, 190 Theiler's murine encephalomyelitis virus, 4 8 : l S Theiler's virus, responses in MHC class I-deficient mouse, 55:409 T helper cell responses, 61:374-375 B cell antigen receptor-activated, CD23 antigen and, 49:159 clones, 54:89 CTL and, 41:136, 137 cytokines, 46:111 55:269-273 cross-regulation of differentiation, 46:130-133 differential induction, 46:127-130 functions, 46:114-117 DTH, 46:117 helper, 46:117-120 human clones, 46:121, 122 isotype regulation, 46:120, 121 macrophage activation, 46:122 human subsets, 46:138, 139 immune responses, 46:133-138 precursors of differentiation states antigen expression, 46:123-125 bulk cultures, 46:122, 123 clones, 46:123 heterogeneity, 46:125, 126 phenotypes, 46:126, 127 secretion patterns, 46:lll-114 cytolysis and, 41:276 cytotoxicity and, 41:274, 297 function, Crohn's disease and, 42:300, 301 in P-galactosidase-induced antibody Id recognizing, 39:257-262 IL-2-dependent, o-abl effect, 39:41 Zr genes and, 38:188 response, 39:88-90 B cells and, 39259-260 antigen binding, 38:105-107 cross-reactive Iysis, 38:187 cytotoxic T cells, 38:165, 170-172 expression, 38:58-60 germline repertoire, 38:118 H-Y antigen, 38:175-179 immunodominance, 38:183 macrophage factors, 38:111 T helper cells (continued) suppression, 38137-139, 141-144 T cell-T cell interactions, 38:154, 157-160 tolerance, 38:124 leukocyte integrins and, 46:163 surface antigens of human leukocytes and, T cell subsets and, 41:40 49:77 H-2 molecules in thymus, 41:lOl-103, ti-&-restricted antigen recognition. THO, TH1, and TII2, characterization, THI, 48:86-89 and IL-10 discovery, 56:l-2 CD4+, 52:175-177 function roles and cross-regulation. in oitro stimulations of primed cells, 56:13-14 in d u o expression correlated to TH2 responses, 56:14-15 PCD induction, inhibition, T helper epitopes, pathogen-derived, Theophylline, IL-l and, 44:160 Tliiol-activated Iysins, 41:317, 318 Thoracic duct lymphocytes, hybrid resistance Threonine and, 41:356-358 antinuclear antibodies and, 44:115 genetically engineered antibody molecnles phosphorylation. 48:270-277 and, 44:84 Threonine phosphatases, as ~5 6 \" ' targets in T Threonine protease, proteasome, 64: 18-19 Threonine/tyrosine phosphatase, PAC-1,",
            "latex": null,
            "type": "table"
        },
        "TABREF123": {
            "text": "hinnord irnmune response and, 4546. 71 independent signal-transclucing ~nolecule, 48239 isolation. 48:23X surface antigens of hiinian leukocytes and, 49:117 Thyinectomy adoptive T cell therapy of tumors ;md, a\\ian, 50:102 helper T cell cytokines and, 46:125 MC: and, 42253. 259-260, 270-272 neonatal, autoimmune thyroiditis and. pituitary secretion induction, 39:314-3 15 similarity to neuropeptides. 39314 Thyinic fragments, hunian postnatal. and Thymic hormones, SCID and. 49:384, 391 Thyinic hyperplasia, MC: and, 42235, Thymic lineages SCID mice, 50309 2.59-260, 270 major, ontogeny of. 51:13:3-1:38 minor, 51:138-139 Thyniic lytnphomas. 54:92 Thymic nurse cells, spontaneous autoinimune. thyroiditis and, 473455, 4.56, 475, 491 Thymic stroma, SCID and. 49:384, 392-393 Thymic stroinal cells, autoreactive T cells Thymidine, 38380 and, 45:421-425 ii~iiiiunosenescence and, 46231 -234. 243 T cell devel~piiient and, 44:236 Thymidine kinase, expressing cells, killing, 58:434 Tliyirioc.~e-activating rnolecule, 48:250 Tliyinocytes accinnnlation of TCHG rearrangeinents, dt,letion, blockade by cyclosporin A, dcpletion by testosterone m d estradiol, grneration und turnover, 58:151-153 reduction in [-deficient mouse, '. mature. expressing male-specific TCH, 58:26l CD4'8-tind CD4. X', generation from CD4'8' precursors, 58:15:3-16.5 C1)4 and CDX molecules and, 4 differentiation, and IL-2, 50:158-160 functional maturation, 51: 139-164 auxiliary signaling receptors. 51:157-160 CD2, 51:157-159 (:1>2S, 51:1.59-160 vs cornmitin~iit to T cell lineage, mature vs immature characteristics, 51:162-164 history, 51:139-140 Thymocytes (continued ) postthymic maturation, 51:160-162 response gene inducibility, 51:151-157 cortical cells, loss of responsiveness in, early, in immature thymocytes, TCWCD3 complex, 51:140-143 helper T cell cytokines and, 46:116 hybrid resistance and, 41:337, 376, 409 Ig gene superfamily and, 44:22, 30, 31, 35, IL-1 and, 44:173, 174, 189, 190 immature, early inducibility of responsive genes in, 51:151-153 Zr genes and 36,41 expression, 38:54 T cell suppression, 38:135 T cell-T cell interactions, 38:154, 155, 158 irradiated, biochemical events in, 50:70 lymphocyte homing and, 44:345, 351, maturation, 59:lOl-105, 108-109 mature vs immature characteristics, history, mechanism of selection by CD4 and CD8, medullaly, 39:20erSDH expression, 23 murine lupus models and, 46:82, 94-100 negative selection, 58:165-174 non-selected, death, 50:67-68 progenitors, inhibition of migration, 54:299 rodent, and DNA damage, 50:58-59 scid with broken DNA coding ends, T cell receptor and T cell subsets and, 41:96-98, 105-108, 112 VP8+, SEB-induced depletion, 58:259-260 Thymoma,",
            "latex": null,
            "type": "table"
        },
        "TABREF124": {
            "text": "CD4 molecular biology,44:288  CD8 molecular biology, 44:272, 278, 279  CD5 B cell and, 47:120, 121, 129  CD23 antigen and, and TCRP  cells, cortex, related cells, and rescue, MC: and, 42:265 potential effector mechanisms, 47:466, 469 prevention, 46:308, 310-312, 314, 315 antigen-presenting cells and, 47:76 IFN-y effect on, 62:93 spontaneous autoimmune thyroiditis and, Thyroid disease, antibodies to self-antigens froin human donors, 57:242-244 Thyroid epithelial cells, spontaneous autoimmune thyroiditis and, 47:493 altered thyroid function, 47:458, 459, clinical symptoms, 47:440 disturbed immunoregulation, 47:472 effector mechanisms, 47:469 genetics, 47:497 histopathology, 47:442 effector mechanisms, 47:466, 467, 469 immunoregulation, 47:473, 475 Thyroiditis, see also Autoimmune thyroiditis; Thyroid-infiltrating lymphocytes, 47:492 Experimental autoimmune thyroiditis; Spontaneous autoimmune thyroiditis allergic, rnurine lupus models and, 46:79 Thyroid peroxidase, 46:272, 273, 298, 317",
            "latex": null,
            "type": "table"
        },
        "TABREF125": {
            "text": ", 470 TIA-1 granule proteins, polyadenylate binding Tissue edema, in IBD, 42:310 Tissue factor pathway inhibitor, 66:132 Tissue inhibitor of metalloproteinase-1, Tissue inhibitor of metalloproteinase-2, Tissue plasminogen activator, 46:166 Tissues, stem cell factor and SCF receptor Tissue-specific activator protein, B cell distribution, 55:lS-17 genesis, 63:228 Ig heavy-chain variable region genes and, regulators of complement activation and, TL region, gene products, 52:98-101 T lymphoblasts antigen-presenting cells and, 47:76, 84, 102 spontaneous autoimmune thyroimtis and, 47:467, 473 TMV coat protein, 43:54, 76 TNF, see Tumor necrosis factor TNF-a, see Cachectin: Tumor necrosis Tobacco mosaic virus protein factor a secondary B cell lineage and, 42:68-69 synthetic T and B cell sites and, 45:227, T cell receptor and, 45:132 Tocopherol, action of, 65:122 Tolerance, 59:279-281, 342-344 B cell, see B cell tolerance 244 early stiidies affecting antibody formation, 52:284-287 dissection of T cell vs B cell tolerance, cell repertoire, 38:132, 133 monoclonal repertoires, 59:310-:311 perspectives including antigen presentation by B cells. 52:321-322 SCID and, 49:398-399 self-tolerance checkpoints, 593281 -342 site-specific, peripheral lyinphocytes, 53:201-203 Tolerance indiictir)n, 42:48 B cell rrpertoire expression and, 42:35, 82 B cell subpopulations and, 42:77-78 IijLrid resistance and, 41:356, 361, 409 Mtv superantigens in. 65:203-208 niurine lupus models and, 46:65 T cell subsets and, 41:107-110 TOMS-1, 59:65 Tongue, invariant yS T cell receptors of Tonsils, hilman. isolation of highly purified TOR1, 61:187 TOR2. 61:187 Tore. 63:I.54 Torprlo, 42:249, 252. 257, 259, 260 Total body irradiation, SCID and, 49:397 Total lymphoid irradiation, hybrid resistance Toxic oil syndrome, with endothelial cell Toxic shock syndrome, 54:128-133 murine IEL, 58:303 F I X from, 51:245, 246 and. 41386, 387 proliferation. 60:225 clinical criteria used in classification, fatal, 54:132-133 54:128, 129 IFN-y and. 62:103 S t~~l i ! i l~~[ ) c #~s awem toxins, 54: 129 TSST-1. 54:129, 131 Toxoplasmosis, P30-induced IgC antibody, Trans-coin~~lemeii~ation. HLA-DQ hybrid niolecule. 48:119-120 Transcription, 42:176 activation, Ig enhancers, 43:241-242 antiniicle;ir antibodies and, 4494",
            "latex": null,
            "type": "table"
        },
        "TABREF126": {
            "text": ", 297 endogenous substrate activation in V(D)J joining of antigen receptor genes, 56:41-43 genetically engineered Ab molecules and, 4489 cloning, 44:73-75 expression, 44:77 lymphoid mammalian cells. 44:70 production, 44:66 gennline, see Germline, C,, transcription; Germline transcripts Transduction, in programmed cell death, CD23 antigen and, 49:161, 169 cell lines, positive and negative regulation CTL and, 41:138, 139, 144, 149-1.52, 163 cytotoxicity and, 41:272 and expression of CD44 cDNA constructs, genetically engineered Ab molecules and, of hyaluranon bindmg, 54:306, 307 54286-287 44:89 antigen-combining sites, 44:84 chimeric antibodies, 44:81, 82 expression, 44:70, 71, 75-77, 79 fusion proteins, 44:85, 86 lymphoid mammalian cells, 44:69, 70 Ig heaq-chain variable region genes and, IL-1 and, 44:165 Ir genes and, 38:91, 169 K V gene promoter, 43:258 T cell",
            "latex": null,
            "type": "table"
        },
        "TABREF127": {
            "text": "386 surface antigens of human leukocytes and, T cell receptor and, 45:124 virus-induced immunosuppression and, Transfer RNA, antinuclear antibodies and, Transformation, malignant, p53, 62226-227 Transformed producer cell line, 48:69 Transforming growth factor, IL-1 and, 44:153 biological effects, 44:164, 168, 169 Transforming growth factor a, mHNA, expression by eosinophils, 60:195",
            "latex": null,
            "type": "table"
        },
        "TABREF128": {
            "text": "CD23 antigen and, 49:160-161 and IgA expression, 54:259, 262 IgA synthesis, 63:54 induced eosinophil apoptosis, 60:184 inhibition of iNOS, 60:338 and its receptor, sources and structure of, production by endothelid cells, 58:358 Transforming growth factor p l , 61:86, 88-90, Transforming growth factor p receptor, complex formation for intracellular endoglin, 55:198 serinekhreonine kinase type,",
            "latex": null,
            "type": "table"
        },
        "TABREF129": {
            "text": "function, 55:203-204 Transforming retroviral protein, 48:253 Transfusion effects, bematopoietic engraftment and, 40:386 Transgene and mutations, effect on T cell development, 58:147-149 T cell receptors, 59:107-108, 113-116, 124-127 Transgenic approaches, to B cell tolerance, 52:303-317 advantages and disadvantages, 52:303-305 anti-DNA transgenic model, 52:314-315 anti-H-2Kk transgenic model, 52:311-313 anti-transgenic models in which B cell tolerance is absent or only partial, 52:315-317 vindicated, 52:305-311 hen egg Iysozyrne model, clonal anergy Transgenic MHC, transcriptional factor,",
            "latex": null,
            "type": "table"
        },
        "TABREF130": {
            "text": "Translocation, 52:35-42 49:283, 320, 323 antinuclearantibodies and, 44:120, 128   chromosomal, see Chromosomal c-myc gene, 64:227-229 Ig heavy-chain variable regiongenes and,   immunosenescence and, 46:224, 225, 235  leukocyte iritegrins and, 46:160 maps of 46:3, 26, 32, 45  MHC ABC protein function, surface antigens of humanleukocytes and,   T cell activation and, 41:17-19, 22, 23  V,,  arid Dn segments, 62:11, 19 Transmembrane channel, cell-mediated Transmembrane domain, 65:56 CTL and, 41:135, 146-148 Transmembrane signaling, 48:227 Transmembrane spanning segments, TAP Transmigration, leukocyte-endothelial, Transplantation, see also specijc type killing and, 41:298 protein, 65:66-67 58:388-389 antigen-presenting cells and, 47:75, 76, 80 bone marrow, for SCID, See Severe CD5 B cell and, 47:128-130 graft-versus-host disease, 61:47 haploidentical. SCID and, 40:393-397, histocompatible bone marrow, 49:392 lung, graft-versus-host disease, 59:420-426 membrane cofactor protein, 61:220 in MHC class I-deficient mouse, Transporters. 65:47-56 processing. see TAP ABC transporters, 65:55, 56-57, 59 antigen processing, see TAP need for, 65:47-49 Trailsport proteins, surface antigens of hiiin:in Transposase. V(D)J recombination. 64:57 Tfimsverse myelitis, ilpL uitilwdies and, 49:209 Transversions. Ars A response and, 42:125, Trenimon, in cancer treatment, 56329. Tricllriris m t r r i s , 54:94 Triggering, leiikocytes. 58:383 Triglycerides, cachectin and, 42:214-215 Trinitrophenyl-derived T cell, 48912 Trinitrophenyl-keyhole limpet hetnocyanin, Trinitrophenyl-memory-antigen-binding cells trk receptors, 61:s tKNA. antiidear antibodies and, 44: 119, 52:199 sensitized B cells, 60:305-308 (TNP-MABCS), 4550, 51 127, 131, 134-138 infection, responses in MHC class killing by major basic protein, I-deficient mouse, 55:413-414 39:190 Tnpmcisotnn rhfensiense, inouse infection anti-Id antibodies as vaccines against, 39:284 Tqpnosomiasis, cachectin and, 42214 Trypsin, 41:210. 227, 297. 298 adoptive T cell therapy of tumors and, directed rnutants, 43:23 Trypsin cleavage sites, PGHS-2, 62:174 Tryptophan Ig gene siiperfarnily and, 44:34, 35. 41 metabolism, IFN-y, 62:71-72 L-Tryptophan, ingestion-induced eosinophilia rnyalgia syndrome, 60:224-225 TS1,63:174-176 TSG-6, 65:18; 66~111-112 TSH, see Thyrotropin TSICSLYQLE (peptide), 66:88 T suppressor cells, see Suppressor T cells IT, see Tetanus toxoid Tuftsin, biological activities of, 40: 11 1-112, Tumor allografts NK cells and, 47:302 115 anterior chamber, 48:204 anterior chamber-associated immune delayed-type hypersensitivity, 48208, 209 deviation, intraocular, 48:207-208 Tumor antigens, 58:418-422; 62217-228, 240-245 B7. see B7 BAGE, 62229, 233 blood group antigens, 62:220-221 carbohydrate antigens, 62:219-221 carcinoembryonic antigen, 62221-222 monoclonal antibody recognition, 56:305 CD28, see CD28 c-myb, 62:227 c-niyc, see c-myc costimulatory pathway, 57:305-307 CTLA-4, see CTLA-4 defined hy antibodies, 62218-229 defined by T cells, 62:227-231 Tumor growth, NK cells and, 42:182, Tumor immunology, 52:104-106 Tumor immunotherapy, preclinical model in uitm studies, 40341-345 in uiuo reactions in animal model systems, Tumor necrosis factor a receptor, see Intraocular tumor rejection adoptive T cell therapy, 49:281-286, antigen recognition, 49:3 18-324 expression of antitumor responses, Tumors. see also Cancer B cells, 49312-31.5 macrophages, 49:306-312 NK cells, 49:315-315 T cell subsets, 49:299-306 requirement, 493294-298 tumor burden, 49:286-294 antigen-presenting cells and, 47:66, 67, 100 autoreactive T cells and. 45:428-430 mechanisms of tumor rejection, 49:299 principles, 49:286 tumor antigen-heterogeneity,",
            "latex": null,
            "type": "table"
        },
        "TABREF131": {
            "text": "Ig gene expression, 47:150, 151, 156 marker for activation, 47:126 CD8 molecules and, 44:271, 273, 276 CD44 expression and metastasis, cell migration, role of CD44 in metastasis, chimeric, and IL-6, 54:51",
            "latex": null,
            "type": "table"
        },
        "TABREF132": {
            "text": ", 313 defined by antibodies, 62:218-227 defined by T cells, 62:227-240 etiology, stein cell factor role CD5 B cell and, 47:118, 125 properties of cell-associated gangliosides, properties of ganglioside antigens gangliosidr antigens and, 40:351-352 Ig heacy-chain variable region genes and, MIIC expression increased by transfection allo-MHC. 57:312-313 self-MHC class I, 57~314-320 self-MHC class 11, 57:313 tumor antigens, see Tumor antigens indnction by MMD', 65:153-156 leukocyte integrins and, 46:150 maps of Ig-like loci and, 46:s metastasis and extracellular matrix, N K cells and, 47:187-189, 295-300 adoptive T cell therapy and, 49:284, 293 anti-Id antibody tlierapy, 39:291-292 spontaneous autoimmune thyroiditis and, studies with B cell lines and, 52:219-220 surface antigens of Iiuman leukocytes and,TAP dysfiinction in, 6594-95 T cell activation and, 4 1 5 T celldevelopment and, 44:209  T cell receptor and, 45:117, 118  T cell subsets and, 41:74. 91 UV-induced, adoptive T cell therapy of CD23 antigen and, 49:158, 162 complement receptor 1 and, 46:187 coniplement receptor 2 antl, 46:201 IgE biosyitliesis and, 47:18, 19 Tnrner's s)ndroine, 63:409 1W23 Rnle, \\'(D)J recombination, 64:45, Twins studies, KA susceptibility 53, 59 discordance i n identical twins. 56: fornial genetics, 56:433-4.35 somatic nonidentity. 56:446-449 448-449 Two-color cytofluorographic analysis, T cell receptor yS proteins, 43:146-147 Two-color iininunofluorescence analysis, NKHl antigen and, 42:189 Two-signal model, T cell activation, 62: 131 -132 Txk gene, 59:184 Tyk2 Janris kinase, 62:68 Tyr385, 62:175, 178, 180 Tyrosinase, 62:233-234 Tyrosine, 4297 in I F N -d O response, 60:7-9 CTL antl, 41:135, 148, 162 phosphorylation, 48:277-283 siirfke antigens of human leukocytes and, 49:77 Tyrosine-containing sequence motifs, T,yrosine kinase, see Protein-tyrosine kinase 58:127-128, 130 Tyrosine phosphorylation, 48277-283 B cell antigen receptor-induced, targets, U937 cells, PGHS-2 expression regulation, U2666 myeloma B cell, 48:182 Ubiquitin 62:194-195 conjugation, 65:117 lymphocyte homing and, 44:348 Ubiquitination, 64:6, 107 Ubiquitin-proteasome system, 643, 5-8 Ubiquitinylation, 63:396 Ulcerative colitis, see also Inflammatory bowel disease antibody secretions and, 42:304 anti-TNF-n therapy, 64:309-310 IgA levels in, 42298 Ultrastructure, purified tonsillar B cells cultured in CD40 system, 52:210-211 Ultraviolet light, induced tumors, adoptive T cell therapy of tumors and, 49281, Upper respiratory tract, pulmonary immunity regulation and, 59:372-373 Upstream induction sequence, 65:% Urea-denatured OVA, IgE biosynthesis and, IL-Ira production, 54:188 anterior chamber, 48:213-215 delayed-type hypersensitivity, 48214 autoimmune, see also Experimental immune regulation, 48215-216 W5C25 Uveitis autoimmune uveitis pituitary hormones, 63:425 V1-2 segment, 62:18 V1-3 segment, 62:18 V1-8 segment, 62:18 V1-12P pseudogene, 6223 V1-18 segment, 62:24 V1-24P segment, 62:16 V1-45 segment, 62:17 V1-58P segment, 62:16, 17 V1-69 segment, 62:18, 19 V2-5 segment, 62:18 V3-7 segment, 62:18, 19 V3-9 segment, 62:18, 20 V3-11 segment, 62:18 V3-13 segment, 6220 V3-15 segment, 62:18, 19 V3-16P segment, 62:16 V3-20 segment, 62:17, 20 V3-21 segment, 6220 V3-23 segment, 62:19 V3-30 segment, 62:18-19, 20 V3-33 segment, 62:20 V3-35 segment, 62:17 V3-38P segment, 62:16 V3-43 segment, 62:20, 25 V3-47P segment, 62:20 V3-48 segment, 62:19, 20 V3-53 segment, 62:18 V3-54P segment, 62:16 V3-60P segment, 62:25 V3-62P segment. 62:25 V3-64 segment, 62:17 V3-72 segment, 62:17 V3 loop, HIV multiple antigen peptides with, 60A31-134 in octameric multiple antigen peptides, 60:137-138 V3 region, 62:24 Vy4, expressed in lung, 58:304 V4-4 segment, 62:18, 25 V4-28 segment, 62:17, 20, 25 V4-39, 62:18, 19 V4-59, 62:18. 19 V4-61, 62:19 V5-51, 62:19 V6-1 segment, 62:18 V7-81 segment, 62:17 V13C segment, 62:24 V54 segment, 6224 Vaccination V4-31, 62:20 antigen-based strategies, 58:435-437 cancer, strategies, 58:427, 433 efficacy of different clones, 58:430-431 GMSBCG vaccine, 62:220 HIV infection and, 47:408, 411, 413 MMTV infection, 65:190-191 multiple sclerosis and, 49:374-375 pulmonary diseases, 59:409-412 and tumor-specific antigens, 58:418-420 Vaccines, 52:106-107; 65:323 HIV, 65:320-322 immune, autoimmune and (NANP).$-TT, for P. falciparum, and Neisseria strain specificity, 60:134-135 neutralizing multiple Chlamydia serovars, 60:136 pneumococcal, mutation to, 60:277 SIV, 65:321-322 SIV as model for, 52:451, 452 sporozoite malaria, see Sporozoite malaria subunit, for dental caries, 60:135-136 synthetic T and B cell sites and, 45195, immunodeficiency states, 52:106-107 60:112-1 I3 vaccine 197, 260-264 bacterial antigens, 455231, 232 candidate synthetic peptide, 45:252-259 globular protein antigens, 45:213 parasitic antigens, 45:228, 230 peptides, 45:239 prediction, 45:251, 252 viral antigens, 45217-219, 222, 223, Tl-multiple antigen peptides, 60:121-122 virus-induced immunosuppression and, Vaccinia virus, see alsu Interleukin-%vaccinia virus cytotoxic T cells and, 38:162-166, regulators of complement activation and, responses in MHC class I-deficient mouse, 55:407-408 Vaccinia virus complement-control protein, Valency, antigens, 59:302-305, 308 Valerylsalicylate, 62:187 61241 VAP-1, 64:147, 161-162 and L-VAP-2, 58:377-378 lymphocyte-HEV interaction, 65:365 Vap-1, B cell, tyrosine phosphorylation after Variable domain structures, superposition, Variable region, see also Heavy chain variable anti-Ig stimulation. 55:243 43:18-20 region diversity, 42:95-96, .see alsu Arsonate idiotypic system, A/J mouse gene expression, see also B cell repertoire expression evolutionary selection vs random somatic events in, 42:8-9 age factor, 42:30-32 antigen responsive cell populations, clonal expansion, 42:32-34 fetal and neonatal development, junctional diversity, 42:15-18 predominant clonotype expression, segment selection, 42:18-19 somatic mutations, 42:s-15 secondary B cell lineage and, 42:69-71 Variable region (continued) secondaly B cells and, 42:72-73 unresolved issues in, 42:s-8 genes, Ig heavy-chain, see Heavy chain variable region, genes recornbinational mechanisms involved in 17,1 gene and, 42:117, 125-127 Varicella Zoster virus, antibodies from Vascular addressins 377 combinatorial libraries, 57:221-222 lymphocyte-HEV interaction, 65:361-363. lymphocyte homing and, 44:322, 353 mucosal, lymphocyte-HEV interaction, 65:362-363 Vascular adhesion protein-1, see VAP-1 Vascular cell adhesion molecule-1, see VCAM-1 Vascular endothelial cells, specific antigen presentation by, 50:2fil-267 dloantigen presentation. 50:266-267 protein antigen presentation, 50: regulation of MHC inolecule expression, 265-266 50:262-265 Vascular endothelial growth factor. Vascular endothelial injury, TNF as cause, Vascular leak syndromes, NO role, Vasoactive intestinal peptide, 48:170-172; CAMP in lymphocytes and, 39:311 in cerebral artery walls, 39:304 gene, 65:20 Ig production by Peyer's patches and, ligand for a461 integrin, 58:374-375 lymphocyte homing and, 64:158, 188 to mucosa, 64:176-177 mAhs. 60:168-171 pregnancy and, 64:194-195 properties, 64:147 recruitment of leukocytes to inflammation site, 58:395 shedding, 64:171 upregulation, 64:165 12/23 role, 56:32 agents 60:172-173 V(D)J joining, antigen receptor genes biochemically defined, 56:69-73 cutting, 56:71-72 genetically defined, 56:73-79 hairpin-nicking activity, 56:79 joining signals, binding of, 56:69-71 ligation, 56:72-73 molecular genetics, 56:64-69 properties, 56:64 RAG-1, 56:64-67 replication role, 56:80-81 severe combined immunodeficiency, terminal deoxynucleotidyl transferase, truncation factors, 56:79-80 64:39-42 RAG proteins, 64:45-48 relevance of joining activity, 58:45 SCID defect and, 64:49-50 signal joints, 64:40, 41 signal sequence recognition, 64:54-56 stages, 64:40-41 and switch recombination, comparison, 54235-237 and TCR gene expression, 58:116-117 VH pseudogenes, 62:16-17 V, segments, 62:l-2, 7-8, 12-19 uf gene. HIV-1 infectivity, 63:106 Vinca alkaloids, in cancer treatment, mAb germline, 62:l-26 60: 128-134 multiple antigen peptides as iminunogens, Viral genomes, viruses used as animal models Viral infection for AIDS, organization, 52:429 and autoimmune diabetes, 51:308 and bacterial, induction of NF-KB, 58:6 IFN-y and, 62:77, 95 IL-6 and, 54:37 and lymphopenia, 58:233-237 MG and,42:272 NF-IL6 in, 65:9-11 NK cells and, 42:182, 183 plasmacytomagenesis-induced, 64:230-232 pneumonia, 59:406-409 responses in MHC class I-deficient mouse, 55406 influenza virus, 55:406-407 lymphocytic choriomeningitis virus, 55:409-412 Sendai virus, 55:408-409 Theiler's virus, 55:409 vaccinia virus, 55:407-408 switch from latency to productivity, role of X-linked agammaglobulinemia, 59:145, 150 CD8' cells, 66:273-275, 281 NF-KB, 58:16-17 Viral inhibition cell-xnediated effects, 66:286-287 cytolysis, 66:283-286, 287-291 HIV-1-specific lytic activity, 66:275-277, mechanism, 66:280-291 cheinokines and, 66281-282 1L-16, 66:283 Viral replication, HIV, CD8' and, 65:281-282 Viral subterfuges, 52:74-76 Vird vectors, and gene transfer techniques, Virulence factors, 63:308-309 Virus-dependent cellular cytotoxicity, NK Viruses, see also spec$c virusescells and, 47:286    adoptive T cell therapy oftumors and,  49~282-283,323, 334  mechanisms, 49:311,313-314, 318   animal models for AIDS, relationships antibodies, from combinatorial libraries cytomegalovirus, human, 57:220-221",
            "latex": null,
            "type": "table"
        },
        "TABREF133": {
            "text": "in life cycle, 54:107-108 humoral immuneresponse and, 45:24, 78,   hybrid resistance and, 41:375, 378, 390, Ig heavy-chain variable region genes and, exogenous superantigens produced by, production of exogenous superantigens, 54:115-117 54:115-117 maps of Ig-like loci and, 46:l NF-KB, strategies to control, 65:127-128 regulators of complement activation and, superantigens of, 65:208 surface antigeus of human leukocytes and, synthetic T and R cell sites and, 45:195, -V gene, recombination event, 48:56 VL pseudogene 5 , sequence comparison, VL pseudogene 7, sequence comparison, V,,-VII interface, 43:103, 110, 112 V,,-Vl, pairing, 43:112 von Willebrand factor, leukocyte integrins and. 46:158, 159 \"pr, HIV-1 infectivity, 63:86-87 VpWR, 63:7-8, 29 IIIV-1 infectivity, 6387, 106 V region, 62:l V region genes, T cell receptors and, 38:15, 16 V-rel oncogene, 4858 Vp rule, modifications, 54:123-124 superantigens, 54:109 Vp selective elements, see also T cell receptor, Vp selective elements transfer of Vbse among cells, 50:32 general nomenclature, 50: 13-14 in oitro suppression induced by. 50:37 miirine, not stimulating primary T cell null alleles, 5014 role in T cell tlevelopment nnd function, suppression indoced by Vp selective elements in G i f r o , 50:37 Waldenstroin's ~nacroglobulinemi~~.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": " signal transduction, 61:181 RAG, 64:46 RAGI, 64:46, 48 RAG1 B cell development, 63:215 in rabbit B lymphopoiesis, 56:184, 186 as 2 and, 206, 207, 209, 210 RalGDS, 63:144 RAMIG, see Immunoglobulin, rabbit RANTES, 62:285; 64:154 composed of basophil chemotaxins, 60: 177-178 HIV and, 65:282 effect on eosinophil survival,  SCID and, [392] [393] 398, 400, and seeding, 48:169; 52:172-173: 615, 22, 24, 25-26; 62:81, 86, 139; 63:303-304 ",
            "cite_spans": [
                {
                    "start": 1,
                    "end": 21,
                    "text": "signal transduction,",
                    "ref_id": null
                },
                {
                    "start": 22,
                    "end": 33,
                    "text": "61:181 RAG,",
                    "ref_id": null
                },
                {
                    "start": 34,
                    "end": 45,
                    "text": "64:46 RAGI,",
                    "ref_id": null
                },
                {
                    "start": 46,
                    "end": 52,
                    "text": "64:46,",
                    "ref_id": null
                },
                {
                    "start": 53,
                    "end": 80,
                    "text": "48 RAG1 B cell development,",
                    "ref_id": null
                },
                {
                    "start": 81,
                    "end": 114,
                    "text": "63:215 in rabbit B lymphopoiesis,",
                    "ref_id": null
                },
                {
                    "start": 115,
                    "end": 122,
                    "text": "56:184,",
                    "ref_id": null
                },
                {
                    "start": 123,
                    "end": 126,
                    "text": "186",
                    "ref_id": null
                },
                {
                    "start": 130,
                    "end": 136,
                    "text": "2 and,",
                    "ref_id": null
                },
                {
                    "start": 137,
                    "end": 141,
                    "text": "206,",
                    "ref_id": null
                },
                {
                    "start": 142,
                    "end": 146,
                    "text": "207,",
                    "ref_id": null
                },
                {
                    "start": 147,
                    "end": 151,
                    "text": "209,",
                    "ref_id": null
                },
                {
                    "start": 152,
                    "end": 163,
                    "text": "210 RalGDS,",
                    "ref_id": null
                },
                {
                    "start": 164,
                    "end": 177,
                    "text": "63:144 RAMIG,",
                    "ref_id": null
                },
                {
                    "start": 178,
                    "end": 197,
                    "text": "see Immunoglobulin,",
                    "ref_id": null
                },
                {
                    "start": 198,
                    "end": 212,
                    "text": "rabbit RANTES,",
                    "ref_id": null
                },
                {
                    "start": 213,
                    "end": 220,
                    "text": "62:285;",
                    "ref_id": null
                },
                {
                    "start": 221,
                    "end": 227,
                    "text": "64:154",
                    "ref_id": null
                },
                {
                    "start": 274,
                    "end": 282,
                    "text": "HIV and,",
                    "ref_id": null
                },
                {
                    "start": 283,
                    "end": 320,
                    "text": "65:282 effect on eosinophil survival,",
                    "ref_id": null
                },
                {
                    "start": 321,
                    "end": 321,
                    "text": "",
                    "ref_id": null
                },
                {
                    "start": 322,
                    "end": 331,
                    "text": "SCID and,",
                    "ref_id": null
                },
                {
                    "start": 332,
                    "end": 337,
                    "text": "[392]",
                    "ref_id": null
                },
                {
                    "start": 338,
                    "end": 343,
                    "text": "[393]",
                    "ref_id": null
                },
                {
                    "start": 344,
                    "end": 348,
                    "text": "398,",
                    "ref_id": null
                },
                {
                    "start": 349,
                    "end": 353,
                    "text": "400,",
                    "ref_id": null
                },
                {
                    "start": 354,
                    "end": 366,
                    "text": "and seeding,",
                    "ref_id": null
                },
                {
                    "start": 367,
                    "end": 433,
                    "text": "48:169; 52:172-173: 615, 22, 24, 25-26; 62:81, 86, 139; 63:303-304",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}